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In the tuberculosis patients, Mycobacterium tuberculosis can stimulate production of 
hydrogen peroxide in the host as a result of immune response. The H2O2 accumulate 
in pulmonary cells, causing oxidative stress that could lead to the cancer. We select 
TB patients for this study which investigates the effects of quercetin as there is an 
increased incidence of latent TB among the migrant population in the past few years 
and TB can increase the risk of cancer.  
Sperm and lymphocytes were treated with DNA damage inducers and quercetin 
(10µM, 25µM and 100µM), the responses evaluated using the Comet and 
micronucleus techniques. The gene expressions of COX1, COX2, P53 and Bcl-2 and 
catalase protein expression were investigated using the qPCR and Western blot 
techniques. 
The results showed that a substantial reduction of DNA damage in lymphocytes from 
TB patients and sperm from healthy donors from * P ≤ 0.0283 to *** P≤0.001in the 
Comet assay. In the MNi assay, the effect of quercetin in lymphocytes was more 
significant in reduce DNA damage, whereas the DNA damage induced by a food 
mutagen was significant, from *p 0.0405 to ***p 0.001. The qPCR showed 
significance down-regulation of COX1 and Bcl-2 gene expression, rated between *p 
ii 
 
0.045 and **p 0.0074. However, the catalase protein was up-regulated by the nano 
form of quercetin when using lymphocytes from TB patients and showed significant 
changes at *p 0.0236. 
 In conclusion, the nano form was found to be more efficient at the reduction of DNA 
damage in the Comet and micronucleus assays. Also, it down-regulated COX1 and 
Bcl-2 and up-regulated the catalase proteins indicating a possible role for quercetin, 
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Biomarkers can be defined as characteristics that are calculated and estimated 
accurately as a mark of a normal biological process (Strimbu and Tavel, 2010). 
Biological characteristics deal with a broad subcategory of medical symptoms; that 
is, impartial marks of a medical state observed from outside the patient’s body, which 
can be calculated correctly and reproducibly in genetics (Ochekpe et al., 2009). 
Genotoxicity represents the characteristics of a chemical or physical material that 
damages the DNA within a cell, which could cause mutations that can potentially 
progress to cancer; however, genotoxicity is often confused with cell mutagenicity. 
Somatic or germ cells of the organism can be affected by permanent heritable 
changes, which can be passed on to new generations (Nagarathna et al., 2013). 
Cellular metabolism process can stop chemically-induced mutations by either 
apoptosis or DNA repair; however, this system may not always function normally, 
leading to mutagenesis (Brendler-Schwaab, 2005). Interestingly, some current drug 
improvement efforts are focusing on DNA repair as a way to monitor malignancy. 
More specifically, nanotechnology has generated a new dynamic in the 
pharmaceutical and medical sciences due to its ability to improve many intrinsic 
properties of materials at the nano-scale (Chen et al., 2009). This type of technology 
extends the field of pharmaceutical preparations presently used in cancer treatment 
as their properties might be improved by a decreased particle size. Promising results 
have already been obtained in our laboratory using aspirin and ibuprofen 
nanoparticles (NPs) when compared to bulk substance in cancer prevention and 
treatment, which is the primary focus of the present research on these NPs for the 
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Treatment of various diseases. 
1.1 Genotoxicity  
Eastmond et al. (2009) explained that genotoxicity is related to damage or changes 
in genetic material and structure that may be connected with mutagenicity in some 
cases. This includes gene mutations, such as insertions, deletions, and point 
mutations, as well as DNA strand breaks. These breaks lead to chromosomal 
structural changes, which is also referred to as a clastogenic effect, and the 
induction of a DNA enzyme that is responsible for the formation of DNA adducts by 
chemical or physical substances with genotoxic properties, they can cause genetic 
and substitutions that lead to additional mutations and increase the risk of 
inflammation, congenital defects, and cancer. Therefore, genetic toxicology has 
become a crucial component of laboratory research related to drugs and other 
compounds to examine the impact of chemicals, and physical agents. 
1.2 Lymphocytes 
Lymphocytes are a type of white blood cell that originates from stem cells in the bone 
marrow. Lymphocytes are cells of the immune system, living in lymph nodes, also 
can be present in the blood stream and body organs. There are three types of 
lymphocytes B cells, T cells and natural killer cells (Verywell Health, 2018). 
Lymphocytes can be used to study the effects of genotoxic compounds because 
lymphocytes may reflect cancer cells and other disease states (Anderson, 2014; 
Najafzadeh et al., 2012). Henderson et al. (1998) explained that lymphocytes should 
be examined for viability 30 minutes after a treatment to avoid cytotoxic effects of 
chemical compounds. Viability should be above 75% using the trypan blue stain test, 
which is very useful for unknown chemicals to avoid false positive results in the 
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Comet assay. In 2000, the World Health Organization suggested that viability 
changes, and 50% viable cells measured via trypan blue are considered viable 
(World Health Organization, 2000). However, 75% was preferred and confirmed as a 
cut-off point to avoid false positives (Henderson et al., 1998). The fact that even 
untreated lymphocytes can display 0–10% DNA in the tail (Collins, 2004), and sperm 
can exhibit up to 20% DNA in the tail (McKelvey-Martin et al., 1997) should also be 
taken into consideration during interpretation of results. 
1.3  Respiratory disease 
The present study focuses on tuberculosis, which is one from respiratory diseases 
that including lung cancer, chronic pulmonary obstructive disease (COPD) and 
asthma, which are common diseases that threaten human health. Our laboratory 
studies biomarkers of genotoxic and reprotoxic effects after chemical exposure. We 
use human lymphocytes, whole blood, and sperm samples from healthy and 
disease-state individuals. In this study, we are examining cells from TB patients. 
Since asthma, chronic obstructive pulmonary disease (COPD) and lung cancer have 
already been examined to some extent, we decided to investigate tuberculosis 
patients, with DNA damage induced in lymphocytes by genotoxic substances such 
as, hydrogen peroxide or food mutagens and treated with nano and bulk forms of 
quercetin. Since many disease states involve oxygen radical damage, we used 
quercetin, a flavonoid, which is known to reduce free radicals. Tuberculosis is an 
infectious disease, but humans can control it by avoiding direct contact with TB 
patients and changing their lifestyle, engaging in regular exercise, avoiding smoking, 
and maintaining a healthy diet. Fruits and vegetables have been found to play a 
protective role by inhibiting inflammatory diseases and cancer transformation (Van 
4 
 
Duyn and Pivonka, 2000). Moreover, many people with chronic respiratory disease 
and tuberculosis are at risk of developing lung cancer (Yu et al., 2011).  
Tuberculosis (TB)  
TB is an infectious disease caused by bacilli bacteria named Mycobacterium 
tuberculosis and is known to have existed for more than 17,000 years. It spreads 
during contact with infected patients, especially after sneezing or coughing. 
Moreover, TB has been categorised as one of the ten most infectious diseases and 
is a major cause of death globally (Sandhu, 2011). About 9.6 million people were 
diagnosed with TB in 2014: 3.2 million women, 5.4 million men, and 1.0 million 
children. Additionally, HIV-positive patients comprised 12% of the total TB patient 
population in 2014 (WHO, 2014). Approximately 1.4 million people die due to TB 
infection annually (Petti, 2016; Zumla et al., 2015). The most important organ of the 
human body affected by TB is the lungs, but the bacteria can also infiltrate other 
areas of the body, such as the nervous system and bones. TB is more deadly in 
elderly and HIV-positive patients. Generally, TB patients have symptoms such as 
chest pain, weight loss, cough, and difficulty breathing, and these patients more 
likely to transmit the disease (World Health Organization, 2014). Although TB is 
present in nearly every country, Cayla and Orcau have reported that London is the 




Figure 1: Symptoms and sings of TB in human body (Image.slidesharecdn.com, 2019). 
 
1.3.1.1 Tuberculosis and DNA damage   
Lung cancer (LC), Chronic Obstructive Pulmonary Diseases (COPD) and 
Tuberculosis (TB) have been studied to evaluate DNA damage and the frequency of 
cellular abnormalities in LC, COPD, and TB, patients by comparing them to healthy 
Individuals. Results showed that The COPD group had a high percentage of 
apoptotic cells compared to TB and LC group, whereas the TB group presented a 
higher incidence of DNA damage, apoptotic and necrotic cells. Patients with Lung 
cancer had a lower frequency of chromosomal abnormalities than COPD and TB 
patients (da Silva et al., 2015). Increased oxidative stress in the lung tissue of elderly 
people leads to an escalation in the activity of free radicals, which damages the DNA 
of pulmonary and blood cells (Valavanidis et al., 2013). The interactive influence of 
6 
 
breathable molecules leads to oxidative stress. These molecules have a high 
carcinogenic potential and can lead to the increased production of pulmonary 
inflammatory mediators, which are thought to cause oxidative damage to all cellular 
components (e.g., DNA, proteins, and membrane lipids) (Valavanidis et al., 2013). 
The chemical and physical properties of molecules, including their size and shape, 
as well as stable free radicals and transitional metal content play a major role in 
oxidative stress damage. Oxidative stress starts the synthesis of mediators of 
pulmonary inflammation in lung tissues and stimulates carcinogenic mechanisms 
(Valavanidis et al., 2013). It has been stated that the progression to cancer from 
pulmonary disease is connected with a different biological pathway of DNA oxidative 
damage, macrophage activation, and gene expression modifications that stimulate 
transcription factors and play a significant role in carcinogenesis (Valavanidis et al., 
2013). Conversely, some types of bacteria, like Mycobacterium tuberculosis, 
producing free radicals (H2O2) in the host as a result of numerous defence 
mechanisms (Ng et al., 2004). DNA repair has been examined as a significant 
mechanism for the survival of Mycobacterium tuberculosis in the host (Kurthkoti and 
Varshney, 2012). Mycobacterium tuberculosis-inducible DNA repair genes which are 
arranged via LexA (Protein) homologs, which depend on RecA (Protein).  Studies 
have examined RecA’s involvement in two major pathways, which are the promoters 
of gene expression following the DNA damage present in Mycobacterium 






1.3.1.2 Mechanism of DNA damage in Tuberculosis 
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1.4  Genes related to study 
 
1.4.1  Cyclooxygenase enzyme (COX) 
Cyclooxygenase (COX) is the principal enzyme in the biosynthetic pathway of 
prostaglandins. The enzyme changes free arachidonic acid originating from 
membrane phospholipids using phospholipase A2 to produce prostaglandin H2 and, 
finally, prostaglandins and thromboxane. There are two isoforms of COX, which are 
COX1 and COX2 (Gao et al., 2014). COX1 can be found in any site of inflammation; 
it has the ability to maintain tissue homeostasis and regulates angiogenesis. Both 
COXs are responsible for prostaglandin synthesis and use a similar pathway. Nagao 
et al. (2013) reported that COX1 and COX2 are encoded by different genes found on 
separate chromosomes, and their expression pattern is completely different. COX1 
is substantially expressed in general tissues and is responsible for the synthesis of 
prostaglandins involved in various housekeeping functions, such as in the 
gastrointestinal tract and the regulation of renal and platelet functions. COX2 can be 
immediately activated by an inflammatory stimulus and produces a large number of 
pro-inflammatory cytokines and mitogens that increase the amount of prostaglandins 
and affect cell proliferation, angiogenesis, and apoptosis, which finally lead to 
malignant transformations (Kuroda and Yamashita, 2002). Furthermore, a study has 
illustrated that genetic polymorphisms of both COXs are associated with developing 
cancer and affecting drug efficacy (Nagao et al., 2013). Different studies have 
examined links between changes in COX1 and COX2 gene expression and the 
effect of nonsteroidal anti-inflammatory drug (NSAID) intake on cancer risk; they 
have reported conflicting results but confirmed that the COXs’ expression depends 
on the tumour’s aggressiveness and size, as well as lymph node enlargement 
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(Nagao et al., 2013; Gao et al., 2014). Decreased COX-2 expression could inhibit the 
proliferation of cancer cell lines in vitro (Davis et al., 2012). Yu et al. (2010) noted 
that genetic polymorphisms of COX-2 change its expression and affect the carrier’s 
susceptibility to different carcinomas.  
1.4.2  Tumour protein p53 (Tp53) 
TP53 is classified as a tumour suppressor and considered ‘the protector of the 
genome’ because it is responsible for many cellular pathways, such as cell cycle 
arrest, apoptosis, and DNA repair (Kim et al., 2015). The importance of p53 in cancer 
inhibition is evident; however, the results have been controversial as it is inactive in 
about 50% of the total malignancy (Bieging et al., 2014). Our understanding of p53’s 
role in vivo is clear in the elderly.  In a modified mouse, a shortened form of p53 that 
enhances wild-type p53 activity improved resistance to spontaneous malignant 
transformation. Wilson et al. (2010) demonstrated that p53 expression is reduced in 
neural progenitor cells and mesenchymal stem cells and related to age and p53’s 
effectiveness is reduced when age is increased at the organismal level (Feng et al., 
2007). The results generally indicate that the loss or reduction of p53 expression, 
particularly in the elderly, leads to the development of cancer (Kim et al., 2015). 
Furthermore, one of p53’s most important functions is its ability to trigger apoptosis, 
and quercetin can induce apoptosis in cancer cells through the upregulation of Bax 
and Bak and the downregulation of Bcl-2 (Gibellini et al., 2010).  
1.4.3 B-cell lymphoma 2 (Bcl-2) 
The Bcl-2 protein is from the Bcl-2 family that regulates programmed cell death 
(apoptosis) and can be referred to as B-cell leukaemia/lymphoma 2 protein 
(Papadopoulos, 2006). This protein helps control whether a cell lives or dies by 
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blocking a pattern of apoptosis. The gene for Bcl-2 is located on chromosome 18, 
and the translocation of the Bcl-2 gene to various chromosomes is determined in 
different types of leukaemia and lymphomas (Youle and Strasser, 2008). Bcl-2 can 
monitor apoptosis by controlling mitochondrial external membrane permeability, 
which is the key point in the apoptosis pathway (Papadopoulos, 2006). Furthermore, 
quercetin is considered a generator of apoptosis in cancer and inflammatory cells by 
triggering apoptosis through the mitochondria pathway; the quercetin can release the 
cytochrome c from mitochondria to cytosol that activates two types of caspases, 
caspase -3 and caspase-7 which guide cells to apoptosis. Quercetin adjusts anti-
apoptotic and pro-apoptotic proteins. Specifically, quercetin promotes the 
upregulation of Bak and Bax and downregulation of Bcl-xL and Bcl-2. Once the bcl-2 
is downregulated apoptosis may have increased therefore detecting the 
multimerization of Bax to the membrane of mitochondria. These steps are then 
joined by the division of procaspase 9 and poly (ADP-ribose) polymerase (PARP) 
(Gibellini et al., 2010). 
1.4.4 Catalase  
Catalase was unknown until 1818 when Louis Jacques, who identified hydrogen 
peroxide, suspected its breakdown is due to a foreign material. Oscar 
Loew (1900) was the first scientist to use the name catalase. In 1937, catalase from 
cow liver was isolated is a crystallised form by James B. Sumner and Alexander 
Dounce, and the molecular weight of catalase was detected in 1938 (Sumner and 
Gralen, 1938). In 1969, the amino acid structure of bovine catalase was determined 
(Schroeder et al., 1969). Lastly in 1981, the protein’s three-dimensional structure 
was discovered.  
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The human catalase gene is positioned on the small arm of chromosome 11 and has 
all the properties of a housekeeping gene. Also, catalase is displayed in all human / 
animal body tissues, especially in the liver, kidney, and red blood cells. Cancer cells 
usually produce high levels of ROS, which could be due to defects in mitochondria 
functions and reduced antioxidant enzyme production, such as catalase. Low levels 
of catalase have been observed in different genetic diseases, for example, non-
small-cell lung cancer, allele loss, chromosome 11p deletion, mental retardation, and 
Wilms tumours (Glorieux et al., 2015). Habas et al. (2018) studied DNA damage 
using Comet and micronucleus assays in peripheral blood lymphocytes collected 
from chronic pulmonary obstructive disease (COPD) patients and compared the 
results with lymphocytes collected from healthy individuals. The lymphocytes were 
treated with nanoparticle (NP) and bulk forms of the flavonoid quercetin. mRNA and 
protein expression levels of catalase have also been investigated using qPCR and 
Western blot techniques. Furthermore, changes in oxidant-antioxidant inequality of 
the catalase gene have been examined in connection with the accumulation of 
oxidative stress in peripheral lymphocytes collected from patients with COPD. The 
results showed that lymphocytes where DNA damage was induced by 140 μM IQ 
and treated with 10, 25 μM quercetin bulk and nano forms for 30 mins. The 
significant decreases in DNA damage (***p≤0.001) was shown using the Comet and 
micronucleus assays. Also, Habas and colleagues studied the regulation of the 
catalase enzyme activity by IQ at the protein or gene expression levels using the 
Western blot and qPCR techniques; they found that the quercetin nano form was 
more effective in terms of reducing catalase protein and relative catalase mRNA 




1.5  Spermatogenesis 
Hess (2005) showed that sperm production is the process that produces male 
haploid germ cells from stem cells called diploid spermatogonia, which is shown in 
Figure 3. The procedures have been simplified morphologically through recognising 
associated cellular steps and phases of spermatogenesis that are vital for 
continuous sperm production; this development can be dependent on several 
factors, including joining paracrine and autocrine (from Sertoli and germ cells) and 
endocrine function (e.g., androgens, retinoic acids) (Hess and Franca, 2005).  
Spermatogenesis can be described as the production of haploid spermatozoa from 
diploid spermatogonial (primordial) male germ cells via both mitotic and meiotic cell 
division. The main cells in these stages are called spermatogonia, which produce 
spermatocytes by mitosis. These processes are controlled by hormones and cell to 
cell reaction (germ –and Sertoli cells) to produce final sperm. Three stages of 
spermatogenesis occur in the mammalian cells in the testes (seminiferous tubules), 
which require about 12 weeks to complete in humans. Spermatogenesis begins with 
a proliferation stage during which primordial cells undergo multiple mitotic divisions 
that produce stem cells of spermatogenesis (gonocytes). Once the differentiation of 
gonocytes is complete, spermatogonia are created. Next, spermatogonia 
proliferation occurs through several mitotic cell divisions. Some spermatogonia cells 
can differentiate to produce primary spermatocytes, while other cells continue 
proliferating. After primary spermatocytes divide in the meiosis stage, secondary 
spermatocytes are shaped and divide into haploid spermatids, which develop into 
mature spermatozoa (Marchetti and Wyrobek, 2005). The spermatogenesis process 
takes approximately 74 days. However, studies of healthy men have indicated that 
the total time required to produce sperm is 42–76 days. The expected daily sperm 
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production per human male fluctuates between 150–275 million spermatozoa (Neto 
et al., 2016). During this time, some factors, such as nutrition and hormones, can 
cause DNA damage in sperm (Appasamy et al., 2007). Other factors can influence 
spermatogenesis, for example, alcohol consumption, some drugs used to treat 
chronic diseases, an inadequate diet, and oxidative stress (McKay et al., 2015). The 









1.6 Chemicals used in this study 
1.6.1  Quercetin 
 Reactive oxygen species (ROS) can be formed in living cells due to low antioxidant 
capacity or an escalation of oxidative stress. Excessive oxidative stress has been 
shown to be responsible for DNA damage in cellular macromolecules, including 
proteins and lipids (Nordberg and Arner, 2001; Valko et al., 2007). The creation of 
ROS can produce single and or double strand breaks in the DNA and causes a 
change in the chemical structure by substituting pyrimidine bases, 2′-deoxyribose, 
and purine (Hazra et al., 2007). Bjelland and Seeberg (2003) reported that DNA 
damage from oxidative stress is a vital promoter of cancer transformation, especially 
in the elderly. Base excision repair (BER) can modify this type of DNA damage, and 
specific types of oxidative lesions can be adjusted by mismatched repair (MMR) and 
nucleotide excision repair (NER) (Dusinska et al., 2006; Svilar et al., 2011). Fruits 
and vegetables are known to have antioxidant properties, which have a significant 
impact on inhibiting DNA damage and malignant transformation. One of the most 
common compounds in fruits and vegetables are flavonoids, which have been widely 
studied; there is a strong indication that they work as antioxidant compounds or pro-
antioxidants depending on their ability to react with food mutagens and their 
concentrations to reduce DNA damage (Duthie et al., 1996; Anderson et al., 1998). 
Flavonoids can be obtained in significant amounts from the daily diet and offer anti-
inflammatory and anti-oxidant benefits (Serafini et al., 2010). Flavonoids like 
quercetin (Q) can be obtained from the rinds and bark of several types of fruits and 
plants, and the consumption of apple skins, onion bulbs, and the dry outer skin of 
onions is highly recommended (Hard et al., 2007). The evaluated average dietary 
consumption of quercetin is mainly as glycoside at 0.1–0.2 mg/Kg. It has been 
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shown that quercetin is carcinogenic in male rats at very high concentrations; it 
induces renal adenomas after feeding at 2000mg/Kg for 6 months to 2 years (Hard 
et al., 2007). In combination with hydrogen peroxide the quercetin decreases the 
DNA damage level (Gschwendt et al., 1983). Quercetin is known by several 
chemical names, including CAS 117-39-5, sophortin, meletin, xanthaurine, and 
quercetol; its molecular formula is C15H10O7, and its molecular weight is 
302.2357g/mol. 
 
Figure 4: Quercetin chemical structure (McKay et al., 2015). 
 
Sources of flavonoids vary between countries. In South Europe, red wine is the best 
source, while in China green tea is the most common source of flavonoid; however, 
in the United States, apple, onion, and fermented food, is the main source of 
flavonoid compounds. In 2007 it was reported that the human body needs 5-40 mg 
of quercetin/day (Wach et al., 2007, Russo et al., 2012). Another type of flavonoid 
such as rutin which has a high ability to reduce blood pressure due to decreases in 
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the permeability of blood vessels and scavenging free radicals, these flavonoids are 
widely used in different countries (Li et al., 2001). 
1.6.1.1  Quercetin mechanism  
 
 
Figure 5: Mechanism of quercetin in reducing DNA damage (Shalini Kapoor et al., 2015). 
 
Localised levels of oxidative stress are due to dissimilarity of the two anions 
(superoxide) from oxygen and H2O2, while quinones and semiquinones can also 
damage DNA directly (Bolton, 2002). Consequently, the production of free radicals at 
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high levels may cause DNA damage in a pro-oxidative state, resulting in 
chromosomal instability (Gibellini et al., 2010). However, quercetin has a strong 
effect in scavenging free radicals by inhibiting lipid peroxidation (Bentz, 2009). 
Following that the oxidation of free radicals which are catalyzed by molecular oxygen 
to produce lipid peroxy radicals, the continuum in the reaction induced by additional 
hydrogen from unsaturated fatty acid to produce more free radicals where the metal 
ions catalyzed the processes (Bentz, 2009). The toxic features of lipid peroxidation 
can cause cardiovascular disease and malignant transformation, but antioxidants, 
such as quercetin and myricetin can block the reaction by scavenging free radicals 
(Bentz, 2009). Studies have confirmed that quercetin has the ability to stop low 
density lipoprotein (LDL) oxidation, which is responsible for cardiovascular diseases 
and arteriosclerosis (Hollman et al., 1999). It has been shown that oxidative stress 
causes the accumulation of amyloid beta-peptide in brain membrane lipids, which 
leads to Alzheimer’s disease; thus, the regular intake of antioxidants can prevent 
amyloid synthesis (Ansari et al., 2009). In this case, quercetin can increase the 
amount of glutathione (GSH), which has a significant role in the neuron defines. 
Furthermore, GSH can prevent the formation of H2O2 by separating H2O2 into H2 and 
O2 and stop free radical production (Balazs and Leon, 1994). Quercetin can also 
regulate the development of inflammation because it stops free radical production 
and transcription factors that are responsible for generation of pro-inflammatory 
cytokines, which are formed in patients with chronic inflammatory diseases (Boots et 
al., 2008). Environmental factors can also increase the production free radicals, such 
as smoking, and it has been found that flavones, which are the principle structure of 
quercetin, can protect erythrocyte membrane that is damaged by smoking (Begum 
and Terao, 2002). As indicated previously, quercetin induces apoptosis via ROS 
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generation and through the subsequent activation of the ROS/ AMPKα1 and AMPK 
α1/COX2 signalling pathways (Lee et al., 2008). COX1 can be present in any site of 
inflammation (Kuroda and Yamashita, 2002). Quercetin activates apoptosis by 
balancing pro-apoptotic and anti-apoptotic proteins and upregulates Bax and Bak, 
but it downregulates Bcl-2. Hence, it was decided to study the gene expression of 
COX1, COX2, Bcl-2, and p53. 
1.6.2 Hydrogen peroxide (H2O2) 
Hydrogen peroxide is a chemical compound with the formula H2O2, which mean two 
hydrogens and two oxygen molecules are connected together This compound has 
an oxygen-oxygen single bond and can be used as an oxidiser, and in high 
concentrations, it leads to formation of reactive oxygen species (Chapurkin, 2016).   
   
Figure 6: Chemical structure of hydrogen peroxide (Chapurkin, 2016). 
Hydrogen peroxide is commonly used as a DNA damage inducing agent at 50µM on 
human lymphocytes and caused significant DNA damage detected by the comet 
assay (Anderson et al., 1994). The most important oxygen-containing free radicals in 
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several disease conditions are H2O2 and superoxide anion radical, but the level of 
free radicals and other reactive oxygen species in the human body can be controlled 
by antioxidant compounds like quercetin (Lushchak, 2015). Sierens et al. (2002) 
reported that H2O2 was used to induce sperm DNA damage after pre-treatment with 
antioxidants; they used a Comet assay to evaluate DNA damage and found 
significant protection against DNA damage at 100µM. 
  
1.6.3 Bleomycin 
Bleomycin (BLM) is a natural glycopeptide anti-cancer drug synthesised from Gram 
positive bacteria called Streptomyces verticillu. Bleomycin was discovered in 1976 by 
Umezawa in Japan. The drug has a unique composition and method of action 
amongst chemotherapy treatments (Sikic et al., 1985). It can be used to treat 
different types of cancer, such as Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, 
ovarian cancer, cervical cancer, and testicular cancer. Chen et al. (2008) 
demonstrated that the drug has anticancer properties because it has the ability to 
alleviate DNA damage with participation factors such as Fe (II), O2, and a one-
electron reduction. Many hypotheses have been proposed to explain BLM’s 
mechanism of action, and one study demonstrated that it has the ability to stop the 
combination of thymidine into DNA (Murray et al., 2018). Moreover, BLM can 
produce metal-bleomycin when it reacts with metal ions, which then combine with O2 
to produce free radicals (i.e., hydroxide and superoxide), which lead to single and 
double strand breaks (SSB, DSB). Another study suggested that BLM may affect 
certain locations on the DNA strand and persuade cleavage by reducing the 
hydrogen atom from the nitrogen base, which leads to strand breakage (Chen et al., 
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2008; Huls and ten Bokkel Huinink, 2003). BLM can connect to DNA at specific 
locations and operates as a mini enzyme after creating a compound from O2 and 
iron that forms free radicals that are responsible for DNA strand breakage (Sikic et 
al., 1985). Other studies have reported that chromosomal breaks increased 
significantly during the treatment period when BLM was used as an anti-cancer 
agent (Hu et al., 2013). 
 
1.6.4 Food mutagens 
There is substantial evidence that dietary factors contribute to cancer risk in humans; 
approximately 30–40% of cancers are thought to be influenced by dietary 
substances (Doll and Peto, 1981; Popkin, 2007). Epidemiological studies have 
provided most of the evidence regarding diet and cancer development (Wasson et 
al., 2008). In 1970, Sugimura and others worked on the heterocyclic amines (HCAs) 
and showed that pyrolysates of amino acids of foods contained high proteins 
(Knasmuller et al., 1999). Researchers published several studies to clarify how these 
compounds negatively impacted human health. Heterocyclic amines 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-
f]quinoline (IQ) are both carcinogens that cause DNA damage (Overvik and 
Gustafsson, 1990; Sugimura, 1997). 
 
1.6.4.1  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)  
 PhIP is one of the most significant heterocyclic amines formed when meat is 
cooked. This compound (see Figure 7) is considered carcinogenic and could be 




Figure 7: https://www.researchgate.net/figure/Fig-4-Structures-of-PhIP [accessed 8 Oct 2019] 
The generation of PhIP is a result of a complex reaction in the presence of 
monosaccharides, which play a role in the Maillard reaction (Skog, 1993). Another 
PhIP source is smoking tobacco (Ushiyama et al., 1991). Peluso et al. (1991) 
demonstrated that DNA adducts related to PhIP could be isolated from smokers’ 
urine. PhIP stimulates the development of lymphomas, colon cancer, and breast 
cancer in rats (Ito et al., 1997), although cells have a defense mechanism against 
PhIP with compounds that eliminates toxicity and repair DNA damage. The actions 
of phase II enzymes, such as UDP-glucuronosyltransferase (UGT), are specific to 
removing PhIP toxicity through the production of easily absorbed compounds, such 
as N-OH-PhIP-N2-glucuronide (Bromberg, 2000; Groner and Gouilleux, 1995). The 
effect of PhIP genotoxicity leads to mutations, including DNA damage and 
chromosome aberration, and increases sister chromatid exchange (Otsuka et al., 
1996; Wu et al., 1997). Unsuccessful DNA repair processes could develop to cancer, 
especially once damage occurs in tumour suppressor genes and proto-oncogenes 
(Aboyade-Cole et al., 2008)  
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1.6.4.2    2-Amino-3methyylimidazo [4, 5-f] quinolone (IQ) 
The heterocyclic amine IQ was discovered in 1980. IQ can be formed by cooking 
proteinaceous food (Felton and Knize, 1991). The daily intake of heterocyclic amines 
can reach 50 µg or 70 ng/g of meat (Knizeetal., 1995; Kruletal., 2000). 
 
IQ  
Figure 8: Chemical structure of IQ 2-Amino-3 methylimidazo [4, 5-f] quinoline (Han et al., 2008). 
 
Endo et al (1994) studied the effect of PhIP and IQ food mutagen on fibroblasts 
isolated from the human body, The dominant mutation originated with IQ and PhIP 
was G:C to T:A trans version, then G:C to A:T conversion, also G:C to C:G trans 
version (Endo et al., 1994). Moreover, IQ caused mutations in the Ki-ras or p53 
gene; this genetic alteration has been identified in colon carcinogenesis (Huang et 
al., 1996; Kakiuchi et al., 1995). IQ was observed in cigarette smoke at 0.26 ng per 
cigarette (Yamashita et al., 1986). It has been reported that IQ promotes colon 
tumours in rats and liver tumours in monkeys via base substitution. IQ was expected 
to cause base deletions, but the effects were not acute, site-specific, or unique 
(Kakiuchi et al., 1995). However, in combination with food mutagens, flavonoids 
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have produced antigenotoxic effects since DNA damage was reduced in 
lymphocytes and sperm when analysed using a comet assay (Anderson et al., 
1998). 
1.7  Nanotechnology 
Nanotechnology is the manufacturing, characterisation, and use of materials at a 
measure of one-billionth of a metre (10-9). Materials at these measurements have 
been used in several aspects of computer, medical, and engineering sciences. The 
effectiveness of NPs depends on their ability to remove the size-related barriers of a 
substance. When a substance is decreased to the nano size, it displays new 
characteristics, such as changes in their biological and physicochemical properties, 
compared to bulky substances (Ochekpe et al., 2009). Researchers have been able 
to understand these particles and assess advantages of their valuable 
characteristics at this scale (Chan, 2006). When materials change from their bulk 
form to a NP form, their solubility and surface area increase, as well as their 
immunogenicity and drug delivery properties, due to improved contact between the 
NP and the surrounding materials, which develop reactivity (Zhang et al., 2008). The 
boundless capabilities generated by nanotechnology have spurred significant 
interest in various fields, including power generation, electronics, and medicine, 
resulting in speedy modifications and creating new fields of study (Zhang et al., 
2007). Whereas the effects of nanomedicine are endless, with the opportunity of 
modifying the diagnosis, imaging, and treatment of a disease, the toxicity of these 
particles has not been sufficiently examined in expressions of the increased risk rate 
of these particles and environmental effects. NPs can be swallowed, injected, 
inhaled, and absorbed through the skin. As such, the increased use of NPs in 
25 
 
manufacturing and industrial settings leads to an increase in the exposure rate. 
Therefore, risks and effects of NPs on human cells need further study (Oberdörster 
et al., 2005). An understanding of the genotoxic effect of special NPs on living cells 
and the mechanisms of this toxicity is significant when reducing a bulk compound to 
the nano-scale. 
 
1.7.1  Nanoparticle applications  
1.7.1.1  Nanoparticle applications in medicine 
Nanotechnology has contributed significantly to the development of cancer treatment 
drugs due to the particles’ ability to pass through typically resistant barriers, for 
example, the blood–brain barrier and tumour vesicles. The expansion of the surface 
area of the particles improves solubility with a high level of dissolution, which leads 
to increased bioavailability and enhanced therapeutic action (Chan, 2006). Damm et 
al. (2008) stated that the antimicrobial effectiveness of silver NPs was more effective 
than that of bulk-sized silver. The quantity of silver ions discharged from NPs was 
assessed and found to be more than some bulk particles, which is related to the 
large surface area of NPs. For this reason, silver nanoparticles are active in wound 
and infection treatment (Damm et al., 2008). Recently, nanoparticles have been 
used in gene treatments, biochemical imaging, drug delivery, protein detection, and 
tissue engineering. The change to the NP form allows the particles to act as a 
platform for the accumulation of several functions and constructions that can be used 
in drug targeting, recognition, and imaging. The shape and size of NPs can be 
reformed by the chosen drug loading and can affect the cellular intake and protection 
of drugs. Nano technology can deliver drugs more efficiently and effectively than 
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current techniques, and the improved pharmacokinetics increase patient observation 
and drug shelf life. Changing the size is responsible for releasing wavelengths that 
are produced from semiconductor and metallic nanostructures that facilitate 
biomedical imaging (Doane and Burda, 2012; Parveen et al., 2012). The surface 
area of NPs has specific characteristics that make them the best delivery vectors to 
improve the adsorption, concentration, and protection abilities of DNA and RNA (Sun 
et al., 2014).  
1.7.2 Size-dependent toxicity 
Once the size is reduced from the bulk form to the nano form, chemical and physical 
properties are changed such as surface area and immunogenicity were improved. 
For this reason, NPs are more active compared to the bulk form in term of reducing 
DNA damage with an increase in their fundamental characteristics that change their 
biological influences (Chen et al., 2009) Toxicological researchers have confirmed 
the increased toxicity of nanoparticles (<100 nm) compared to bulk form particles of 
the same chemical, raising interest in the effect of nanoparticles on human health. 
Several symptoms, including changes in hair colour, fatigue, loss of appetite, and 
weight have been detected in mice treated with gold NPs 8-37 nm. These symptoms 
were witnessed as a result of damage in the lung, liver, and spleen cells. After 
completing a 21-day course, all the treated mice died. Using genotoxic doses of NP 
forms, 50–100 nm sizes were found to be nontoxic in mice as these doses allow the 
production of an adequate antibody response and regulate the influence of diffusion. 
Toxic levels were observed when the surface genotoxic NPs were modified to 8-37 
nm. The toxicity displayed by the genotoxic NPs was due to their failure to stimulate 
an immunological response, allowing the NPs to diffuse freely into the cells (Chen et 
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al., 2009). Evidence of toxicity was exposed when copper oxide (CuO) NPs were 
used to identify acute and chronic toxicity in Daphnia magna. Copper oxide NPs 
were ten times as toxic as micro particles, with the same result in Vibrio fischeri 
(Rossetto et al., 2014). Furthermore, many signs and symptoms of toxicity, such as 
epithelioid granulomas, necrosis, bronchial inflammation, and intestinal inflammation 
have occurred in mice treated with doses of carbon nanotubes; treating the mice with 
carbon bulk lowered the toxic effect. The effect of the carbon nanotubes was 
approximately the same when compared with a positive control (Lam et al., 2004). In 
conclusion, NPs are not always more toxic than micrometre particles, but the high 
toxicity levels of NPs raise specific concerns. 
1.7.3 NP toxicity 
Conflicting results have been reported in (2013) by Magdolenova et al in terms of 
explaining Nano form genotoxicity, because the mechanisms of toxicity depend on 
the physicochemical characteristics of Nano form that involve, dimensions, structure, 
crystal-like, solvation, external area of Nano form, also possibility of accumulation. In 
recent years, the mechanism of NP toxicity has been studied extensively by 
Magdolenova et al. (2013) and Manke et al. (2013). These researchers found that 
NPs can have direct or indirect effects on living cells, including primary or secondary 
genotoxicity, and the produce inhibition of the cell cycle, apoptosis, inflammation and 
reactive oxygen species (ROS). 
1.7.3.1 Primary genotoxicity of NPs 
Direct primary genotoxicity might operate by different mechanisms, such as the 
action of ROS, generated from reactive particle surfaces, or DNA-adduct formation, 
generated by reactive metabolites of a particle-associated organic compound. When 
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NPs infiltrate in the nucleus, they can interact with DNA replication, transcription, and 
repair. This interaction can be a mechanical interference or chemical binding to DNA 
molecules, which cause DNA instability and structural damage. In the mitosis phase 
of cell division, NPs can create acentric chromosome fragments or chromosomes 
alteration and inhibit the progress of mitosis (Magdolenova et al., 2013). Li et al. 
(2013) concluded that the association between NPs with a high binding to DNA and 
the strong inhibition of DNA replication, whereas NPs with less affinity had minimal 
or no effects on DNA replication. It has also been observed that hematite NPs can 
bind to DNA and modify its structure, and zinc and silver oxide (ZnO) NPs can affect 
the DNA form the effect can produce a specific protein, which is necessary for 
transformation, transcription, or mending, which are unable to penetrate the genetic 
material bound locations because the nano form controls the locations straight or by 
changing the structure of the DNA by alternate location relationships (Magdolenova 
et al., 2013).  
1.7.3.2 Secondary genotoxicity 
Genotoxicity produced by NPs does not require the NPs to be in continued direct 
contact with DNA; toxicity can be produced indirectly. Indirect primary genotoxicity 
can arise during many different mechanisms, such as interaction with nuclear 
proteins, disruption of the cell cycle, ROS generation, and the inhibition of 
antioxidant action (Magdolenova et al., 2013). Schins (2002) noted that secondary 
genotoxicity is related to an NP’s dosage and length of exposure. NPs have been 
shown to produce reactive nitrogen species (RNS) and ROS in phagocytes through 
the beginning of DNA repair mechanisms and inflammation (Schins, 2013). In 
previous research, changes in cytokine levels were a product of an inflammatory 
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reaction in the peripheral blood of mice when treated with titanium dioxide NPs. The 
perused of inflammatory mediators increased phagocyte action to eradicate the NPs 
producing the genotoxicity. Proinflammatory gene transcription factors, such as 
mitogen-activated protein kinases, nuclear factor kappa B, and activator protein-1, 
were stimulated in response to NP treatment (Trouiller et al., 2009; Donaldson et al., 
2012). When silica nanoparticles were used to treat mice and the RAW264.7 cell 
line, tumour necrosis factor (TNF)-α and levels of interleukin (IL)-1β and nitric oxide 
increased. This effect has an association with an amplified mRNA expression of 
inflammatory genes from macrophages with nitric oxide, IL-6, cyclooxygenase-2, and 
TNF-α. Treatment of the RAW264.7 cell line demonstrated ROS generation with a 
low expression of the antioxidant glutathione (GSH). Furthermore, Park and Park 
(2009) found that the generation of ROS contributes significantly to genotoxicity, and 
NPs that produce ROS can trigger the expression of proinflammatory mediators and 
stimulate immune cells. 
1.7.4 Toxic NP-mediated oxidative stress 
Oxidative stress is produced as a normal product of aerobic metabolism and can 
result in damage; oxidative stress is increased in some pathophysiological disorders. 
Antioxidant expression is stimulated via a number of methods. A direct correlation 
between ROS levels and oxidative stress is produced under NP toxicity. 
Furthermore, high levels of ROS generation or reduced levels of cellular antioxidants 
can lead to oxidative stress formation (Manke et al., 2013). NPs’ size and surface 
area are thought to be connected to ROS. Li et al. (2008) reported that stimulated 
ROS formation was connected to the dissolution of NPs, changes to the surface of 
the metal, and the release of metal ions. Akhtar et al. (2012) demonstrated that ROS 
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formation, which can be exogenous or endogenous, is the product of free radicals, 
including hydroxyl radicals and superoxide anions, which damage DNA and other 
cellular structures. ROS has an effect on DNA and may lead to strand breaks or 
oxidised base lesions leading to cell death or mutation (Magdolenova et al., 2013). 
Free radicals cause electron chain dysfunction and membrane damage, which 
induces mitochondrial apoptosis because NPs can stop catalysis and the 
transmission of electrons to molecular oxygen or the electron transport chain of 
mitochondria (Manke et al., 2013). A relationship was found between ROS 
generation and cellular death after the treatment of HepG2 cells with silica NPs. 
Protein and mRNA levels of apoptotic genes p53, Bax, and caspase-3 were raised 
after exposure to silica NPs, and expression of the antioxidant GSH and the anti-
apoptotic gene bcl-2 decreased, causing apoptosis (Ahmad et al.,2012). The 
transformations motivated by silica NPs were weakened, and treatment with the 
vitamin C scavenger ROS and increased cell viability, which shows ROS is 
responsible for medicinal cytotoxicity. Furthermore, there is a relationship between 
the disruption of cellular calcium homeostasis and NP-mediated ROS generation. 
Calcium regulates cellular metabolism, gene expression, and signal transaction; 
consequently, intracellular calcium levels are firmly adjusted, with an increase in 
intracellular calcium leading to metabolic imbalances, cellular dysfunction, and cell 
death. Levels of intracellular calcium increased with ZnO NP treatment, which 
caused cell death. This influence was somewhat inhibited by treatment with the 
antioxidant N-acetylcysteine, and cytotoxicity was completely reduced, which 




1.8  Reactive oxygen species (ROS)  
ROS have received considerable attention in genotoxicology studies. ROS can be 
defined as molecules that can discharge oxygen atoms. Basically, they can be 
present in various concentrations as picomolar or micromolar in natural metabolism 
(Burns et al., 2012). Canonica et al. (2005) explained that hydrogen peroxide, O2, 
OH, OOH, CO3, and environmental systems have the ability to oxidise a range of 
biomolecules. Oxidative stress could cause cancer due to DNA, protein, or 
membrane lipid damage; for this reason, ROS have received significant attention in 
genotoxicology studies (Kumar et al., 2014). Bartosz (2006) reported that photolysis, 
as well as energy and electron transfer reactions, are responsible for ROS 
production. The reduction of oxygen can create free superoxide and hydroxyl 
radicals (Gutteridge, 1994). The activity of certain enzymes, such as xanthine 
oxidase and NADPH oxidase, leads to the production of the superoxide radical (. O-
2). Dohi et al. (2010) demonstrated that superoxide (. O-2) is the original source of 
free oxygen radicals that work as oxidants or reductants (Dohi et al., 2010). High 
reactivity can be caused by the superoxide radical that is created by the organic 
more agents than any (. O-2) produced in interior biological processes where this 
might cause substantial DNA damage (Gutteridge, 1994). The active form of H2O2 
could originate from the enzymatic processes of the superoxide. The combination of 
(. O-2) and H2O2 produce the hydroxyl radical (. OH) (Ben Shaul et al., 2001; 
Sewerynek et al., 1996). The hydroxyl radical is the name of the oxygen radical in 
chemistry; it has a large chance to cause biological damage when it becomes in 
direct interaction with all biological molecules. The hydroxyl radical can easily 
damage pyrimidine, purine bases, and other DNA structures (Gutteridge, 1994). 
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Furthermore, reactive oxygen species can cause very aggressive mitochondrial DNA 


















1.9 Techniques used to measure genotoxicity 
1.9.1 The Comet assay on lymphocyte 
The Comet assay is a reliable and relatively uncomplicated technique used to 
estimate genotoxicity from DNA damage and repair. It was developed by Ostling and 
Johanson in 1984. Two different types of comet assays are used, depending on the 
type of DNA strand breakage. The first one is the neutral comet assay, which 
essentially determines double-strand DNA breakage. The second one is the alkaline 
comet assay, which detects single-strand damage and alkaline labile sites (Collins, 
2004). However, the neutral type limits the potential of the assay. In 1988, Singh et 
al. further developed the Comet assay by using electrophoresis in alkaline conditions 
(pH >13). The alkaline method increases DNA migration and the sensitivity of the 
assay, which is useful in analysing genotoxic materials. Increasing DNA migration 
generates increased levels of partial excision repair single-strand breaks (SSBs) and 
double-strand breaks (DSBs), and as a result, alkaline-labile sites change to SSBs. 
The SSBs are quickly repaired and not measured as a mutagenic lesion; 
consequently, a high number of breaks found via the Comet assay could show high 
levels of damage (Collins, 2004). Treating cells with lesion-specific repair 
endonucleases helps determine the specific repair mechanism. Genotoxicity studies 
using Comet assays have compared the unscheduled DNA synthesis assay and the 
alkaline elution assay. The alkaline elution assay detects low levels of DNA damage, 
and generally a small sample is needed to perform the assay; it is also a sensitive 
technique with uncomplicated procedures, and solutions are easy to prepare (Tice et 




This technique is extremely sensitive in evaluating SSBs, DSBs, and alkaline labile 
sites, but it is incapable of efficiently detecting DNA crosslinks. DNA crosslinks have 
a special ability to stabilise DNA and prevent its migration (Brendler-Schwaab et al., 
2005). DNA crosslinks are important in mutagenesis; therefore, these cases will 
need more investigation in the form of extending the electrophoresis time or treating 
controls and treated samples with added genotoxic materials to compare DNA 
migration with and without the genotoxic effect (Tice et al., 2000). It has been shown 
that the adjusted comet protocol, although it can detect DNA–protein crosslinks, is 
not well suited for estimating DNA–DNA crosslinks and causes of reduced 
genotoxicity (Merk and Speit, 1999). Comet assays are also commonly used in 
molecular epidemiology to determine oxidative stress and carcinogenesis in human 
subjects, but different lifestyles should be accounted for as confounding variables 
when evaluating data as physical exercise and advanced age can induce an 
increase in DNA migration (Hartmann et al., 1994; Collins et al., 1997a’ Anderson et 
al., 1998).  
Comet assay on sperm 
Spermatogenic cells are very sensitive and have a higher mutation rate than somatic 
cells (Walter et al., 1998; Winn et al., 2000). Moreover, Muriel et al. (2004) found that 
sperm chromatin has nine-times more single strand segments, and sperm nuclei 
contain more than double the rate of SSB compared to lymphocytes. Two different 
types of cells are found in the human body, diploid cells, which contain double the 
number of chromosomes, and haploid cells, which include sperm and ova and have 
half the number of chromosomes (World Health Organization, 2000; Walter et al., 
1998). In the current study, the effect of flavonoids, such as quercetin, on both cell 
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types is applicable. In the alkaline sperm comet protocol, two lysis buffers are used: 
lysis 1 containing DL-dithiothreitol and lysis 2 with proteinase k from tritiracchium 
album. Two lysis buffers are freshly prepared and incubated for one hour.  
1.9.2 Micronucleus assay 
Fenech (2007) pointed out that a micronucleus (MN) is a small extra nuclear body 
that can be shaped throughout the anaphase of nuclear division. This small extra 
nuclear body cannot join into one of the daughter nuclei. Scientists first described 
micronuclei in red blood cells and called them Howell–Jolly bodies (Kirsch-Volders et 
al., 2003). The MN assay is classified as a preferred technique for evaluating DNA 
damage because it provides an accurate indication of chromosome mutations and 
breakage that are an expressed as a result of DNA damage, which is a substantial 
incident in carcinogenesis. Fenech (2000) illustrated that the shape of the 
micronucleus can be measured in one divided binucleated cell in humans and other 
mammalian cells by using an inhibitor substance (cytochalasin-B) to block the 
cytokinesis stage. Once cytochalasin B was applied in the MN assay, the name of 
the technique changed to the cytokinesis-block micronucleus assay (CBMN); this 
technique is the preferred method to measure micronuclei because micronucleus 
recurrences are changeable with repeated divisions and cannot be recognised in a 
population of dividing cells (Fenech, 1997). DNA damage, gene amplification, loss of 
chromosomes, inhibition of cell division, excision repair, necrosis, and apoptosis can 
be easily detected efficiently by CBMN (Fenech, 2006; Fenech et al., 2011). The 
CBMN assay can be used to easily recognise and score micronuclei in cells that 
have completed nuclear division. The cells can be used for the recognition of 
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micronuclei, nuclear buds (NBUDs), and nucleoplasmic bridges (NPBs)
 
Figure 9 : The cells scored in the CBMN assay. (a) mononucleated (MonoNC cell); (b) binucleated 
(BiNC) cell; (c) multinucleated (multiNC) cell; (d) early necrotic cell; (e) late apoptotic cell; (f) BN cell 
with one or more MNi; (g) BN with an NPB and a MN; (h) BN cell with NBUDs (Fenech, 2007). 
 
Advantages of the CBMN technique are that it is a relatively quick process and has a 









1.9.3  Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) uses the capability of DNA to create another 
strand opposite of the exhibited template strand. Saiki et al. (1988) indicated that the 
amplification of a few copies or at least a single copy of DNA proceeds through some 
preparations of magnitude. The preparations, which create more than one million 
specific DNA sequences, need a primer that accelerates the DNA sequence by 
adding a nucleotide. The primers are considered the specific fragment of the 
template sequence that the detector is requested to amplify (Saiki et al., 1988). In 
1993, the American biochemist Kary Mullis was awarded a Nobel Prize for 
developing modified PCR in 1984, although Gobind Khorana was the first to describe 
the basic principles of amplifying a part of DNA using primers in 1971 (Joshi and 
Deshpande, 2011).  
The PCR technique is often used in molecular biology and medical research 
because it has many advantages; for example, small samples can be used, 
chemicals and primer are priced reasonably, its procedures and steps are easy and 
understandable, and an unlimited number of copies of any DNA sequence can be 
synthesised. Additionally, the PCR can amplify a small DNA fragment even if the 
fragment of the DNA is of poor quality (Joshi and Deshpande, 2011). This technique 
has several uses in many fields, such as forensic medicine, which is using the PCR 
to confirm the paternity from genetic fingerprints. Moreover, PCR can be used to 
diagnose infectious diseases, such as hepatitis and human immunodeficiency virus, 
as well as Mycobacterium tuberculosis via qualitative PCR. Bartlett and Stirling 
(2003) reported that PCR can be used for DNA cloning, genetic mapping, mutation 
generation, and gene expression. In this study, the PCR technique was used to 
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investigate gene expressions connected with the inflammatory pathway, such as 
COX1 and COX2, as well as p53 and Bcl-2, which are related to apoptosis. Lindahl 
(1993) pointed out that PCR cannot differentiate between a DNA sequence collected 
from a living cell and DNA obtained from a dead cell. 
Another technique, called real-time PCR (RT-PCR), can be used for gene 
expression when only a small sample of DNA, cDNA, or RNA (PCR products) is 
available. The RT-PCR protocol depends on the determination of fluorescence made 
by the cumulative target molecules. This fluorescent target molecule has dyes that 
link to the sequence-specific probes or DNA strands. RT-PCR is commonly used 
because of the accuracy of results and the quickness and sensitivity of the method. 
Another advantage of RT-PCR is its low rate of contamination due to PCR products 
(i.e., cDNA or RNA) (Klein, 2002). Wong and Medrano (2005) reported that 
experiments using RT-PCR require a full understanding of the technique because it 
is a very sensitive procedure. PCR is an effective technique commonly used in 
genotoxicity and gene expression studies.  
1.9.4 Western blots (WB) 
Western blotting (WB) is a powerful technique and the most common method used 
to examine the presence of a specific protein in extracted complex cells. After 1979, 
there was a huge development of protein blotting (Kurien, 2006). WB can be 
described as comprising five main steps: (1) the target proteins are diffused through 
polyacrylamide gel electrophoresis (SDS-gel); (2) the proteins are transferred and 
repositioned from the SDS-gel to an artificial membrane made from nitrocellulose 
and polyvinylidene fluoride PVDF (electroelution); (3) the specific primary antibody is 
used to fix the protein attached to the membrane; (4) the secondary antibody is 
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incubated to bind the protein-primary antibody complex, for example, horseradish 
peroxidase (HRP); and (5) the detected protein bands can be imaged using an ECL 
substrate and dye (Liu et al., 2014; Mahmood and Yang, 2012). Westermeier and 
Marouga (2005) stated that compared to other immunoassay techniques, WB is an 
ideal technique for measuring protein expression because it produces easy-to-
understand results, is accurate, and has a reasonable cost. It is generally a reliable 
technique and provides additional information through the principal steps. When the 
results are not well-matched, there are marks regarding what should be investigated 
to determine the potential error: the band could have a higher or lower molecular 
weight than supposed, or it could be a poly band instead of a single band. A small 
band shows that the protein has been fragmented or destroyed, whereas a band that 
occurs at a higher level could reflect an enlargement in the protein size. This refers 
to the formation of glycosylation or multimeter and the accumulation of amino acids 
found in proteins. This technique also has the capability to display the presence of a 
particular protein by size or during the binding of an antibody, which confirms the 
capability of the method to monitor protein fractions through the protein purification 
procedure. This is useful for comparing protein expression from various cells or the 
specific proteins that respond to drug treatment.  
Dechend et al. (2006) reported that in the Western blot experiments; there is a 
particular reaction between an antigen and an antibody. The antigen is usually a 
peptide or a protein, and it is detected by the antibody. The important point of the 
reaction is between the sites found on the arms of the antibody and small parts of 
the antigen (epitope). Kurien and Scofield (2006) explained that two categories of the 
antibody are used in the Western blot test: the polyclonal antibody and the 
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monoclonal antibody. The polyclonal antibodies are prepared by injecting a whole 
antigen into the animal body to activate the immune system to create specific 
antibodies against that antigen, whereas monoclonal antibodies can be prepared 
when injecting only epitopes, which are the main part of the antigen to the animal 
body. This method yields monoclonal antibodies that bind to single epitopes, while 
polyclonal antibodies can bind to different epitopes.  
The Western blotting technique has been commonly used recently to evaluate the 
genotoxicity of nanoparticles. Kumar et al. (2014) investigated protein expression 
using the effect of ZnO-engineered NPs in lymphocyte cells from healthy donors and 
chronic obstructive pulmonary disease, lung cancer, and asthma patients. They 
found significant results (P<0.05) showing a rise in the protein expression of tumour 
suppressor proteins p53 and p21, in all except the asthma patients (Kumar et al., 
2014). Furthermore, the expression of Fanconi anaemia and connection of the 
breast cancer pathway to genes was confirmed by the Western blot test when the 
effect of PJ34 was studied. Also, the genotoxicity of cells was induced by melphalan 
in human multiple myeloma cells. The apoptosis and cell cycle phases were scored 
by flow cytometry, and no significant result of PJ34 and melphalan on cell 
proliferation were determined (Xiong et al., 2015). Genotoxicity and cytotoxicity were 
studied in breast cancer cell lines (MCF-7 and MCF-10A) using 4-hydroxytamoxifen 
with Malaysian Tualang honey; the effect on cellular DNA damage was detected by 
the Comet assay, and the expression of DNA repair enzymes was examined using 
Western blotting. The results indicated that 4-hydroxytamoxifen was cytotoxic to both 
cell lines, whereas Tualang honey was only cytotoxic to the MCF-7 cells; it 
significantly decreased the cytotoxicity effect of 4-hydroxytamoxifen in MCF-10A 
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cells but not in MCF-7 cells. Tualang honey has the capability to improve the 
proliferation of MCF-10A and inhibit growth caused by 4-hydroxytamoxifen. Tualang 
honey can protect cancer cells from DNA damage caused by increased levels of 4-
hydroxytamoxifen, which is how it decreases the genotoxic effect of 4-
hydroxytamoxifen on non-cancerous cells. This result was supported by the elevated 
expression levels of DNA repair proteins Ku70 and Ku80 in MCF-10A cells of 
Tualang honey. The results show that Tualang honey can improve the effectiveness 
of the DNA repair mechanism in these cells (Yaacob and Ismail, 2014).  
Aims and Objectives 
This study aims to investigate the geno protective effect of the bulk and nanoparticle 
(NP) forms of the antioxidant compound quercetin; in lymphocytes from TB patients, 
to reduce the spread of the disease that become prevalent again in the UK due to 
the migrants. 
Objectives: Quercetin will be used to treat ex-vivo lymphocytes and sperm. DNA 
damage will be estimated using the Comet assay; the results will be confirmed by 
micronucleus assay in peripheral blood lymphocytes collected from tuberculosis 
patients and the results will be compared with data collected from healthy individuals 
(i.e., lymphocytes and sperm). The influence of two forms of quercetin on diploid and 
haploid cells will be compared; as lymphocytes are diploid cells with two sets of 
chromosomes, and spermatozoa are haploid cells with one set of chromosomes, 
both of these will be tested using three different concentrations of quercetin. The 
Comet repair assay’s usefulness in monitoring DNA damage repair will be studied by 
treating lymphocytes with PhIP and IQ, a DNA damaging food mutagen and 
analysing DNA repair in the presence and absence of both forms of quercetin. The 
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role of bulk and nano forms of quercetin on catalase protein expression will be 
studied using the WB technique to analyse lymphocytes from patients with TB and 
compare the results with lymphocytes from healthy individuals. Finally, the gene 
expression of cyclooxygenase enzymes that show an inflammatory pathway, such as 
COX1 and COX2, will be examined, as well as p53 and bcl-2, which reflect 
apoptosis. Lymphocytes collected from patients with TB will be compared with 






































2.1 Materials and Methods 
2.2 Materials 
List of reagents and chemicals which are used in this study illustrated in the following 
tables, CAS number and provider. 








 2-amino-3-methylidazo[4,5-f] quinoline (IQ) 76180-96-6 Toronto Research 
Chemicals, Toronto 
Canada 
Agarose, low gelling temperature  39346-81-1 Fisher scientific 
Albumin, Bovine serum, Fraction V, 
minimum 96% lyophilized power 
9048-46-8 Sigma, UK  
Bis-acrylamide,30% solution  110-26-9. Sigma, UK 
Bleomycin sulfate   9041-93-4  Sigma UK  
 Bradford Protein Assay Kit 1   9015-82-1  Bio-Rad  
Corning® cell culture flasks  Sigma-Aldrich 
Cytochalasin-B  14930-96-2  Sigma-Aldrich UK  
DL-Dithiothreitol 3483-12-3 Sigma-Aldrich UK 
DMSO  67-68-5  BDH, UK  
Ethanol  64-17-5 Sigma, UK 
Ethidium bromide  1239-45-8  Sigma, UK  
Fast SYBR® Green Master Mix   Life Technologies  
Foetal Bovine Serum  9014-81-7 GIBCO Invitrogen UK  
Hs ACT 1 SG Quanti Tec Primer Assay  Qiagen 
Hydrogen peroxide 7722-84-1   Sigma, UK   
iScript TM c DNA Synthesis Kit  Biorad 
Low melting point (NMP) agarose  39346-81-1 Invitrogen, UK 
Lymphoprep  26873-85-8  Stem cell Technology 
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MicroAmp® Optical 8-Cap Strips   7732-18-5 Qiagen 
Mitomycin C  50-07-7 Sigma-Aldrich UK  
MTT cell proliferation kit 61825-94-3 Invitrogen, UK 
Na2EDTA·2H2O  6381-92-6  Sigma, UK  
NaCl  7647-14-5  Sigma, UK  
NaOH BDH 1310-73-2  BDH, UK  
Normal melting point (NMP)agarose 9012-36-6   Invitrogen, UK  
Nucleus-Free Water 7732-18-5 Promega  
PBS phosphate buffered saline   n/a  Sigma, UK  
PCR max Eco 48 pates Pk/50 n/a Scientific laboratory 
supplier  
PCR max Eco 48 pates seals Pk/50 
  
n/a Scientific laboratory 
supplier 
Penicillin-Streptomycin P4333-100ML Sigma-Aldrich  
Phytohaemagglutinin-M (PHA-M) L2646-10MG Sigma-Aldrich 
Precision Plus ProteinTM  Dual color 
Standards 
161-0374 Bio-Rad 
Protein Kinase 141436-78-4 Sigma, UK  
QIAamp® RNA Blood Mini Kit ID 52304 n/a Qiagen  
Reverse Transcription System  9068-38-6  Promega  
RPMI-1640 Medium, GlutaMAXTM  251310-57-3 Thermo Fisher Scientific  
Thermo Scientific Microscopic slides                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         n/a Fisher scientific
Thick Blot Filter Paper 7.5x10cm n/a Bio-Rad 
Triton X-100  9002-93-1  Sigma, UK  
 Trizma Base    77-86-1  Sigma, UK  
Trypan blue  72-57-1 Sigma, UK 
Ultra-pure Agarose 9012-36-6 Fisher scientific 
Western ECL Substrate, 200 ml  n/a Bio-Rad  
 
Table 1 : Chemicals and reagent with their CAS numbers, and supplier. 
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Primer  Identification number Provider 
COX-1 Primer QT00210280 Qiagen 
COX-2 Primer QT00040586 Qiagen 
Bcl-2 Primer QT00025011 Qiagen 
P53  Primer QT00050785 Qiagen 
 
Table 2 : Primers used in PCR technique. 
  
Antibodies  Identification number Provider  
Anti-rabbit IgG  7074 Cell Signalling 
technology 
Anti-Catalase antibody[EPR20198] Ab209211 Abcam 
Anti-GAPDH antibody [EPR16891] Ab181602 Abcam 
 
Table 3: Antibodies used in WB technique. 
                         
2.3  Equipment 
 
Equipment Provider 
Cell culture flasks Corning, Fisher Scientific, UK 
Centrifuge Mistral 3000 MSE, gmi, Albertville,USA 
Coplin jar  VWR, UK 
Cover glass  VWR,UK 
Coverslips Strutted, Germany 
Dry incubator LKBBIOCHROM Leec LTD, Nottingham, UK 
Electrophoresis power supply Consort(E861),Belgium 
Electrophoresis tank(Hu20) SciePlas, Renfrewshire, UK 
Slides thermo VWR,UK 
Tubes (Eppendorf) Sigma,UK 
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Incubator  Flow Labs, UK 
Freezer -20and -80°C  Sanyo,Ultra low,Japan 
Fume hood Maich-Aire,Bolton,uk 
Heparinised vacutainers  Geiner-Bio-one ,Germany  
Ice Machine (ScotsmanAF100) Namur, Belgium 
Comet 4 imaging software   Kinetic imaging ,  Liverpool, UK 
Microscope (light) Nikon 
Liquid nitrogen Dewar Biostar,UK  
Small centrifuge  MSE,gmi,Albertville,USA 
Haemocytometer  Sigma-Aldrich 
pH metre  Dummow,uk 
pipette 1,5,10,20,50,100.500.1000µl Gilson, USA 
Sterile tubes 15,30,50ml  BD Swindo,UK 
Water bath  Grant instruments,UK  
Implen nano-photometer  P330 Implen Gmbh. Munich. Germany 
ECO 48 PCR Machin  SLS (scientific laboratory supplier). UK  
Western blots Electrophoresis tank Bio Rad. USA 
MRX-Microplate reader CXD3263 DYNEX-Technologies USA 
Western blots box imaging Syngene. UK 
 
Table 4 : Equipment used in this project. 
 
2.4 Questionnaire 
 The donors who donated sperm or blood both healthy and patients were required  to 
complete a consent form and answer some relevant questions.The questions were 





2.5  Blood and sperm samples collection  
Sperm samples were collected from  20 healthy non-smoking donors after two days 
abstinence. Samples were analyzed immediately based on WHO criteria. Motility, 
viscosity, sample volume, sperm count and pH were evaluated. If all parameters 
were within the normal value the rest of the samples were divided into 100µl 
subsamples in small Eppendorf® tubes and dipped in liquid nitrogen. These 100µl of 
semen subsamples were stored in a freezer at – 80 °C and used in the Comet 
assay.  
Blood was collected using venepuncture blood collection set which was labelled 
lithium heparin coated tubes from both healthy non-smoking volunteers and (TB) 
patients who had completed and signed the consent form by a qualified 
phlebotomist.  Blood was diluted 1:1 with RPMI-1640 medium and then DMSO is 
added to 10% from the total volume, then samples were subdivided into 1ml in each 
Eppendorf® and stored at -80°C. However, fresh blood samples which were not 
diluted were used in the micronucleus assay, qPCR, and Western blot techniques. 
Patient’s blood was collected from St.Luke’s Hospital in Bradford, West Yorkshire, 
UK. All patient’s  donated 10-20 ml of blood, the blood samples were kept at room 
temperature for a maximum of 48 hours while waiting for use. 
2.6 Ethical considerations 
The laboratory received ethical approval from the University of Bradford (reference 
number 0405/8), which was accepted by the Research Support & the Governance 
Office Bradford Teaching Hospital NHS Foundation ReDA number 1202 and Leeds 
East local Ethics Committee (Reference number 12/YH/0464). The information was 




2.7 Preparation of quercetin nano particles 
The preparation of a nanoform of quercitin involved dissolving bulk quercitin in 
ethanol to prepare a concentration of 1mg/ml and 5ml from this preparation was 
injected through one side of the channel of Microfluidic reactors (Y shape)  shown in 
figure 10 which was used to prepare a nano form of quercetin. The other side of 
Microfluidic reactors were used to inject 20 ml of water at the rate  of 15 ml/hr and 60 
ml/hr respectively. The production was collected in a beaker of 50ml capacity 
containing 0.5 % w/w HPMV and PVP and 1% SLS on the magnetic stirrer. The 
magnetic stirrer was used to mix the component together. The mixture was left on 
the stirrer for 10 min. Finally the Malvern nano sizer DLS was used to measure the 















Figure 11 : Size Distribution by intensity of quercetin nano using Malvern nano sizer. 
 
 
2.8 Quercetin concentrations  
Three concentrations of quercetin were used in this project for both sizes bulk and 
nano forms. The concentrations that were used are 10µM, 25µM, 100µM. These 
concentrations were chosen based on the previous articles that were published by 
(Cemeli et al., 2004), (Najafzadeh et al., 2009) and (Habas et al.,2018). The 
publications were considering three concentrations of quercetin were safely used 
with lymphocytes in vivo and vitro, whereas the concentration above 200 µM of 
quercetin both forms where neglected, they reported that high dose of quercetin is 
cytotoxic dose. Furthermore, quercetin is carcinogenic in male rats, inducing renal 
adenoma when fed at 2000 mg/kg (National toxicology Program Ed.,1-171,1979; 
Harwood et al., 2007). 
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2.9 Cell viability  
 Different quercetin concentrations (nano and bulk forms) 10 µM, 25 µM and 100µM 
were used to treat lymphocytes as usual. The tubes were centrifuged at 705g for five 
minutes at room temperature. After that, 0.4% of Trypan blue stain was added to 
treated cells 1:1 ratio. The lymphocytes were examined under a microscope after 30 
minutes of treatment. A total of 100 cells from treated lymphocytes were scored per 
slide using an improved Neubauer counting chamber.  
 
Figure 12 : IMPPROVED NEUBAUER counting chamber used for Cell viability. 
The cells that were penetrated by Trypan blue and absorbed dark blue colour are 
indicative of cell cytotoxicity and cell death, whereas the cells with colourless 
cytoplasm represent the live cells. The proportion of the live to dead cells was used 
to determine the quercetin concentrations that could be used safely in the Comet 
assay. 
2.10  MTT assay tetrazolium dye 
The MTT assay was used to assess the cytotoxicity of quercetin concentrations in 
cultured lymphocytes.  The MTT powder was prepared at a concentration of 5mg/ml. 
Lymphocytes were seeded 10,000-20,000 cells per well in a 96-well plate and 
incubated at 37 ˚C in a cell culture incubator overnight. The cells firmly attach to 
bottom surface during this time. The next day the medium were aspirated from each 
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well, and the treatment solution was added at the desired concentration. The treated 
cells were incubated at 37 ˚C for desired period of exposure. After the exposure time 
completed the medium were replaced by 90µl per well, and 10 µl of MTT day were 
added to each well and incubated for 4 hours. On completion of the incubation time 
200 µl of DMSO were added to each well. Finally, absorbance was measured after 
10 minutes at 550nm. The cell survival percentages were calculated from 
absorbance of drug concentrations divided by negative control absorbance and 
multiplied by100. 
Ab of drug ÷ Ab of negative control x100= Cell survival ? %. 
 The results of this assay suggested that, the three quercetin concentrations both 
forms were showed the cell survival over 75 %. 
2.11  Lymphocyte Comet assay  
2.11.1  Treatment 
Frozen lymphocytes were allowed to thaw at room temperature. Once the blood 
liquefied, 100µl were mixed in an Eppendorf® tube with 890 RPMI-1640 medium. 
The experiments were performed in six Eppendorf® tubes; the first tube contained 
untreated cells and excipient, the second tube was the positive control which 
contained blood, media, excipient and 10µl of 60µM hydrogen peroxide. The rest of 
the tubes were contained 10µl of H2O2 and three concentrations each of quercetin 
nano and bulk forms. The end volume of Eppendorf® tube was 1000µl.The 
incubation time for all Eppendorf’s® 30 were minutes at 37°C. After incubation the 
tubes were centrifuged for 3 minutes at 705g. Next 900 µL of supernatant was 
removed from each Eppendorf® tube and 100µl of low melting point (0.5%) agarose 
was added to residual cells with gently mixing, 100µl from the mixture (cells and 
agarose) was spread on slides previously coated by 1% of normal melting agarose 
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(NMP). Then slides were covered by the cover slip and placed on a tray containing 
ice for 5 minutes for gelation.    
2.11.2  Lysis 
This step was performed by removing the cover slip and immersing the slides in a 
black box that contained freshly prepared lysis buffer; 2.5mM NaCl, 100mM EDTA, 
10mM Trizma, 10% DMSO 1%Triton X-100. The solution was adjusted at pH 10. 
The slides stayed overnight in the lysing buffer at 2-4˚C This solution concentrated by 
salts and detergent can easily dissolve cell membranes and protein bonding, and the 
RNA bonds were lacerated. 
2.11.3  Electrophoresis  
After cell lysis, the electrophoresis tank was cleaned and filled with a fresh alkaline 
solution that consisted from10 ml of 200mM EDTA plus 60ml of 10M NaOH to allow 
an alkaline PH >13. Slides were arranged horizontally in an electrophoresis buffer 
tank in the refrigerator for 30 minutes that was enough to unwind the DNA.  
Electrophoresis was performed in the refrigerator for 30 minutes at 300mA and 25 
volts using a special power supply pack. 
2.11.4  Neutralization 
The neutralization buffer used in this step consisted of 0.4M Tris-HCl, pH 7.5. Slides 
were washed by this buffer three times for 5 minutes each time. 
2.11.5 Staining and scoring 
The stain which was used in this laboratory was ethidium bromide (20µg/ml), 60µl of 
this solution were added for each slide in the dark room. Slides were covered with a 
coverslip and scored after 10 minutes to avoid cell dehydration. A fluorescence 
microscope linked to a computer was used. The magnification used was 20x, and 
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100 cells from each slide were scored randomly, the data were transferred to 
another computer and analysed. Two parameters, %Tail DNA and Olive tail moment 
were considered for the Comet assay 
2.11.6 Sperm comet assay 
The procedure used for the sperm comet assay and lymphocyte comet assay were 
similar except for the steps listed below. 
1) 2µl of sperm was added to Eppendorf® tubes in treatment stage. 
2) Incubation was performed at 32°C for one hour in the water-bath. 
3) Two lysis buffers were used in the sperm comet assay. First lysis buffer contained 
77mg of DL-Dithiothreitol/50mL of the original lysis buffer. Second lysis buffer has 
2.5mg of Protein Kinase /50mL of original lysis buffer. 
4) Time for DNA unwinding in the refrigerator and electrophoresis was 20 minutes 





2.12   Micronucleus assay  
2.12.1   Preparation culture media 
The preparation was carried out under strict sterile conditions in a laminar fume 
hood. The process was started with addition of 1% of Penicillin-streptomycin and 
15% Foetal bovine serum to RPMI 1640 medium which contained 25mM Hepes 
buffer and L-Glutamine amino acid. Once the medium is prepared, 4.5ml was 
transferred to 25 cm3 Corning cultures flasks. The flasks are ready to use and can be 
stored at -20°C for three months to use later.   
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2.12.2  Lymphocyte cultures   
Corning culture flasks, 25 cm3 in capacity, were incubated for 30 minutes at 37°C 
until medium was completely thawed. Then at zero hours, 500μl of fresh blood 
collected from healthy volunteers or TB patients was added to each flask, followed 
by 130μl of phytohaemagglutinin (PHA). 50μl of excipient (basic solution of drug 
components) was added to the untreated cells. 50μl of mitomycin C (0.4μM) was 
added as the positive control. Different concentrations of quercetin 10 µM, 25 µM, 
100µM from both bulk and nano forms were added to the rest of the flasks. After that 
the flasks were incubated at 37°C for 24 hours. In total there were nine flasks. The 
following table illustrates the number of flasks and the chemicals that were used. 
Phytohaemagglutinin is used to induce the cultured lymphocytes for cell division. The 
micronuclei of divided binucleated cells (indicating cell division) are then measured 
to identify and evaluate DNA damage (chromosome breaks or loss). Nuclear-
cytoplasmic buds (NPBs) specify DNA disrepair, and an amplified DNA repair 
complex can be confirmed by NBUDs and chromosome rearrangement. 
Chromosome losses or fragments increase the number of micronuclei (Fenech, 
2000; Schmid, 1975). Asymmetrical chromosome rearrangement or DNA strand 
break disrepair can be detected by NPBs, which might be the reason for chromatids 
being transported to the opposite end of the cell (Thomas et al., 2003). Fenech 
(2002) and Serrano-Garcia and Montero (2001) demonstrated that NBUDs reflect 
the probability of gene amplification, which is considered to be evidence of genotoxic 
exposure. The CBMN technique is an efficient method, but its efficiency is 
dependent on the Cytochalasin-B concentration; then, the optimal dose should be 
adjusted for each cell type to confirm that no cells escape from the cytokinesis-block 






Media Blood PHA Chemicals 
Flask 1 NC 4.5 ml 500µl 100µl  50µl Excipient 
Flask 2 PC 4.5 ml 500µl 100µl  50µl Mitomycin+50µl Excipient 
Flask 3 B 4.5 ml 500µl 100µl  0.75 µg/ml Bleomycin +50µl Excipient 
Flask 4 4.5 ml 500µl 100µl  10µl of quercetin bulk (10µM) + 0.75 µg/ml Bleomycin 
Flask 5 4.5 ml 500µl 100µl  10µl of quercetin nano (10µM) + 0.75 µg/ml Bleomycin 
Flask 6 4.5 ml 500µl 100µl  25µl of quercetin bulk (25µM) + 0.75 µg/ml Bleomycin 
Flask 7 4.5 ml 500µl 100µl  25µl of quercetin nano (25µM) + 0.75 µg/ml Bleomycin 
Flask 8 4.5 ml 500µl 100µl  100µl of quercetin bulk (100µM) + 0.75 µg/ml Bleomycin 
Flask 9 4.5 ml 500µl 100µl  100µl of quercetin nano (100µM) + 0.75 µg/ml Bleomycin 
 
Table 5 : Micronucleus experimental design and amount of chemicals 
 
2.12.3  Blocking stage  
Cytochalasin B is the chemical used to block the culture processes, 30µl of this 
chemical (6µg/ml) were added to each flask, after 44 hours of incubation. Cyto B 
blocks cytoplasmic division inhibiting formation of actin filaments, thus arresting the 
cells in the bi- nucleated form.  
2.12.4 Hypotonic treatment 
All the flasks were removed from incubation at 77 hours and contents transferred to 
separate falcon tubes. The falcon tubes were centrifuged at 107g for 8 min. The 
supernatants were removed using vacuum suction, leaving 500µl with the sediment 
of the cells. The cells were then -suspended again in 5ml of cold freshly prepared 
hypotonic solution (110Mm potassium chloride). Next; the tubes were incubated at 4 
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OC for 15 min.  The centrifugation was repeated with the same time and speed. The 
supernatant was removed, and the cells were re-suspended by gently shaking.  
2.12.5  Cell fixation 
A fixing solution that is called carneys solution (1 volume of glacial acetic acid and 3 
volumes of ethanol) was prepared; also 38% formaldehyde is required. The solution 
was used three times to fix the cells. 
2.12.5.1 First fixation 
5 ml of carneys solution were added in each tube drop by drop, and the contents of 
the tubes were mixed by vortex machine followed by three drops of formaldehyde. 
The tubes were centrifuged 8 minutes at 107g. Subsequently, the supernatant was 
removed by vacuum suction leaving 500μl. Tubes were gently shaken to re-suspend 
cells again.   
2.12.5.2 Second and third Fixation   
Second and third fixations were the same at the first fixation, but without adding 
formaldehyde. 
2.12.5.3  Staining of cells and scoring   
After centrifugation, 100µl cell suspension was mixed with 300-600µl of carneys 
solution. 20-30µl of cell suspension was placed on clean and dry glass slide; two 
slides were made for each concentration to confirm the result. Subsequently, slides 
were kept drying overnight. The slides were then stained with 5% Giemsa stain (51 
ml 0.2 M NaH2PO4 with 49 ml 0.2 M Na2HPO4) for 20 minutes. The slides were 
washed using tap water and dried. Once the slides were completely dry, they were 
fixed by rubber fix gum (DPX) and protected by a coverslip.  500 cells were scored 
for each slide to obtain 1000 cells for each tube.  Scoring of micronuclei, nuclear 
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buds (NBUDs), nucleoplasmic bridges (NPBs), and chromosome rearrangement was 
performed to evaluate the cytogenetic damage.  
 
2.12.6 The influence of heterocyclic amines PhIP and IQ on DNA in 
lymphocytes and sperm that were treated with different concentrations 
of quercetin 
The concentrations 160µM and 140µM of 2-amino-3-methylidazo [4, 5-f] quinoline 
(IQ) and also 140µM and 100µM of 2-amino-1methyl-6-phenylimidazo [4,5-b] 
pyridine (PhIP) were used as genotoxic agents to induce DNA damage in 
lymphocytes and sperm. These were incubated for 20-30 minutes at 37°C before 
being embedded in 5% low melting point (LMP) agarose on slides pre-coated with 
agarose. The stock solutions of IQ and PhIP were prepared using deionized distilled 
water (ddH2O) and stored in a freezer at 2-4°C. The oxidative DNA damage resulting 
from the food mutagens was evaluated by the Comet assay.  
2.12.6.1 Cell treatment  
Nine Eppendorf® tubes were selected and labelled to study the influence of both 
PhIP and IQ food mutagens on lymphocytes and sperm; the experiments were 
designed by untreated cells, positive control with 60 µM H2O2 in lymphocytes and 50 
µM H2O2   in sperm, the third Eppendorf® tube was PhIP or IQ only and the rest of 
Eppendorf®   were induced DNA damage using PhIP or IQ and treated with quercetin 







The following table illustrates the experimental design. 
Eppendorf Number 
 
Media PRMI  Blood Chemicals 
Eppendorf 1 NC 890µl 100µl 10µl Excipient 
Eppendorf 2 PC 880µl 100µ l 10µl Excipient +10µl (60 µMH2O2) 
IQ 
Eppendorf 3 PC  880µl 100µ l 10µl Excipient +10µl (160 µM) IQ 
Eppendorf 4 870µl 100µl 10µl Excipient +10µl of quercetin 
bulk (10µM) +10µl (160 µM) IQ 
Eppendorf 5 870µl 100µl 10µl Excipient +10µl of quercetin 
nano (10µM) + 10µl (160 µM) IQ 
Eppendorf 6 870µl 100µl 10µl Excipient +10µl of quercetin 
bulk (25µM) +10µl (160 µM) IQ 
Eppendorf 7 870µl 100µl 10µl Excipient +10µl of quercetin 
nano (25µM) + 10µl (160 µM) IQ 
Eppendorf 8 870µl 100µl 10µl Excipient +10µl of quercetin 
bulk (100µM) + 10µl (160 µM) IQ 
Eppendorf 9 870µl 100µl 10µl Excipient +10µl of quercetin 
nano (100µM) + 10µl (160 µM) IQ 
 
Table 6 : Experimental designs for comet assay were lymphocytes induced DNA damage by IQ or 
PhIP and treated nano and bulk forms of quercetin. 
 
 
2.12.6.2  Mixing the cells with agarose  
Once the incubation period was completed, all the tubes were centrifuged for 3 
minutes at 110 g, after centrifugation 900μl supernatant was removed and the 100 μl 
of supernatant along with the cell pellet was mixed gently with 100 μl of LMP 
agarose. 100 μl each from the mixture was placed on slides pre-coated with NMP 
agarose and covered by a coverslip; two slides for each Eppendorf® tube were 
made to determine the results. The slides were kept on the ice surface for 5 minutes 
for gelation. This was followed by removal of coverslips transfer of slides into a black 
box containing cold lysis solution. The components of fresh cold lysis solution 
included 100 mM EDTA, 2.5 M NaCl, 10 mM Trizma base, 10% DMSO and 1% 
Triton X-100, pH 10. The reason for using lysis solution is to denature protein and 




2.12.6.3  DNA electrophoresis  
 
This step starts by unwinding DNA for lymphocytes or sperm. Slides were arranged 
in a horizontal position inside the electrophoresis tank; the slides were covered by an 
electrophoresis buffer which consisted of (300 mM NaOH and 1 mM EDTA, pH > 
13). The cells were incubated for 30 minutes at 4°C for DNA unwinding, after that 
electrophoresis was operated for 30 minutes at a constant voltage of 25 V and 290-
300 mA. 
 
2.12.6.4  Neutralisation and scoring 
  
Once the electrophoresis time was completed, the slides were washed by 
neutralisation buffer consisting of (0.4 M Tris-Hcl, pH 7.5) three times where each 
time takes 5 minutes. The ethidium bromides stain 20 μg/ml was used to stain the 
cells in the dark room and covered with cover-slips for 10 minutes and scoring. 100 
cells were scored randomly for each slide by a fluorescence microscope linked to a 
CCD camera and Computer system (Andor Technology Ltd, Belfast, UK). Two 
parameter % Tail DNA and Olive tail moment were used to analyse data by kinetic 
imaging software (Andor Technology Ltd, Belfast, UK). 
 
 
2.13 Polymerase Chain Reaction (PCR) 
The principle of the PCR technique depends on repeated cycles of DNA sequencing 
under various temperatures in three different steps. One DNA fragment is used to 
yield two copies, then four, then eight, and so on. Three major steps that rely on 
changes in temperature are documented in one PCR cycle. In the first step, the 
double strand of DNA is denatured and separated at 90–97°C. Strengthening occurs 
60 
 
at 55–65°C, which is the second step. The extension takes place at 72°C, which is 
the third step. The PCR experiment needs the following reagents: a specific protein 
called polymerase (Taq polymerase); a DNA template (i.e., the target protein); a 
small DNA fragment, also called the primer, to attach the building blocks; nucleotides 
(i.e., guanine, cytosine adenine, and thymine), and a reaction buffer. If these 
components are accessible, the enzyme produces typical copies of the template 
(Joshi and Deshpande, 2011). 
 
Isolated lymphocytes from fresh blood were used in both PCR and Western blots 
techniques. Blood was diluted with (0.9% NaCl) 1:1, with gentle mixing using 50ml 
graduated tube. 6 ml from the mixture was placed in a 15ml Falcon tube containing 
3ml of Lymphoprep™ all the tubes were centrifuged 20 minutes at 600xg. Once the 
centrifugation was completed the mixture was divided into three layers, red layer at 
the bottom then, Lymphoprep, white layer which is isolated lymphocytes and plasma 
layer at the top. The white layer was collected and transferred to another Falcon™ 
tube and washed with saline. The washed cells were centrifuged at 375g for 15 
minutes. White pellets were suspended, and cultured lymphocytes were cultured at a 
concentration of 200,000 cells in 1 ml of medium RPMI 1640 glutamax® containing 
25mm hepes, 75ml foetal bovine serum for 24 hours. 10 µl of PhIP 140µM final 










2.13.1  RNA Extraction  
 
Cultured lymphocytes (2x105cells/ml) were mixed with (EL) buffer using Falcon™ 
tube to obtained RNA from cultured lymphocytes. The isolated RNA was stored at -
80°C for further use. 
 
2.13.2  Synthesis cDNA 
 
  
The iScript™ cDNA Synthesis Kit was used to prepare the cDNA from lymphocyte 
RNA. First step: 10 μl of extracted RNA was mixed with 4 μl 5XisCript reaction buffer 
plus 1 μl of Improm ɪɪ RT (reverse transcriptase) and 5 μl nuclease-free water. All 
the components were mixed together in small Eppendorf® tubes in ice. Second step: 
all the Eppendorf® tubes were transferred and incubated using a Thermocycler 
machine for the first incubation: Priming 5 min at 25°C. Then the reverse 
transcriptase step for 20min at 46°C. Subsequently, RT was activated for 1 minute at 
95°C. Lastly the Eppendorf® tubes were holed in a PCR thermo cycler at 4°C for 10 




2.13.3  Quantitative real time PCR analysis (QPCR) 
 
 
The procedures of qPCR included preparation of mixture 1 which has a primary end 
volume of 12 μl; this amount was enough for 24 wells. Mixture 2 which is β actin. 
Mixture 3 which is cDNA as prepared before; all mixtures were mixed in separate 
Eppendorf® tubes. The experiments were designed in triplicate with both primary 
and Fast SYBR® Green for the confirmation of the results. PCR max ECOPLATE 48 
was used to mix all the mixtures 1, 2 and 3 and covered by Eco 48 real time PCR 
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seals. Mixtures were immediately vortexed and a plate spinner to collect the mixtures 
at the bottom of the plate and air bubbles were removed. The plate was put into an 
ECO 48 Real-Time PCR machine; also, the proposed protocol was followed. All 
experiments were done in triplicate wells. For each experiment, β actin was utilized 
as a housekeeping gene. ΔCq value was calculated. The gene expression was 
normalised against β actin; the ΔΔCq was further calculated for gene expression and 
normalised against untreated cells to evaluate the gene expression fold. The data of 
qPCR such as ∆Cq and ΔΔCq values were analysed using SPSS and Graph bad 
prism 6 to evaluate gene expression. The design was repeated with other primaries 
such as COX1, COX2 and Bcl-2. The ΔCq and ΔΔCq was calculated according to 
the method in ECO 48 qPCR. 
 
2.14  Western blot Technique 
2.14.1  Cell culture and protein isolation  
Once lymphocytes were isolated from whole blood of TB patients or healthy 
individuals, the cells were cultured in 6 well cell culture plates for 24 hours. Each well 
contained 1 ml of prepared GlutaMAX RPMI 6140 and 26 μl of PHA for 
200,000cells/well. After 24 hours the DNA damage was induced in lymphocytes by 
addition of 10 µl of PhIP (140µM final concentration) for half hour. The lymphocytes 
were then treated with10 µl of 100 µM of quercetin bulk and nano forms for two 
hours.  After the treatment the medium was removed using a pipette and the wells 
were washed twice with 2 ml of lysis buffer to lyse the cells and scrub de-attach the 
cells using a plastic scrubber. All suspensions from each well were transferred to 
Eppendorf tubes. The cell suspension was heated for 10 min at 90°C in a water bath 
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and stored in the - 20 °C freezer. The isolated protein measurement was performed 
using the Bradford protein assay (Bradford, 1976; Ernst and Zor, 2010). 
 
2.14.2  Isolated protein calculation 
 
The Bio-Rad Bradford assay kit was used to measure isolated protein form each 
sample according to the manufacture’s guidelines. The following table illustrates the 
protein assay experimental design. 
 









10 µl PhIP 
140µM + 




10 µl PhIP 
140µM+ 






250 µl 250 µl+0.625 
µl from 
stander  
250 µl 250 µl 250 µl 250 µl 
 250 µl 250 µl+1.25 
µl+ standard 
    
 250 µl  250 
µl+ 2.5 µl 
standard 
    
 250 µl 250 µl+5 µl  
standard 
    
 250 µl 250 µl+10 µl 
standard 
    













Table7: illustrates Bio-Rad Bradford protein assay. 
 
 
The reagent and sample were mixed and incubated for 5 minutes in the dark room. 
The MRX-Microplate reader was used to measure protein concentration in each 
sample. Each sample was evaluated in triplicate. The absorbance calculated 
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spectrophotometrically at 540 nm using a microplate reader. Protein concentrations 
were measured depending on standard concentrations. 
  
2.14.3  Gel preparation and electrophoresis  
Glasses were washed with water, dried, and then fixed in cassettes. Each cassette 
with glasses was placed on the Perspex rack holder. 5 ml of spreading gel (6.67 ml 
30% acrylamide, 5 ml ddH2O, 4 ml 1.5 M Tris pH 8.8, 160 μl 10% APS, 160 μl 10% 
SDS, and 16 μl TEMED) was injected between glasses using 1 ml pipette until it 
reached the green edge of cassette. The spreading gel and glasses were kept at 
room temperature for one hour to solidify, then 1 ml from stacking gel (freshly 
prepared) (2 ml 30% acrylamide, 5.3 ml ddH2O, 2.5 ml 1.5 M Tris pH 8.8, 100 μl 
10% APS, 100 μl 10% SDS, and 10 μl TEMED) was injected using 1 ml pipettes to 
the top of each cassette. A comb was inserted between glasses and kept at room 
temperature for 45 minutes until complete gelation. Cassettes and glasses were 
adjusted on the electrophoresis plate holding rack which fixed in the electrophoresis 
tank. Freshly prepared running buffer (30.29 g Tris base 25 mM, 142.63 g 
glycine190 mM and 10.0 g SDS 0.1% in 1L distilled water) was added in the 
electrophoresis tank, combs were removed. Samples were mixed with laemmli buffer 
(10% 2-mercaptoethanol, 4% SDS, 20% glycerol, 0.004% bromophenol blue and 
0.125 M Tris-HC) at a rate dependent on the concentration of total protein in each 
sample. 30 μl of each prepared sample was loaded into one of the wells. At 200 V 




2.14.4  Transferring the protein from the gel to the Polyvinylidene difluoride 
(PVDF) membrane 
 The membrane was cut into a small size that covered the gel size, dipped in 
methanol 70% for 30 seconds and then transferred to distilled water for 1 minute. 
Transferring buffer was freshly prepared (14.26 g glycine 190 mM, 3.02 g Tris base 
25 mM, 200 ml methanol in 1L distilled water). The components were mixed together 
in a clean and dry beaker, 3000 ml capacity placed on a magnetic stirrer at room 
temperature. The gel holding the electrophoresed protein and PVDF membrane 
were attached together and covered by a filter paper on both sides and finally 
protected by two pieces of a sponge on both sides. The air bubbles in the sandwich 
were removed by pressing one side of sponge using a 1ml pipette. The membrane, 
gel, filter paper, sponges were assembled in the transfer sandwich. The sandwiches 
were fixed to blot connect to the cathode, and the gel was linked to the anode. The 
cassette was fixed in the tank containing transfer buffer and ice block, then the 
power supply was adjusted at 100 V, 300 AM and run for 1 hour. 
 
2.14.5  Antibody staining 
Once the transferring time was completed the PVDF membrane was moved to 
sterilised square petri dish containing blocking buffer (KCl 50mg +NaCl 2g + Trisma 
Base 57mg were dissolved in 250 ml dH2O, pH 7.4 then 250 μl of Tween 20 and 
PSA 9g 4% were added). The square petri dish was fixed on a rotator in a cold room 
for 1 hour. Then the membrane was transferred to another square petri dish 
containing 7.5 μl of primary antibody diluted with 15 ml of blocking buffer and 
incubated overnight on a rotator in the dark cold room. Subsequently, the membrane 
was washed by washing solution consisted of (PBS/0.05%-0.1% Tween-20) three 
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times for 5 min each. After that, the membrane was transferred to Squair Petri dish 
contained secondary antibody diluted by Blocking buffer 1:2000 and incubated in 
dark place for one hour at room temperature under rotating.  
 
2.14.6  Bands imaging 
After the secondary antibody incubation time finished, the membranes were washed 
three times five minutes each time by washing solution.  5ml from reagent 1and 
reagent 2 (ECL) were prepared in the dark room. The membrane was covered by 
prepared (ECL) in dry and clean square petri dish and placed on the rotator for five 
minutes. An Image was captured by darkroom development techniques for 
chemiluminescence or normal image scanning methods for colorimetric examination. 
 
2.14.7 The re-staining of membrane 
 
The membrane was immersed for ten min in 35 ml of re-staining solution, after that 
the volume was completed up to 1litre. The membrane was then transferred to the 
square petri dish containing PBS for ten minutes, this step was repeated twice. 
Subsequently, the membrane was placed in 35ml of TSBT solution. The entire 
components were dissolved in 250 ml dH2O and the pH fixed at 7.4, then 250 μl of 
Tween 20 and PSA 9g 4% were added for 5 min, this step was repeated twice. Then 
follow the same procedures. 
 
2.15 Statistical analysis  
 
Twenty blood samples and twenty sperm samples from healthy individuals were 
used in the Comet assay for control samples. Three fresh blood samples from 
healthy individuals and three fresh samples from TB patients were used in the 
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CBMN assay. Ten blood samples were used from each group of TB patients and 
healthy individuals to investigate genotoxicity of food the mutagens (PhIP) and (IQ). 
Three fresh blood samples from healthy individuals and TB patients were cultured 
and were used to evaluate the catalase protein by the Western blot technique and 
COX1, COX2, P53 and Bcl-2 using qPCR. Each sample for Western blot and qPCR 
were repeated in triplicate to confirm the results. The means of group data were 
calculated with standard errors. For qPCR, the ΔCq and ΔΔCq method were used, 
which is a suitable way to study the relative changes in gene expression from real-
time quantitative PCR experiments. The normal distribution of the data was 
examined by the Kolmogorov-Smirnov and Shapiro Wilk’s test to select the correct 
parametric. A test One Way ANOVA test was used to compare untreated cells and 
TB blood samples in the Comet assay, Western blot, and qPCR, while the T-test was 
used in the CBMN assay. 
The variances between groups were examined by the Kruskal-Wallis method and 
Mann-Whitney U-test. Concentration response correlations were detected using 
Pearson’s test for both nano and bulk forms of quercetin. The value of p ≤ 0.05 was 
selected as statistically significant. All analyses were created by Graph pad prism 6 





















3 Chapter (3) The Comet assay in sperm and peripheral 
lymphocytes after treatment with quercetin bulk and nano form, 















3.1 Introduction  
  
Many studies have examined the influence of antioxidant as a protective compound 
in respiratory diseases (Nguyen et al., 2004; Habas et al., 2018). Bischoff (2008) 
reported that the regular intake of a quercetin dose could help to prevent and protect 
certain illnesses. Kandaswami and Middleton Jr. (1994) reported that flavonoids 
characteristics could protect cells from lipid peroxidation and oxygen free radicals. 
Also, complex pathological conditions such as cancer can arise due to oxygen free 
radical and lipid peroxidation. Accordingly, antioxidants could contribute to 
preventing cancer and chronic inflammation (Haliwell, 1994). The average dietary 
intake of flavonoid was calculated by per cent, where tea is a principle source 
occupying 48% of total intake, while onions take 29%, but apples only have 7%. The 
lowest amount was with fruit and vegetables (Hollman and Katan, 1999). There are 
conflicting reports on the daily dietary requirements of flavonoids. For example, 
Hollman and Katan in 1999 described that the human body needs a small amount 
daily intake of flavonoids which is a few hundred milligrams. Kühnau in 1976 
reported that 650 mg/day from flavonoid were required. 
Many of studies examined the action of antioxidants where levels of oxidative stress 
are reduced by inequality of the two anions hydrogen peroxide and (superoxide) 
from oxygen, while quinones and semiquinones can also damage DNA directly 
(Bolton, 2002). Therefore, producing high levels of free radicals can induce DNA 
damage in a pro-oxidative state by producing chromosomal instability (Gibellini et al., 
2010). However, quercetin has a strong ability to scavenge free radicals by 
suppression of lipid peroxidation (Bentz, 2009). In the last twenty years, a noticeable 
improvement has been presented in methods which can identify and estimate DNA 
69 
 
damage. Wu and Jones in 2012 pointed out the single strand DNA breaks in sperm 
and peripheral lymphocytes were assessed by the Comet assay. In the present 
study sperm and peripheral lymphocytes that were collected from healthy individuals 
and lymphocytes obtained from TB patients were embedded in to slides pre-coated 
by agarose gels 5% and positioned horizontally in an electrophoresis tank which had 
alkaline conditions at pH 13. During electrophoresis, fragments of DNA travelled to 
the anode (+ve) because they have a negative charge and migrated faster compared 
undamaged DNA. This method created a comet shape which was stained with 
ethidium bromide and examined under a fluorescence microscope. DNA damage 
was measured in terms of the % Tail DNA and Olive tail moment (Wu and Jones, 
2012).  
Lymphocytes were collected from healthy individuals and examined using the MTT 
assay and only samples with over 80% viable cells were used in the experiments. 
The lymphocytes from the healthy individuals were then treated with 60µM hydrogen 
peroxide in the presence of three different concentrations of bulk form of quercetin 
(10µM, 25µM, and 100µM) and also similar concentrations of the nano form of 
quercetin. The positive control Eppendorf® contained 60µM of H2O2 in lymphocytes, 
because this concentration produced the highest damage in DNA without causing 
toxicity, while in sperm 50 µM of H2O2 was selected as a positive control. The lower 
concentration of the positive control in the sperm could be because of the higher 
sensitivity of sperm to H2O2 and contained half the number of chromosomes. 
Lymphocytes collected from TB patients were incubated with 60µM of H2O2 and the 
same concentrations of bulk and nano forms of quercetin as in the case of 
lymphocytes in healthy individuals. Once the individuals were examined, data were 
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analysed by special software (cuhat software) to estimate the influence of both forms 
on reducing DNA damage. 
3.2  Materials and Methods   
All the materials and methods used in this chapter have been shown and described 
in chapter 2, section 2.11.1 to 2.11.5-page number 53-54.  
3.3 Scoring and result analysis  
All slides were scored by a fluorescence microscope connected to the computer and 
camera designed with Comet 6 software (Andor Technology Ltd, Belfast, UK). All the 
procedures related to this assay have been explained in chapter 2 section 2.15-page 
number 70. Graph pad prism 6 and SPSS for Windows statistical package (version 
18.0) were used to calculate the P value (≤0.05) of % Tail DNA and Olive tail 














3.4  Results  
3.4.1 Results of tetrazolium dye (MTT) assay 
The lymphocytes collected from three different healthy individuals were treated with 
quercetin bulk and nano forms at different concentrations 10 µM, 25 µM, 100 µM to 
investigate cytotoxicity of quercetin using the MTT assay. The average of three 
experiments from three different healthy individuals was calculated and represented 
by a line graph to show cell survival. It was clear that the percentage of cells survival 
obtained from quercetin treatments were rated from 95.8% to 97.9%.  The data were 
calculated based on negative control absorbance as described in chapter 2 section 
2.8-page number 51. The results confirm that the quercetin bulk and nano form 
concentrations were safe to use in this study. 
 
 
Figure 13: Graph showing the means of cell survival of lymphocytes collected from three different 














3.4.2  Comet assay results  
3.4.3 Control samples sperm and lymphocytes 
The Comet assay was performed on 20 sperm and 20 blood samples collected from 
different healthy individuals.  All the sperm samples were processed as per the 
guidelines in the WHO laboratory manual for the examination and processing of 
human semen and blood samples, they were diluted 1:1 with RPMI1640 medium; 
and all the samples were stored at -80°C. Twenty dose response experiments each 
sample was performed for sperm and peripheral blood lymphocytes after treatment 
with different concentration of hydrogen peroxide to determine positive controls in 
this study. All the experiments have been assessed by Comet assay to detect DNA 
damage based on %Tail DNA and Olive tail moment. The Average of % Tail DNA 
and Olive tail moment of the 20 healthy donors were calculated for sperm and 
lymphocytes that were treated by hydrogen peroxide and the concentration 
responses were determined. All the concentrations were compared to the negative 
control value.  
3.4.4  Dose response experiments with lymphocytes form healthy individuals 
The DNA damage reached the peak at 65µM of H2O2 Figures 14 and 15. The striking 
features are that 65µM, and 55µM of H2O2 showed the maximum damage for both 
parameters % Tail DNA and Olive tail moment. Furthermore, the Graph pad one-way 
ANOVA test showing high significance ***P ≤0.001 for these concentrations of H2O2. 
This prompted the use the mean value i.e.60µM of H2O2 as the concentration for 




































Figure 14 : Different concentrations of H2O2 
presented as means of % Tail DNA treated 
lymphocyte collected from 20 different healthy 
individuals, ± SEM One-Way AVOVA test and 
significance compared with the untreated cells 
(donors=20). 
Figure 15: Different concentrations of H2O2 
presented as means of Olive tail moment  
treated lymphocytes collected from 20 different 
healthy individuals, ± SEM, One-Way AVOVA 
test and significance compared with 
theuntreatedcells(donors=20).
 
3.4.5  Dose response experiments with sperm from healthy individuals 
 
In the case of sperm, the DNA damage reached the peak at concentrations of, 45µM 
and 55 µM of H2O2, and generated highly significant DNA damage (figures 16 and 
17). This confirmed that the statically significant calculation using Graph pad prism 
One-Way ANOVA test gave a P value ***P ≤ 0.001 compared to the negative 
control. Consequently, the mean of two concentrations is 50 µM of H2O2 that why 
taken as a positive control of sperm experiments without toxicity (Henderson, 
Albertini and Aardema, 2000). 
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Figure 16: Different concentrations of H2O2 
presented as means of % Tail DNA treated 
sperm collected from 20 different healthy 
individuals, ±SEM One-Way AVOVA test and 
significance compared with the untreated cells 
(donors=20). 
 Figure 17: Different concentrations of H2O2 
presented as means of Olive tail moment 
treated sperm collected from 20 different 
healthy individuals, ±SEM One-Way AVOVA 
test and significance compared with the 
untreated cells (donors=20). 
 
3.4.6 Effect of quercetin bulk form on DNA damage induced by H2O2 in 
lymphocytes collected from healthy individuals.  
This experiment involved the use of lymphocytes from 10 healthy individuals. Figures 
18 and 19 illustrate how different concentrations of the bulk form of quercetin reduce 
DNA damage induced by H2O2 in lymphocytes collected from healthy individuals. It is 
evident that the influence of quercetin bulk was not significant statistically using both 
% tail DNA and Olive tail moment as the P value was ≥0.05 compared to the positive 
control. The figures include the mean value of ten individuals showing the standard 
error and significance using a One-Way ANOVA test. All concentrations of quercetin 
and controls were normally distributed.
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Figure 18: The effect of quercetin bulk on DNA 
damage presented as mean of % Tail DNA of 
lymphocytes collected from 10 different 
healthy individuals treated with quercetin bulk 
in the presence of H2O2, (60µM), ± SEM One-
Way AVOVA test and significance compared 
with the positive control (donors=10). 
Figure 19 : The effect of quercetin bulk on 
DNA damage presented as mean of Olive tail 
moment of lymphocytes collected from 10 
different healthy donors treated with quercetin 
bulk in the presence of H2O2 (60µM), ± SEM 
One-Way AVOVA test and significance 
compared with the positive control 
(donors=10).
 
3.4.7  Effect of quercetin nano form on DNA damage induced by H2O2 in 
lymphocytes collected from healthy individuals   
This experiment involved the use of lymphocytes from 10 healthy individuals. Figures 
20 and 21 depict the influence of quercetin nano on DNA damage that was caused 
by hydrogen peroxide in lymphocytes obtained from healthy individuals. Overall 
perspective, in both figures 15 and 16 all the concentrations of quercetin nano were 
not significant using % tail DNA and Olive tail moment based on one-way ANOVA 
test. The comparison between each concentration and the positive control display P 
value ≥0.05. Even the concentration of 100µM was not significant. The negative 
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Figure 20 : The effect of quercetin nano on 
DNA damage presented as   means of % Tail 
DNA of lymphocytes collected from 10 
different healthy individuals treated with 
quercetin nano in the presence of H2O2 (60µM) 
± SEM One-Way AVOVA test and significance 




Figure 21 : The effect of quercetin nano on 
DNA damage presented as means of Olive tail 
moment of lymphocytes collected from 10 
different healthy individuals treated with 
quercetin nano in the presence of H2O2 
(60µM) ±SEM One-Way AVOVA test and 
significance compared with the positive control 
(donors=10). 
 
3.4.8 Effect of quercetin bulk on DNA damage induced H2O2 in lymphocytes 
from patients with TB  
Both figures 22 and 23 provide information on the effect of different concentrations of 
quercetin bulk on the lymphocytes from a patient with TB. All the concentrations 
reduce DNA damage caused by H2O2, however; the reductions were non-significant 
as the P value was (P≥0.05) based on a one-way ANOVA test in both the 
parameters namely the % tail DNA and Olive tail moment.  
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Figure 22 : The effect of quercetin bulk on 
DNA damage presented as means of % Tail 
DNA of lymphocytes collected from 10 patients 
with TB treated with quercetin bulk in the 
presence of H2O2 (60µM), ± SEM One-Way 
AVOVA test and significance compared with 
the positive control (donors=10). 
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Figure 23: The effect of quercetin bulk on DNA 
damage presented as means of Olive tail 
moment of lymphocytes collected from 10 
patients with TB treated with quercetin bulk in 
the presence H2O2 (60µM), ± SEM One-Way 
AVOVA test and significance compared with 
the positive control (donors=10). 
 
3.4.9 Effect of quercetin nano on DNA damage induced H2O2 in lymphocytes 
from patients with TB. 
Figures 24, 25 illustrate information about lymphocytes which are collected from 
patients with TB induced DNA damage by 60µM of H2O2 and treated with quercetin 
nano. It was obvious that from both bars graph the DNA protection was more 
significant at 100µM of quercetin nano compared to the positive control, whereas the 
concentration 10µM was not significant in both parameters of % tail DNA and Olive 
tail moment. The best reduction of DNA damage was at the same concentration in 
both parameters. All the concentrations were compared to the positive control using 
the one-way ANOVA test. Furthermore, statistically, the concentration 100µM of 










































































































Figure 24: The effect of quercetin nano on 
DNA damage presented as mean of % Tail 
DNA of lymphocyte collected from 10 TB 
patients treated with quercetin nano in the 
presence of H2O2 (60µM), ± SEM One-Way 
AVOVA test and significance compared with 
the positive control (donors=10). 
 
Figure 25: The effect of quercetin nano on 
DNA damage presented as mean of Olive tail 
moment of lymphocytes collected from 10 TB 
patients treated with quercetin nano in the 
presence of H2O2 (60µM), ± SEM One-Way 




3.4.10 Effect of quercetin bulk in reducing DNA damage induced by H2O2 in 
sperm collected from healthy individuals. 
Figures 26 and 27 illustrate data of healthy sperm treated by quercetin bulk in the 
presence 50µM of H2O2. All concentrations of quercetin in reduced DNA damage 
were not significant statistically in DNA protection when compared with the positive 
control in both parameters, % tail DNA and Olive tail moment the P value was P 
≥0.05 based on one-way ANOVA test. All concentrations and both controls were 
distributed normally.  
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Figure 26: The effect of quercetin bulk on DNA 
damage presented as mean of % tail DNA of 
sperm collected from 10 healthy individuals 
treated with quercetin bulk in the presence of 
H2O2 (50µM) ± SEM One-Way AVOVA test and 
significance compared with the positive control 
(donors=10).  
Figure 27: The effect of quercetin bulk on DNA 
damage presented as mean of Olive tail 
moment of sperm collected from 10 healthy 
individuals treated with quercetin bulk in the 
presence of H2O2 (50µM) ± SEM One-Way 
AVOVA test and significance compared with 
the positive control (donors=10). 
 
3.4.11  Effect of quercetin nano in reducing DNA damage induced by H2O2 in 
sperm collected from healthy individuals 
Figures 28 and 29 illustrate information about the effect of the nano form of quercetin 
on sperm collected from healthy individuals in the presence of 50µM of H2O2. It was 
clear that there was significant protection of DNA damage by quercetin nano. The 
protection was observed at concentrations ranging from 25µM to 100µM respectively 
using % tail DNA, whereas the concentration 10µM was non-significant in both 
parameters Olive tail moment and % tail DNA. The two parameters display the 
maximum reduction in DNA damage at a concentration of 100µM of quercetin nano. 
The statistical analysis using the one-way ANOVA test showed the P value was ***P 
0.001 for the highest concentration.   
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Figure 28 : The effect of quercetin nano on 
DNA damage presented as mean of % Tail 
DNA of sperm collected from healthy 
individuals in the presence of H2O2 (50µM), ± 
SEM One-Way AVOVA test and significance 
compared with the positive control 
(donors=10). 
Figure 29: The effect of quercetin nano on 
DNA damage presented as mean of Olive tail 
moment treated sperm collected from healthy 
individuals in the presence of (50µM), H2O2 ± 
SEM One-Way AVOVA test and significance 
compared with the positive control 
(donors=10). 
 
3.4.12 Comparison of the DNA protective effect of quercetin bulk on DNA 
damage induced by H2O2 in lymphocytes and sperm collected from 
healthy individuals.  
Figures 30 and 31 illustrate a comparison between sperm (figures 26and 27) and 
lymphocytes (figures 18 and 19) from healthy individuals treated with quercetin bulk 
in the presence of H2O2. The DNA damage was analysed using two parameters, the 
% tail DNA and Olive tail moment. Using the two-way ANOVA test, the reduction was 
non-significant in both sperm and lymphocytes collected from healthy individuals with 
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Figure 30 : A comparison between % Tail DNA of sperm (figure 26) treated with 50µM H2O2 and 
lymphocytes (figure 18) treated with 60 µM H2O2 collected from 10 different healthy individuals treated 
with quercetin bulk in the presence of H2O2, ± SEM, Two-Way AVOVA test and significance compared 
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Figure 31: A Comparison between Olive tail moment of sperm (figure 27) treated with 50µM H2O2 
and lymphocytes (figure 19) treated with 60 µM H2O2 collected from 10 different healthy individuals 
treated with quercetin bulk in the presence of H2O2, ± SEM Two-Way AVOVA test and significance 
compared with the positive control (donors=10). 
82 
 
3.4.13 Comparison of the DNA protective effect of quercetin nano on DNA 
damage induced by H2O2 in lymphocytes and sperm collected from 
healthy individuals  
Figures 32 and 33 depict a comparison of the DNA protective effect of three 
concentrations of quercetin nano between lymphocytes (figure 20 and 21) and sperm 
(figure 28 and 29) collected from healthy individuals in the presence of H2O2. The 
influence of quercetin was examined in both diploid and haploid cells to evaluate 
DNA protection by nano form. In sperm, there was the gradual reduction of DNA 
damage because of quercetin nano beginning from a concentration 25µM to a 
concentration of 100µM where the P value was ***P ≤ 0.001 for both the parameters. 
In contrast in the lymphocytes collected from healthy individuals, both % tail DNA   
and Olive tail moment quercetin effect on DNA damage which was not significant at 
all concentrations which registered P values ≥0.05 in a two-way ANOVA test. All 
concentrations and both controls were distributed normally. 
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Figure 32 : A Comparison of % Tail DNA between sperm (figure 28) treated with 50µM H2O2 and 
lymphocytes (figure 20) treated with 60 µM H2O2 collected from 10 different healthy individuals treated 
with quercetin nano in the presence of H2O2, ± SEM Two-Way AVOVA test and significance compared 
with the positive control (donors=10). 
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Figure 33: A comparison of Olive tail moment between sperm (figure 29) treated with 50µM H2O2 and 
lymphocytes (figure 21) treated with 60 µM H2O2 collected from 10 different healthy individuals treated 
with quercetin nano in the presence of H2O2, ± SEM Two-Way AVOVA test and significance compared 
with the positive control (donors=10).
3.4.14  Comparison of the DNA protective effect of quercetin bulk on DNA 
damage induced by H2O2 in lymphocytes collected from healthy 
individuals and patients with TB. 
Figures 34 and 35 show a comparison between lymphocytes collected from healthy 
individuals (figure 18 and 19) and lymphocytes from patients with TB (figure 22 and 
23). The DNA damage was described by two parameters % tail DNA and Olive tail 
moment. The DNA damage reduction was compared to the positive control; in both 
the groups, lymphocytes were treated with three concentrations of quercetin bulk.  
The % tail DNA (figure 29) shows a non- significant effect of three concentrations of 
quercetin bulk in lymphocytes from healthy individuals as well as lymphocytes 
collected from TB patients. The concentration 100µM of quercetin bulk shows non-
significant reduction in the DNA damage.  However, this reduction was statistically 
non-significant in both parameters 
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Figure 34: A comparison of % Tail DNA between lymphocytes (figure 18) from 10 different healthy 
and lymphocytes (figure 22) from 10 TB patients treated with quercetin bulk in the presence of H2O2 
(60µM), ± SEM Two-Way AVOVA test and significance compared with the positive control 
(donors=10). 
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Figure 35: A comparison of Olive tail moment between lymphocytes (figure 19) from 10 healthy 
individuals and lymphocytes (figure 23) collected from 10 TB patients treated with quercetin bulk in 
the presence of H2O2 (60µM) ± SEM Two-Way AVOVA test and significance compared with the 
positive control (donors=10). 
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3.4.15 Comparison of the DNA protective effect of quercetin nano on DNA 
damage induced by H2O2 in lymphocytes collected from healthy 
individuals and patients with TB. 
Figures 36 and 37 display a comparison between lymphocytes collected from TB 
patients (figure 24 and 25) and lymphocytes collected from healthy individuals 
(figures 20 and 21) treated with the quercetin nano in the presence of H2O2 using % 
tail DNA and Olive tail moment. It was shown that the influence of quercetin nano 
was noN-significant in healthy lymphocytes compared to the positive control, while 
the effect was significant in lymphocytes collected from TB patients where the P 
value recorded was **P≤0.0120 at a concentration 25 µM and ***P≤0.001 at 
concentration of 100 µM. The concentration of 10µM of quercetin nano was not 
significant for % tail DNA and Olive tail moment in the Two-Way ANOVA test. 
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Figure 36 : A comparison of % Tail DNA  between lymphocytes (figure 20) from 10 different healthy  
individuals and lymphocytes (figure 24 ) collected from 10 patients with TB treated with quercetin 
nano in the presence of H2O2 (60µM), ± SEM Two-Way AVOVA test and significance compared with 
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Figure 37: A comparison of Olive tail moment between lymphocytes (figure 21 ) collected from10 
different healthy individuals and lymphocytes (figure 25 ) collected from 10 patients with TB treated 
with quercetin nano in the presence of H2O2(60µM), ± SEM Two-Way AVOVA test and significance 
compared with the positive control (donors=10). 
 
 
3.4.16  Comparison of the DNA protective effect of quercetin bulk and 
quercetin nano on DNA damage induced by H2O2 in lymphocytes 
collected from patients with TB. 
 The bar chart 38 and 39 give information about a comparison between bulk (figures 
22 and 23) and nano (figures 24 and 25) of quercetin in treated lymphocytes 
collected from TB patients, compared to the positive control. The % tail DNA showed 
the effect of the bulk form of quercetin was non-significant at three concentrations 
10µM, 25µM, 100µM, whereas the nano form was significant at two concentrations 
which are 25µM and 100µM. However, the nano form at10µM concentration had a 
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value of P≥0.05 (Figure 33). In figure 33 where the comparison used Olive tail 
moment, the three concentrations of nano form showed statistically significant 
reduction of DNA damage in lymphocytes from TB patients in the Two-Way ANOVA 
test; furthermore, 25µM and 100µM concentrations of the nano form gave the same 
significance of ***P≤0.001. However, the 10µM concentration showed a non-
significant reduction in DNA damage compared to the positive control. The bulk form 
did not bring about significant reduction in DNA damage at the lowest concentration 
of 10µM but was effective in reducing the DNA damage significantly at the higher 
concentration of 25 µM *P≤0.0024, and 100 µM **P≤0.0014 based on the same 
statistical analysis. 
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Figure 38: A comparison of % Tail DNA between bulk form (figure 22) and nano form of quercetin 
(figure 24) treated lymphocytes collected from 10 patients with TB in the presence of H2O2 (60µM), ± 
SEM Two-Way AVOVA test and significance compared with the positive control (donors=10). 
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Figure 39: A comparison of Olive tail moment between bulk form (figure 23) and nano form (figure 25) 
of quercetin treated lymphocytes from 10 patients with TB in the presence of H2O2 (60µM), ± SEM 



















Figure 41: Typical comet image in lymphocytes collected from TB patients showing damage in 





3.5  Discussion  
In the last two decades, the Comet assay has become one of the most influential 
and standard assays to evaluate DNA damage and measuring the changes in 
genomic instability (Anderson et al., 2013). Collins et al (1997) and Wu and Jones 
(2012) pointed out that the Comet assay is the most sensitive technique to assess 
DNA strand breakage using neutral or alkaline forms of the assay. The advantages 
of this method include rapidity, ability to measure DNA damage at the level of a 
single cell, simplicity and the requirement of small blood samples (Collins et al., 
1997, Wu and Jones, 2012). It has been reported that lymphocytes collected from 
healthy individuals or patients may reflect cancer cells and other disease states to 
estimate genotoxicity. Furthermore, lymphocytes are suitable for monitoring 
chromosomal abnormalities, mutations, and sister chromatid exchanges, and after in 
vitro exposure (Najafzadeh et al., 2012, Anderson et al., 1991). Once a chemical 
change from the bulk form to the nano form, the surface area of the material is 
increased, as well as its immunogenicity, drug delivery and solubility due to improved 
contact between the NPs and the surrounding materials, which increase reactivity 
(Zhang et al., 2008). The nanoparticles form having a greater surface area than the 
bulk form, where a greater surface leads to a high opportunity of inflammation in the 
respiratory system and improved oxidant capacity (Frampton et al., 2004).   Nano 
and bulk forms of quercetin were used to treat ex-vivo sperm and lymphocytes in 
vitro. Lymphocytes and sperm collected from healthy individuals and lymphocytes 
obtained from TB patients were treated with three different concentrations of 
quercetin (10µM, 25 µM and 100 µM) nano and bulk form at the same time. All the 
experiments were done in vitro in the same settings. The study used H2O2 as a 
positive control, lymphocytes used 60 µM of H2O2 as the positive control and 50 µM 
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of H2O2 was used with sperm, this was because sperm are more sensitive and 
contains half number of chromosomes. Dissimilar results were noticed in the present 
project between quercetin concentrations and reduction of DNA damage in sperm 
and peripheral lymphocytes collected from patients with TB from a mean of ten 
different individuals. Results showed significant protection regarding DNA damage 
by the nano form compared to the bulk form which treated lymphocytes collected 
from TB patients (Figures 38 and 39). Using Graph pad prism Two-Way ANOVA test 
the protection was significant where the P value was ***P≤0.001. While, lymphocytes 
collected from healthy individuals were induced by 60 µM of H2O2 and treated with 
both forms of quercetin, the effect of quercetin was statistically non-significant 
(Figures 18, 19, 20, 21).   The high response was at 100 µM of quercetin in the nano 
form where the P value was ***P≤0.001 with both sperm samples and lymphocytes 
from TB patients (Figures 24, 25 and 28, 29). The reason for this could be that 
quercetin was more effective as an anti-oxidant compound with a concentration of 
100µM. Furthermore, it was shown at 10 µM of quercetin that the nano form was not 
effective in reducing the DNA damage significantly (Figures 36 and 37, and 17) 
compared to lymphocytes collected from healthy individuals. In contrast 25 µM of 
quercetin nano form showed a P value of **P≤0.0026. The highest concentration 
reduced DNA damage compared to the negative control was 100µM of quercetin 
nano. The concentrations above 100 µM of quercetin were neglected because recent 
studies reported that it leads to DNA damage. Moreover, it is difficult to prepare 
higher concentrations as a nano form (Oztopcu-Vatan et al., 2009). In this present 
study the results of the Comet assay were compatible with the previous 
recommendation that flavonoid such as quercetin has antimicrobial resistance for TB 













4 Chapter (4) The antigenotoxic effect of quercetin nano and bulk 













4.1 Introduction   
The Comet assay data from the previous chapter shows that lymphocytes collected 
from healthy individuals and patients with TB exhibit a noticeable reduction in DNA 
damage brought about by H2O2 treatment in the presence of both the nano and bulk 
forms of quercetin. The current study employs the micronucleus assay to confirm 
these findings as this assay is one of the reliable methods of assessing chromosome 
damage. Both for chromosome loss and chromosome damage (Fenech, 2007). In 
this technique, genetic instability is measured by analysing the presence of the 
micronucleus (MN), nucleoplasmic bridges (NPBs), and nuclear buds (NBUDs) in 
binucleated cells.  The assay involves culturing of lymphocytes. The lymphocyte cell 
cycle takes 24 hours. In the first stage (G1) cells start to produce enzymes that 
necessary in S phase (Collins et al., 1997b). Chromosomes are replicated in the S 
phase to yield two copies. Following this, all substances which are required in M 
phase and help the cell to divide are started by synthesis in the G2 phase (Norbury 
and Nurse, 1992) Nuclear division is completed in M phase; this stage can be further 
divided into five different substages starting with prophase, followed by 
prometaphase, then metaphase, after that anaphase, and finally telophase. The 
DNA damage is scored in binucleated cells (BiNC) formed due to cytochalasin B 
(cyto B) stopping cell division at the cytokinesis stage. Genotoxic compounds can 
cause mutations and DNA damage due to their interfering with chromosomes 
throughout the cell division (Fenech, 2007). Formation of micronuclei MNi can be 
created from a fragment or a whole chromosome at the mitosis stage after 
anaphase.  The presence of micronuclei in binucleated cells reflects the presence of 
chromosome breakage and or whole chromosomes (Fenech, 2007). Nuclear buds 
NBUDs and Nucleoplasmic bridges (NPBs) which are small bridges linking two 
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nuclei together are biomarkers of DNA miss-repair and/or telomere end-fusions, and 
elimination of amplified DNA and/or DNA repair complexes respectively (Fenech, 
2007). Furthermore, a dicentric chromosome which occurs as a result of DNA miss- 
repair is leading to NBUDs which is useful to detect gene amplification. The NBUDs 
are normally connected to the indigenous nuclei; this is the difference between buds 
and micronuclei, which are not the only difference. The MNi are separated from both 
nuclei (Fenech, 2007, Luzhna et al., 2013). The Micronucleus assay has been 



















4.2  Materials and Methods  
4.2.1  Materials  
All chemicals and reagents are already shown in chapter 2 table (1) page number 47   
4.2.2  Methods  
Fresh blood was used in this technique; the collection of blood samples from healthy 
individuals and patients is as reported in chapter 2.5. page 50. The protocol of this 
assay is described in chapter 2 section 2.11 (page numbers 56-59). DNA damage 
was induced in lymphocytes using Bleomycin and treated with different 
concentrations of nano and bulk forms of quercetin as shown in chapter 2, table 5-
page number 57.  Examination of lymphocytes collected from healthy individuals and 
lymphocytes collected from patients with TB were repeated three times to confirm 
the results depending on MNi frequency and other cytogenetic parameters.
 
 




Figure 43: Mono-nucleated cells with one 
micronucleus.
 
Three concentrations of quercetin were used in this technique 10µM, 25 µM and 100 
µM with both untreated cells and positive control which was 0.4 μM of mitomycin c.  
In this assay, two slides were made for each concentration, 500 cells were scored for 
each slide under a light microscope to detect MNi, NBUDs, and NBPs. Cells were 
calculated to determine the percent of MonoNC, BiNC, and MultiNC. The Nuclear 
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index division (NDI) can be calculated using three cell types; (NDI) can reflect the 
rate of mitotic division (Fenech, 2007). 
4.2.3  Statistical Analysis 
All the results were obtained by investigating 500 cells for each slide and at every 
concentration there was a need to score two slides as per the Fenech protocol 
(Fenech, 2007). The (NDI) was determined for each slide and compared with the 
result obtained for bleomycin. The Graph pad prism T test two tail and two-way 




























4.3  Micronucleus results 
4.3.1  Bleomycin concentration response results:  
Bleomycin is a natural glycopeptide used as an anticancer treatment; at the same 
time, it can cause DNA damage due to free radicals that are released.  Micronucleus 
can be formed due to the effect of bleomycin, Nucleoplasmic bridges, and nuclear 
buds reflect DNA damage in cancer and normal cells (Dedon and Goldberg, 1992). 
For this reason, five different concentrations of bleomycin (0.55, 0.65, 0.75, 0.85, 
0.95µg/ml) were chosen to treat lymphocytes collected from three different healthy 
individuals to identify the concentration causing the highest damage. Table 9 and 
figure 44 display the mean of the results from lymphocytes of three healthy 
individuals treated with five different concentrations of bleomycin. The total 
cytogenetic damage that included (MNi, NPBs, and buds mean) described the 
influence of bleomycin on lymphocytes collected from healthy individuals where the 
NDI rate was between 1 - 1.5 and bi-nucleated cells occupied 30% to 45%. Different 
cytological scoring parameters were expressed as a percentage out of all types of 
500 cells scored. It is clear from the bar chart (figure 44) that the concentration of 
0.75µg/ ml produced the highest damage according to One-Way ANOVA test results 
with a significance value ***P≤0.001 compared to the negative control. The 
concentration 0.65µg/ml displayed significance *P≤ 0.027 and other concentrations 
exhibited non-significant levels of DNA damage. Based on these results, the 
concentration of 0.75µg/ml was chosen as the most appropriate concentration to 
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Figure 44: Concentration response of lymphocytes from three different healthy individuals treated with 
range of concentrations of bleomycin, ± SEM One-Way AVOVA test and significance compared with 
the control (donors=3). 
 
Bleomycin Negative  0.55µg/ml 0.65µg/ml 0.75µg/ml 0.85µg/ml 0.95µg/ml 
Mon % 52.00 60.00 60.80 64.70 68.80 84.00 
Bio % 45.00 35.70 35.70 31.40 30.80 30.60 
NID  1.50 1.43 1.42 1.41 1.34 1.16 
MNi mean 1.00 4.30 7.30 11.30 6.30 1.00 
Buds mean 3.00 2.00 7.60 9.00 5.00 3.60 




6.00 11.60 19.30 26.30 15.30 7.60 
 
Table 8: Summary of micronucleus test on lymphocytes from three different healthy individuals 
treated with range concentrations of bleomycin. The results expressed over 1000 cells each 





4.3.2 A comparison of the genoprotective effect of bulk and nano forms of 
quercetin on lymphocytes from healthy individuals treated with 
bleomycin using micronucleus assay 
Bar chart 45 and table 10 provide information on the genoprotective effect of bulk 
and nano form of quercetin on lymphocytes treated with bleomycin using the 
micronucleus assay.  Lymphocytes were collected from healthy individuals incubated 
with bleomycin and treated with the two forms of quercetin separately. It is obvious 
from the bar graph 45 and table 10 that both forms of quercetin brought about 
reduction in the percentage of micronuclei compared to bleomycin (0.75µ/ml). The 
only concentration that was non-significant is the 10µM quercetin bulk form where 
the P value was greater than P≥ 0.05, while the concentration of 100µM of the bulk 
and nano forms of quercetin showed a significant reduction in the formation of 
micronuclei, statistical significance based on Two-Way ANOVA test ***P≤ 
0.001compared to the bleomycin. 






























































b u lk  fo rm







Figure 45: A Comparison between bulk and nano form of quercetin based on MN frequencies in 
lymphocytes collected from three different healthy individuals treated with quercetin bulk and nano 




File NC PC Bleomycin 10µMQB 10µMQN 25µMQB 25µMQN 100µMQB 100µMQN 
Mon% 50.50 59.00 53.00 55.00 58.50 57.00 55.00 55.50 55.30 
Bio % 44.00 34.20 44.00 39.00 36.50 45.00 41.00 40.90 41.30 
Multi % 3.80 4.80 7.30 4.80 3.70 3.10 3.30 3.20 3.10 
NID 1.50 1.50 1.50 1.50 1.40 1.47 1.49 1.47 1.48 
MNi  1 15 15.5 9.5 2 5 2 2 1 
Bio-Buds 6 10 8.5 9.5 11 11.5 8 4.5 2 




8.00 29.00 27.50 24.00 14.00 20.50 11.00 8.00 4.00 
 
Table9: Summary of different cytological parameters from the micronucleus assay of lymphocytes 
from healthy individuals treated with bulk and nano forms of quercetin represented by Mon-
nucleated%, Bi-nucleated %, nuclear division index, MNi micronucleus cells, Bi-nucleated Buds, Bi-
NPBs and total cytogenetics damage. The results expressed over 1000 cells each concentration 
scored (donors=3). 
4.3.3  A comparison of the genoprotective effect of bulk and nano forms of 
quercetin on lymphocytes from TB patients treated with bleomycin 
using micronucleus assay 
Bar chart 46 and table 11 illustrates the comparative genoprotective effect of bulk 
and nano form of quercetin in bleomycin treated lymphocytes collected from TB 
patients.  Overall, the effect of the nano form was more significant than the bulk form 
based on the comparison with bleomycin using a Two-Way ANOVA test. The first 
concentration of the bulk form reduced micronucleus formation partially, and 
statistically was significant at *P≤ 0.0281. However, the other two concentrations of 
bulk and the concentration 10 µM of the nano form were shown the same 
significance and the P value gives **P≤ 0.027. The higher effect of quercetin was 
with the nano form with two concentrations 25 µM and 100µM where the significance 
was ***P≤ 0.001.   
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Figure 46: A Comparison between MN frequency in lymphocytes collected from three different patient 
with TB treated with quercetin bulk and nano form in the presence of 0.75µg/ml of bleomycin. The 
results expressed over 1000 cells each concentration scored including ± SEM and significance level 
using T test two tail (donors=3). 
 
File NC PC Bleomycin 10µMQB 10µMQN 25µMQB 25µMQN 100µMQB 100µMQN 
Mon% 53.80 53.00 52.20 60.20 61.00 64.00 59.60 57.50 56.00 
Bio % 43.50 41.00 44.20 38.40 35.80 37.80 40.10 36.70 41.00 
Multi % 2.7.00 6.00 3.6.00 1.40 3.20 1.00 1.00 6.50 3.00 
NID 1.47 1.48 1.48 1.39 1.48 1.38 1.40 1.40 1.43 
MNi  1.3 14 14.3 11.6 11 11.3 3.3 10.6 1.3 
Bio-Buds 5.3 7 12 12.6 6.3 10.6 9 7.6 4.3 




10.60 25.30 31.30 27.50 17.60 23.50 16.30 17.90 8.20 
 
Table 10: Summary of MN frequencies in lymphocytes collected from healthy individuals treated with 
the bulk and nano forms of quercetin represented by Mono-nucleated%, Bi-nucleated %, nuclear 
division index, MNi micronucleus cells, Bi-nucleated Buds, Bi-NPBs and total cytogenetics damage. 
The results expressed over 1000 cells each concentration scored (donors=3). 
101 
 
4.3.4 A comparison of the ability of quercetin bulk form in reduction of 
micronucleus induction in lymphocytes from healthy individuals and 
lymphocytes from TB patients treated with bleomycin  
Bar graph 47 shows a comparison of the genoprotective effect of the bulk form of 
quercetin in terms of percentage reduction in the micronucleus in lymphocytes from 
healthy and lymphocytes from patients with TB treated bleomycin. It is clear from the 
bar chart that the decrease in the rate of micronuclei by quercetin bulk in 
lymphocytes collected from healthy individuals was similar to lymphocytes collected 
from TB patients. At 10µM concentration, the bulk form of quercetin shows no 
significant effect with the Two-Way ANOVA test.  The similarity of the effect was 
clear at 25µM where the statistical analysis confirmed identical levels of significance; 
it recorded P *P≤0.0283. The highest reduction for the micronucleus rate was 
observed with 100µM of the bulk form of quercetin treated lymphocytes collected 
from patients with TB which showed a significance level of **P≤0.0271. 
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Figure 47 : A comparison of MN frequencies in lymphocytes from three different healthy individuals 
and lymphocytes from three TB patients treated with quercetin bulk in the presence of 0.75µg/ml of 
bleomycin including standard errors and significance using T test two tail. The results expressed over 
1000 cells each concentration scored (donors=3). 
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4.3.5 A comparison of the ability of quercetin in the nano form in reducing 
micronucleus induction in lymphocytes from healthy individuals and 
lymphocytes from TB patients treated with bleomycin  
Bar chart 48 gives information about the ability of the quercetin nano form in 
reducing the induction of MNi in lymphocytes from healthy individuals compared to 
lymphocytes from patients with TB treated with 0.75µg/ml bleomycin. It is clear from 
figure 48 that the rate of micronucleus induction was significantly reduced when 
treated with 25 µM and 100µM of quercetin nano in lymphocytes from healthy 
individuals and also those from patients with TB. The Two-Way ANOVA test 
revealed significance of ***P≤0.001 with lymphocytes of both healthy individuals and 
TB patients. The decrease of MNi was less significant at 10µM where the P value 
showed **P≤0.0271) with healthy individuals. However, the lowest significance was 
with lymphocytes collected from TB patients and shown *P≤0.0283. 
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Figure 48: A Comparison between MNi frequency in lymphocytes from three patients with TB and 
three lymphocytes from healthy individuals treated with quercetin bulk in the presence of 0.75µg/ml 
bleomycin including standard errors and significance level using T test two tail. The results expressed 




Micronuclei (MNi) are formed during anaphase of the nuclear division. It consists of a 
small, whole chromosome or a fragment of the chromosome which lags behind 
during anaphase and is not joined with the daughter nucleus (Fenech, 2007). The 
MNi were discovered over 100 years ago by Howell and Jolly in the cytoplasm of 
erythrocytes and the haematologist named it the “Howell-Jolly bodies” (Kirsch-
Volders et al., 2003). Later Fenech used Cytochalasin-B (Cyt-B) to block cytokinesis 
resulting in the development of the Cytokinesis-block Micronucleus (CBMN) assay. 
This technique is an inexpensive and reliable technique for scoring DNA damage, 
micronucleus rate (MNi), nuclear buds (NBUDS) and nucleoplasmic bridges (NPBs). 
Moreover, it can evaluate the percentage of mono-, bi-, and multinucleated cells, the 
effect of cytotoxicity and measuring the rate of apoptotic and necrotic cells (Albertini 
et al., 2000). The reduction of MNi by bulk and nano form of quercetin as the 
protective compound in the bio-nucleated lymphocytes was investigated using this 
technique. Many studies have approved that regular intake of flavonoids like 
quercetin and rutin play a major role in cancer prevention (Li et al., 2001). Results 
from tables (10, 11) illustrated a normal value of NDI rated between (1.3 - 1.5). The 
vast majority of lymphocytes had completed one cell division. 1% - 6% of 
lymphocytes from TB patients, and 3% - 7% of lymphocytes from healthy individuals 
were multinucleated. This is proof that a low percentage of lymphocytes have started 
the second cell division (mitosis) in the presence of cyto-B. Different results were 
obtained from lymphocytes collected from healthy individuals and TB patients where 
the MNi production compared to bleomycin using both forms of quercetin. The 
positive control and the negative control in all experiments were normally distributed. 
The bulk size of quercetin at a concentration of 10µM did not significantly reduce the 
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micronucleus frequency in both lymphocytes collected from healthy individuals and 
patients with TB (figure 47), whereas the nano form was significant at the same 
concentration *P≤0.0283 bar graph 48. The best reduction of MNi rate was at 100µM 
of quercetin in nano form the significance was ***P≤0.001 compared with bleomycin 
bar graph 48. Comparing two forms of quercetin (bulk and nano); the result of the 
comparison indicated that the nano form has a significant influence on MNi 
frequency more than the bulk size. In 2009 Singh et al, reported the difference in 
these forms. They pointed out that, nanoparticles have a greater ability to penetrate 
the nucleus membrane than the bulk size (Singh et al., 2009). MNi are assumed to 
reflect the primary stage in development of genomic instability in TB patients. 
Therefore, reducing MN frequency by quercetin in lymphocytes from TB patients was 
applicable (Luzhna et al.,2013). Moreover, Mycobacteria can stimulate reactive 
oxygen species (ROS) production by activating phagocytes where hydrogen 
peroxide (H2O2) is released.  The H2O2 is accumulated constantly by the 
macrophages and a resulting high free radical load in pulmonary cells in TB patients 
which may lead to cancer development, this condition like bleomycin effect that 
releasing free radicals, then oxidative stress that casing DNA damage (Adebimpeet 
al., 2016). Results of this assay suggest that a small dose of quercetin could have a 
therapeutic role as a protective compound with bleomycin to decrease the level of 



















5 Chapter (5) The influence of quercetin on the level of DNA 
damage caused by heterocyclic amines PhIP and IQ in 
























Heterocyclic amines (HCA) have been recognised as having an important effect on 
human health and can raise the risk of cancer (Emmons et al., 2005). Many studies 
reported that colorectal cancer relates to HCA exposure (Knize et al., 1995). The 
HCA can be formed during cooking proteinaceous food; basically, through the 
heating effect on free amino acids, monosaccharides, and creatinine. Moreover, 
HCA can be a causal factor of mutagenic action in the bacterial test systems such as 
Ames/Salmonella assay where the methyl groups' location can cause the 
mutagenicity (Felton and Knize, 1991). The heterocyclic amines can be distinguished 
into three different derivatives: amino-imidazo-pyridines (e.g. PhIP), amino-imidazo-
quinolines (e.g. IQ) and amino-imidazoquinoxalines (e.g. 2-amino-3, 8-
dimethylimidazo [4,5 –f]quinoxaline, 8-MeIQx). The PhIP seemed to be less effective 
in causing DNA damage when examined in bacterial cells (Pfau et al., 1999). 
Anderson et al. (2001) reported that the lymphocytes collected from patients 
diagnosed with a disease state are more sensitive to DNA damaging agents 
compared with those from healthy individuals (Anderson et al., 2001; Najafzadeh et 
al., 2009).  
In the current study the food mutagens, IQ and PhIP were used to induce DNA 
damage in lymphocytes collected from healthy individuals and patients with TB in the 
presence of different concentrations of bulk and nano forms of quercetin. The level of 
DNA damage was measured using the Comet assay to evaluate the genoprotective 






5.2  Materials and methods 
The materials and methods, as well as the experimental design, have been 
described in Chapter 2 section 2.12.6-page number 59. 
5.3  Statistical analysis 
Data obtained as % Tail DNA and Olive tail moment were analysed by Graph pad 
prism 6 and SPSS for Windows, statistical package (version 18.0).  The data were 
tested for normal distribution, using Kolmogorov-Smirnoff and Shapiro Wilk’s test. 
One-Way ANOVA test was used to examine the significance of experimental results 
obtained for the lymphocytes collected from healthy individuals and patients with TB. 
All the results were compared with IQ or PhIP samples in the presence of quercetin 
of different concentrations. Moreover, the two forms bulk and nano of quercetin were 
















5.4  Results 
5.4.1  Concentration response experiments on the IQ induced DNA damage in 
lymphocytes from healthy individuals induced by IQ at different 
concentrations.  
Figures 49 and 50 provide information on the concentration response of IQ induced 
DNA damage in lymphocytes collected from healthy individuals. It is clear from the 
histograms that the DNA damage reaches a peak at 150µM and 175µM of IQ in both 
parameters, % Tail DNA and Olive tail moment. Graph pad One-Way ANOVA test 
showed high significance **P≤0.0043 at 150µM and 175µM using %Tail DNA the 
concentrations were compared to the negative control. The trend was dropped at 
200µM in the two parameters. Based on these results, the concentration of 160µM 
was chosen as a concentration of    IQ used in the experiments. 
























































































Figure 49: Different concentrations of IQ 
treated lymphocyte collected from three 
different healthy individuals presented as 
means of the response of % Tail DNA, ± SEM, 
One-Way AVOVA test and significance 
compared with the untreated cells (donors=3). 
Figure 50: Different concentrations of IQ 
treated lymphocyte collected from three 
different healthy individuals presented as 
means of the response of Olive tail moment, ± 
SEM, One-Way AVOVA test and significance 




5.4.2 The effect of quercetin bulk and nano forms on DNA damage induced by 
160µM of IQ in lymphocytes collected from healthy individuals.  
Figures 51 and 52 illustrate data related to lymphocytes collected from healthy 
individuals treated with quercetin bulk and nano forms in the presence of IQ at 
160µM. On the basis of % Tail DNA, it is clear that both the forms of quercetin can 
reduce DNA damage. The reduction was statistically significant and rated between 
**p ≤ 0.0043 to ***p ≤ 0.001 depending One-Way ANOVA test, whereas all the 
concentrations of the bulk form were non-significant for Olive tail moment. All 
treatments were compared to lymphocytes with IQ only.  









































































































































































Figure 51: The effect of quercetin bulk and nano 
forms on DNA damage presented as the means 
of % tail DNA of lymphocyte collected from 10 
different healthy individuals treated with 
quercetin at different concentrations in the 
presence of IQ 160µM ± SEM, One-Way 
AVOVA test and significance compared with 
160 µM of IQ (donors=10). 
 Figure 52: The effect of quercetin bulk and nano 
forms on DNA damage presented as the means 
of Olive tail moment of lymphocyte collected 
from 10 different healthy individuals treated 
with quercetin different concentrations in the 
presence of IQ 160µM ±SEM,One-Way 




5.4.3 Effect of bulk and nano forms of quercetin on DNA damage induced by 
160µM of IQ in lymphocytes collected from TB patients. 
Figures 53 and 54 show information related to lymphocytes collected from TB 
patients treated with quercetin bulk and nano forms in the presence of IQ 160µM. 
The most striking features of the two bar charts are that the quercetin has the 
potential to reduce DNA damage caused by IQ. The term % Tail DNA illustrates a 
significant reduction where the P value ranged between**p ≤ 0.0043 to ***p ≤ 0.001. 
However, the results of the Olive tail moment were different; the bulk form was 
significant only at 100µM and *p ≤ 0.0405. The maximum reduction in DNA damage 
was observed with 100µM of the nano form. All treatments were compared to 
lymphocyte samples treated with IQ only.  


































































































































































Figure 53: The effect of quercetin bulk and nano 
forms on DNA damage presented as the means 
of % Tail DNA of lymphocyte collected from 10 
TB patients treated with quercetin different 
concentrations in the presence of IQ 160µM, 
±SEM,One-Way AVOVA, significance 
compared with the 160 µM of IQ (donors=10). 
Figure 54: The effect of quercetin bulk and nano 
forms on DNA damage presented as the means 
of Olive tail moment of lymphocyte collected 
from TB patients treated with quercetin 
different concentrations in the presence of IQ 
160µM, ±SEM,One-Way AVOVA, significance 





5.4.4  Dose response experiments with sperm from healthy individuals 
induced by IQ concentrations.  
Figures 55 and 56 provide the concentration response of sperm samples from 
healthy individuals treated with IQ. It is evident from the results (Figures 55 and 56) 
that the concentrations 125µM and 150µM exhibit the highest DNA damage. 
However, the damage at other concentrations is non-significant or less significant 
both in terms of % tail DNA and Olive tail moment. All the concentrations were 
compared with the negative control. Based on one-way ANOVA test, the negative 
control, and all concentrations were normally distributed.  
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Figure 55: Different concentrations of IQ 
treated sperm from three different healthy 
individuals presented as the response means 
of % Tail DNA, ±SEM,One-Way AVOVA test 
significace compared with the untreated cells, 
(donors=3). 
Figure 56: Different concentrations of IQ 
treated sperm from three different healthy 
individuals presented as the response means 
of Olive tail moment, ±SEM,One-Way AVOVA 






5.4.5 Effect of quercetin bulk and nano forms on DNA damage induced by 
140µM of IQ in sperm collected from healthy individuals. 
Figures 57 and 58 illustrate data on the ability of the two forms of quercetin in 
reducing DNA damage induced by IQ 140µM in sperm collected from healthy 
individuals. It was apparent from % Tail DNA and Olive tail moment; that the nano 
form of quercetin significantly reduced the damage to sperm DNA at 25µM and 
100µM where the p-value rated between *p ≤ 0.043 and ***p ≤ 0.001. There was a 
non-significant DNA damage with a bulk form of quercetin based on One-Way 
ANOVA test. All concentrations were compared to sperm sample treated with IQ 
only. The negative control, positive control (50µM H2O2), IQ and quercetin 
concentrations were distributed normally. 













































































                         





















































































Figure 57: The effect of quercetin bulk and 
nano forms on DNA damage presented the 
means of % Tail DNA of sperm collected from 
10 different healthy individuals induced by 
140µMIQ, ±SEM, One-Way AVOVA test 
significace compared with the 140µM of IQ 
(donors=10).                                                            
 
Figure 58: The effect of quercetin bulk and 
nano forms on DNA damage presented as the 
means of Olive tail moment of sperm collected 
from 10 different healthy individuals induced 
by 140µMIQ, ±SEM,One-Way AVOVA test 





5.4.6  Concentration response of PhIP induced DNA damage in lymphocytes 
from healthy individuals. 
Figures 59 and 60 are display information about the concentration response of 
lymphocytes collected from healthy individuals to PhIP. It is clear that from both 
histograms that the DNA damage reached the peak at 150µM of PhIP in both terms 
of % Tail DNA and Olive tail moment, the statistical analysis using a Graph Pad One-
way ANOVA test showing the highest significance at 150 µM where the ***P≤0.001.  
All the concentrations were compared to the negative control. The trend was 
dropped at 175µM in both parameters. Based on these results the concentration 
140µM of PhIP was chosen as a concentration used for experiments involving PhIP 
on lymphocytes.  
 











































Figure 59: Different concentrations of PhIP 
presented as the means of % Tail DNA of 
lymphocytes collected from three different 
healthy individuals, ±SEM,One-Way AVOVA 
test, significace compared with the untreated 
cells (donors=3). 
 
Figure 60: Different concentrations of PhIP 
presented as the means of Olive tail moment 
of lymphocytes collected from three different 
healthy individuals, ±SEM,One-Way AVOVA 





5.4.7  Effect of quercetin bulk and nano forms on DNA damage induced by 
140µM of PhIP in lymphocytes collected from healthy individuals. 
Figures 61 and 62 illustrate information about effect of bulk and nano forms of 
quercetin on lymphocytes from healthy individuals treated with PhIP 140µM. The 
experiment show that two forms of quercetin brought about a reduction in DNA 
damage expressed in terms of both % Tail DNA and Olive tail moment. The 
reduction was statistically significant and rated between *p ≤ 0.0043 and ***p ≤ 0.001 
depending on the One-Way ANOVA test. The best DNA reduction was at 100µM of 
quercetin, while 10µM of quercetin bulk showed *p ≤ 0.0043. All the treatments were 
compared to lymphocyte treated with PhIP only. The negative control, positive 
control (60µM H2O2) and quercetin concentrations were normally distributed. 
 















































































































































































Figure 61: The effect of quercetin bulk and 
nano forms on DNA damage presented as the 
means of % Tail DNA of lymphocytes from 10 
different healthy individuals induced by 
PhIP140µM, ±SEM,One-Way AVOVA test 
significace compared with the 140µM PhIP 
(donors=10). 
Figure 62: The effect of quercetin bulk and 
nano forms on DNA damage presented as the 
means of Olive tail moment of lymphocytes 
from 10 different healthy individuals induced 
by PhIP140µM, ±SEM,One-Way AVOVA test, 






5.4.8 Effect of quercetin bulk and nano forms on DNA damage induced by 
140µM of PhIP in lymphocytes collected from patients with TB. 
Figure 63 and 64 demonstrate data of the genoprotective ability of bulk and nano 
forms of quercetin in lymphocytes collected from TB patients treated with 140µM of 
PhIP. It was clear that both forms of quercetin significantly reduced the damage in 
lymphocyte DNA collected from TB patients compared to PhIP. The reducing was 
rated between *p ≤ 0.0043 and ***p ≤ 0.001 based on the One-Way ANOVA test 
using both parameters % tail DNA and Olive tail moment. All quercetin 
concentrations were compared to PhIP only. The negative control, positive control 
which is 60µM of H2O2 and quercetin concentrations were normally distributed. 























































































           
































































































Figure 63: The effect of quercetin bulk and 
nano forms on DNA damage presented as the 
means of % Tail DNA of lymphocytes collected 
from 10 TB patients induced by 140µM of 
PhIP, ±SEM,One-Way AVOVA test, significace 
compared with the 140µM PhIP (donors=10). 
Figure 64: The effect of quercetin bulk and 
nano forms on DNA damage presented as the 
means of Olive tail moment of lymphocytes 
collected from 10 TB patients induced by 
140µM of PhIP, ±SEM,One-Way AVOVA test, 





5.4.9 Concentration response of PhIP induced DNA damage in sperm from 
healthy individuals  
Figures 65 and 66 give information about damage induced by different 
concentrations of PhIP on sperm collected from healthy individuals treated with 
different concentrations of PhIP to determine the concentration response using % 
Tail DNA and Olive tail moment. It was evident from figure 65 and 66 that the 
concentrations 100µM and 125µM of PhIP caused the highest damage in sperm 
DNA compared to negative control. The comparison used the One-Way ANOVA test 
and showed ***p ≤ 0.001 for both concentrations. The concentrations 25µM, 150µM, 
175µM showed a non-significant DNA damage compared to negative control. 
 
  





























































         






































































Figure 65: Different concentrations of PhIP 
presented as the response for means of % Tail 
DNA of sperm collected from three different 
healthy individuals, ±SEM,One-Way AVOVA 
test significace compared with the untreated 
cells (donors=3). 
Figure 66: Different concentrations of PhIP 
presented as the response for means of Olive 
tail moment of sperm collected from three 
different healthy individuals, ±SEM,One-Way 
AVOVA test significace compared with the 




5.4.10 Effect of bulk and nano forms of quercetin on DNA damage induced by 
100µM of PhIP in sperm collected from healthy individuals. 
The Figures 67 and 68 illustrate the genoprotective effect of the two forms of 
quercetin in sperm from healthy individuals treated with 100µM of PhIP. It is clear 
from figures 67 and 68 that the effect of quercetin on sperm DNA was significant at 
some concentrations, the 10µM of quercetin bulk in both parameters was non-
significant compared to PhIP. It was clear that higher concentrations of both forms of 
quercetin significantly reduced the damage in sperm DNA compared to samples 
treated with PhIP only. The reduction was rated between *p ≤ 0.0043 and ***p ≤ 
0.001 based on the one-way ANOVA test. The greater DNA damage protection was 
at 100µM of quercetin nano. 
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Figure 67: The effect of bulk and nano forms of 
quercetin on DNA damage presented as the 
means of % Tail DNA of sperm collected from 
10 different healthy individuals induced by 
100µM of PhIP, ±SEM,One-Way AVOVA test, 
significace compared with the 100µM of PhIP 
(donors=10). 
 
Figure 68: The effect of bulk and nano forms of 
quercetin on DNA damage presented as the 
means of Olive tail moment of sperm collected 
from 10 different healthy individuals induced 
by 100µM of PhIP, ±SEM,One-Way AVOVA 




5.5 Discussion  
The damaging influences of both food mutagens, IQ and PhIP on the DNA was 
investigated in this chapter, lymphocytes, and sperm collected from healthy 
individuals and lymphocytes from patients with TB where treated in vitro to evaluate 
the ability of quercetin to reduce DNA damage.  A comparison of the responses of 
lymphocytes and rectal cells by Pool-Zobel et al. (2004) have revealed a good 
correlation of the extent of DNA damage on exposure to genotoxic compounds in 
these two types of cells.  These results support our protocol that uses the 
lymphocytes as mirror cells for the study of cancer and other disease states. The two 
food mutagens PhIP and IQ were considered to be carcinogenic and genotoxic 
(Durling and Abramsson-Zetterberg., 2005). Felton et al, (2004) reported that PhIP 
can develop carcinogenicity through DNA damage or oestrogen receptors while IQ 
has the potential to form DNA adducts like, N-(deoxyguanosine-8-yl)-IQ in the 
presence of nitric oxide that instituting a possible cancer risk for patients who are 
diagnosed with colon inflammation (Lakshmi et al., 2008). Also, HCA can cause DNA 
damage through the reactive intermediates, which is another possible mechanism to 
induce-DNA damage; the superoxide anion can be produced when food mutagens 
like IQ are incubated in the presence of NADH (Maeda et at., 1999). 
In this present study, the Comet assay was used to assess DNA damage due to 
oxidative stress induced by food mutagens IQ and PhIP and this is because the 
Comet assay in recent years has becomes a technique used for direct assessment 
of genotoxic DNA damage in lymphocytes and sperm. Furthermore, the Comet 
assay has become one of the most important assays for measuring the changes in 
genomic stability and detecting DNA damage (Anderson et al., 2013). Collins in 1997 
and Wu, Jones in 2012 have also pointed out that the Comet assay is the most 
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sensitive assay to study DNA strand breaks in the alkaline or neutral versions at 
present. The advantages of the Comet assay were linked to the time of the 
experiment, reasonable cost, simplicity, high sensitivity, and only small blood 
samples were needed (Kapka-Skrzypczak et al., 2011). Different sensitivities of 
lymphocytes and sperm samples were assessed. The samples were collected from 
ten different healthy individuals as well as ten patients with TB. The lymphocytes 
collected from healthy individuals had DNA induced damage by IQ 160µM,125 µM 
and PhIP140 µM, 100µM, these concentrations were considered to cause the 
highest damage for lymphocytes and sperm respectively without toxicity (Henderson, 
Albertini and Aardema, 2000). Figures (49, 50,55,56,59,60,65 and 66), the sperm 
and lymphocytes were treated with both nano and bulk forms of quercetin in the 
same time at different concentrations (10µM, 25 µM, and 100 µM). All the 
experiments were completed in vitro in the same settings. Results indicated 
significant protection regarding DNA damage by quercetin in both forms that treated 
lymphocytes collected from TB patients (figures 53 and 54), sperm collected from 
healthy individuals (figures 57 and 58) and lymphocytes collected from healthy 
individuals (figures 51 and 52). Using a One-Way ANOVA test the protection was 
significant and ***P value was (≤0.001). There was a non-significant DNA reduction 
in effect using the bulk form of quercetin treated sperm collected from healthy 
individuals (figures 55 and 56). The results were confirmed by two parameters % Tail 
DNA and Olive tail moment (Figures 57 and 58) the concentration 140µM of PhIP 
was chosen as a concentration that caused the highest DNA damage of lymphocytes 
without toxicity (Henderson, Albertini and Aardema, 2000). Both forms of quercetin 
were seen to reduce the DNA damage in lymphocytes induced by 140µM of PhIP; 
the cells were collected from healthy individuals and TB patients, and % Tail DNA 
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and Olive tail moment were used to evaluate DNA damage reduction. The reduction 
was significant and the p-value were rated between *p ≤ 0.0043 and ***p ≤ 
0.001based on the One-Way ANOVA test figures (59, 60, 61, and 62), whereas 
sperm collected from healthy individuals was induced by 100µM of PhIP depending 
on (figures 55 and 56); quercetin was reduced sperm DNA damage that was induced 
by PhIP more efficiently compared to IQ (figures 55, 56, 65 and 66). The positive and 
negative controls in all experiments highlighted as anticipated. The results have 
suggested that a small concentration of quercetin nano has a protective action to 
reduce DNA damage caused by heterocyclic amines in patient with TB. Vitaglione 
and Fogliano, (2004) reported that antioxidants can be used to decrease the human 




































6 Chapter (6) Investigation of expression of COX1, COX2, P53 and 
Bcl-2 transcripts in lymphocytes collected from healthy 




























6.1 QPCR technique to investigate the expression of COX1, COX2, P53 
and Bcl-2 in lymphocytes from healthy individuals and patient with 
TB.  
6.2 Introduction 
Real-time (RT-) PCR is a method that is commonly used to study gene expression, 
where quantity of DNA, cDNA, or RNA (PCR products) to be measured is small. The 
RT-PCR protocol relies on the detection of fluorescence formed by the amplification 
of the target molecules. This fluorescent target molecule contains dyes that connect 
to the DNA strand or sequence-specific investigations. RT-PCR has many 
advantages, such as quickness, the accuracy of results, and a high rate of 
sensitivity. Another advantage of this technique, which is very important, is that it has 
a low rate of contamination caused by PCR products (cDNA or RNA) (Klein, 2002). 
RT-PCR requires expensive reagents and understanding the experimental design of 
this technique is very crucial, as it is a susceptible procedure (Wong and Medrano, 
2005). The different PCR types are powerful techniques that are used widely in 
genotoxicity and gene expression. Gao et al., (2014) pointed out that prostaglandin 
(PG) and cyclooxygenase (COX) plays an essential action in the inflammatory 
progression through changing the synthesis of prostaglandins from arachidonic acid. 
There are two isoforms of cyclooxygenase namely COX-1 and COX-2 (Gao et al., 
2014) which are differentially expressed. COX1 is expressed in most tissues and is 
responsible for the biosynthesis of PGs and regulation of renal and - platelet 
functions. Whereas, COX-2 can be quickly induced by inflammatory stimuli and a 
significant number of mutagenic and pro-inflammatory cytokines that lead to 
increased levels of prostaglandins which can have an effect on cell proliferation, 
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apoptosis, and contributes to cancer transformation (Kuroda and Yamashita, 2002).  
Satyendra Singh Baghel et al., (2012) pointed out that the G1-M phase of the cell 
cycle checkpoint was controlled by the p53 gene which plays a significant part in cell 
proliferation (Baghel et al., 2012). The p53 gene is classified as a tumour suppressor 
(Kim et al., 2015; Bieging et al., 2014). It has been illustrated that the decrease of 
p53 expression, especially in the ageing, allows the cancer transformation (Kim et 
al., 2015). Gibellini et al., (2010) demonstrated that p53 could trigger apoptosis and 
control programmed cell death; moreover, quercetin can initiate the apoptosis in 
cancer cells through the upregulation of Bak and Bax and the downregulation of    
Bcl-2 (Gibellini et al., 2010). The Bcl-2 is the best indicator for protein families, which 
contributes to the control of programmed cell death, by regulating pro-apoptotic and 
anti-apoptotic factors. The Bcl-2 and Bcl-XL are anti-apoptotic factors that can 
regulate apoptosis either by sequestering caspases or by blocking the production of 
mitochondrial apoptogenic factors such as cytochrome c and apoptosis-inducing 
factor (AIF). Once inside the cytoplasm, cytochrome c and AIF immediately stimulate 
caspases that attach to cellular proteins leading to apoptotic changes. Bax and Bak 
trigger the producing of caspases from death antagonists via inducing the production 
of mitochondrial apoptogenic factors or mitochondrial permeability transition pore, 
that way leading to caspase activation (Tsujimoto, 1998). Quercetin is considered as 
the inducer of   apoptosis in cancer and inflammation via Bax, Bak and Bcl-2. Once 
the cells have been treated by quercetin, the quercetin induces the upregulation of 
Bax and Bak, and downregulation of Bcl2 that guides the cell to apoptosis (Gibellini 
et al., 2010).   
This study aims to examine the effect of both bulk and nano forms of quercetin on 
the expression of COX1, COX2, and p53 and Bcl-2 genes in lymphocytes collected 
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from patients with TB and compare them with those from healthy donors using the 
qPCR technique. The rationale for selecting the QPCR technique is that it is robust 
and offers a high level of specificity and sensitivity compared with other techniques 
such as western blot analysis 
6.3  Material and Methods 
The material and methods as well as experimental design were listed and described 






































6.4  Results 
6.4.1  Both forms of quercetin reduce expression of COX1 mRNA in 
lymphocytes of healthy individuals and patients with TB. 
The expression of COX1 transcripts was investigated in lymphocytes collected from 
healthy individuals and patients with TB. 140µM of PhIP induced optimal DNA 
damage in lymphocyte as shown in figures 59 and 60. Lymphocytes were treated by 
140µM of PhIP and corresponding lymphocytes were measured in the presence of 
either bulk or nano forms of quercetin incubated for 2 hours. The gene expressions 
were normalised against a housekeeping gene (β actin) using the ΔΔCq. The 
quercetin nano form showed significant downregulation in the COX1 gene compared 
with untreated cells and 140µM of PhIP in healthy individuals (Figure 69 and 70). 
The P value was **p ≤ 0.0074 with the One-Way ANOVA test. The down-regulation 
of the COX1 gene was observed in lymphocyte from TB patients treated with both 
bulk and nano forms but was significant only in lymphocytes treated with the nano 
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Figure 69: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative changes of 
COX1 mRNA over the control, using β 
actin as an endogenous housekeeping 
gene in lymphocytes collected from three 
different healthy individuals. The Relative 
expression level of COX1 mRNA after 
treatment with bulk and nano forms of 
quercetin. Results are expressed as mean 
± SEM, One-Way AVOVA test and 
significance compared with the untreated 
cells and 140µM of PhIP (donors =3). 
                                                                                                                                   
Figure 70: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative changes of 
COX1 mRNA over the control, using β 
actin as an endogenous housekeeping 
gene in lymphocytes collected from three 
different TB patients. The Relative 
expression level of COX1 mRNA after 
treatment with bulk and nano forms of 
quercetin. Results are expressed as mean 
± SEM, One-Way AVOVA test and 
significance compared with the untreated 










6.4.2  The bulk and nano forms of quercetin had no significant effect on the 
expression of COX2 mRNA in lymphocytes collected from healthy 
individuals and TB patients treated with 140µM of PhIP. 
The COX2 gene expression was investigated using our isolated lymphocytes 
collected from healthy individuals and TB patients. 140µM of PhIP induced optimal 
DNA damage in lymphocyte as shown in figures 59 and 60. Lymphocytes were 
treated by 140µM of PhIP and corresponding lymphocytes were measured in the 
presence of either bulk or nano form of quercetin incubated for 2 hours. The 140µM 
of PhIP does not induce COX2 down-regulation in lymphocytes that treated with 
100µM with both bulk and nano forms of quercetin. The experiments were designed 
in triplicate, and all the expressions were normalised against a housekeeping gene 
(β actin). The ΔCq was used to represent statistical analysis. The down-regulation 
was compared to untreated cells and 140µM of PhIP (figures 71 and 72). Both forms 
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Figure 71:The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
COX2 mRNA over the control, using β 
actin as an endogenous housekeeping 
gene in lymphocytes collected from three 
different healthy individuals. The Relative 
expression level of COX2 mRNA after 
treatment with bulk and nano forms of 
quercetin. Results are expressed as mean 
± SEM, One-Way AVOVA test and 
significance compared with the untreated 
cells, One-Way AVOVA teste cells and 
140µM of PhIP (donors=3).                                              
Figure 72: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
COX2 mRNA over the control, using β 
actin as an endogenous housekeeping 
gene in lymphocytes collected from three 
different TB patients. The Relative 
expression level of COX2 mRNA after 
treatment with bulk and nano forms of 
quercetin. Results are expressed as mean 
± SEM, One-Way AVOVA test and 
significance compared with the untreated 
cells and 140µM of PhIP (donors=3).
 







6.4.3  P53 mRNA expression was upregulated but not significantly in 
lymphocytes collected from healthy individuals and TB patients treated 
with both forms of quercetin in the presence of 140µM of PhIP. 
The figures 73 and 74 provide information about P53 gene expression in 
lymphocytes collected from healthy individuals and patients with TB. 140µM of PhIP 
induced optimal DNA damage in lymphocyte as shown in figures 59 and 60. 
Lymphocytes were treated by 140µM of PhIP and corresponding lymphocytes were 
measured in the presence of either bulk or nano form of quercetin that incubated for 
2 hours. The 140µM of PhIP did not induced p53 upregulation, and the changes 
were quantified using quantitative PCR. Untreated cells and cells treated with140µM 
of PhIP only were used for comparison to determine the value of the p53 expression. 
The experiments were designed in triplicate, all expressions were normalised against 
β actin using the ΔCq livak method. The results showed that there is non-significant 
up-regulation in p53 expression after two hours of treatment in both lymphocytes 
from healthy individuals and patients with TB treated with the bulk form of quercetin 
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Figure 73: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
p53 mRNA over the control, using β actin 
as an endogenous housekeeping gene in 
lymphocytes collected from three different 
healthy individuals. The Relative 
expression level of p53 mRNA after 
treatment with bulk and nano forms of 
quercetin. Results are expressed as mean 
± SEM, One-Way AVOVA test and 
significance compared with the untreated 
cells and 140µM of PhIP (donors =3). 
Figure 74: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
p53 mRNA over the control, using β actin 
as an endogenous housekeeping gene in 
lymphocytes collected from three different 
TB patients. The Relative expression level 
of p53mRNA after treatment with bulk and 
nano forms of quercetin. Results are 
expressed as mean ± SEM, One-Way 
AVOVA test and significance compared 














6.4.4  Bcl-2 mRNA expressions was significantly down regulated in 
lymphocytes from TB patients treated with the nano form of quercetin in 
the presence of 140µM of PhIP. 
Bcl-2 gene expression changes in lymphocyte collected from healthy individuals and 
patients with TB treated with both forms of quercetin 100µM was specified using 
quantitative PCR. 140µM of PhIP induced optimal DNA damage in lymphocyte as 
shown in figures 59 and 60. Lymphocytes were treated by 140µM of PhIP and 
corresponding lymphocytes were measured in the presence of either bulk or nano 
form of quercetin, two hours incubation was used to assess gene expression. All the 
gene expressions were normalised against β actin using the ΔCq livak method, the 
experiments were designed in triplicate. Figure 75 showed that there was no 
significant (ns) change in Bcl-2 expression in treatments with bulk and nano forms 
compared to untreated cells, whereas the comparison with 140µM of PhIP illustrated 
significant down-regulation where it was *p ≤ 0.0401. The lymphocytes from TB 
patients demonstrated a non-significant change in Bcl-2 expression by bulk 
treatment compared to untreated cells. The non-significance difference was seen for 
two hours incubation using bulk form, while the expression of Bcl-2 was influenced 
statistically by the presence of the quercetin nanoparticle, the effect showed a 
steady, significant decrease **p ≤ 0.0060 at two hours incubations compared with 
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Figure 75: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
Bcl-2 mRNA over the control, using β actin 
as an endogenous housekeeping gene in 
lymphocytes collected from healthy 
individuals. The Relative expression level 
of Bcl-2 mRNA after treatment with bulk 
and nano forms of quercetin. Results are 
expressed as mean ± SEM, One-Way 
AVOVA test and significance compared 
with the untreated cells and 140µM/ml of 
PhIP (donors=3).  
Figure 76: The effect of both forms of 
quercetin using Real-time PCR (qPCR), 
data expressed in relative expression of 
Bcl-2 mRNA over the control, using β actin 
as an endogenous housekeeping gene in 
lymphocytes collected from TB patients. 
The Relative expression level of Bcl-2 
mRNA after treatment with bulk and nano 
forms of quercetin. Results are expressed 
as mean ± SEM, One-Way AVOVA test and 
significance compared with the untreated 














Many studies have investigated the correlation between quercetin and 
cyclooxygenase COX-1 and COX2, but the results are inconsistent. Studies 
suggested that regular intake of quercetin is protective against the inflammatory 
process and cancer (Wach et al., 2007; Russo et al., 2012). COX1 can originate in 
any location of inflammation, while COX2 can be directly activated by an 
inflammatory stimulus and produces a large amount of pro-inflammatory mitogens 
and cytokines that increase the proportion of prostaglandins and affect cell 
proliferation that finally leads to malignant transformations (Kuroda and Yamashita, 
2002). 
 The effect of quercetin both bulk and nano forms on the expression of the COX1, 
COX2, P53 and Bcl-2 were investigated in lymphocytes from three different patient 
with TB and three different healthy individuals. The data illustrated that quercetin had 
no significant effect on COX2 expression in lymphocytes from healthy individuals 
and TB patients’ figures (71, 72). The expression of the COX1 gene was significantly 
downregulated in lymphocyte from healthy individuals and TB patients when treated 
with quercetin. Quercetin bulk decreased the expression of COX1 significantly in the 
lymphocytes from TB patients compared to 140µM of PhIP *P≤0.0120, whereas the 
comparison with untreated cells showed a non-significant effect. In samples treated 
with the nano form of quercetin, the statistical differences showed significant 
changes with both lymphocytes from healthy individuals and TB patients compared 
to 140µM of PhIP where the P value showed *P≤0.0120 and **P≤0.0074 figures (69 
and 70). Affinity results were suggested by Ribeiro (2014), that flavonoid down-
regulate COX-1 and COX-2 in human whole blood, also reported that all flavonoids 
have an arylbenzopyran ring system, and different kinds of flavonoids originated 
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from different rearrangements (Ribeiro et al., 2014). Moreover, Banerjee (2002) 
pointed out that quercetin, at 50 μM concentration downregulate the COX-2 mRNA 
and protein expression (Banerjee, Van der Vliet and Ziboh, 2002). 
Moon et al., (2003) reported that quercetin has inhibitory effects on vascular smooth 
muscle cells. They found that quercetin treatment induced a cell-cycle arrest in G1-
phase, also it down-regulated of cyclins and CDKs and up-regulated of the CDK 
inhibitor p21 expression, whereas up-regulation of p53 by quercetin was not 
witnessed. Our study agrees with the findings of Moon et al, and showed that the two 
forms of quercetin had a non-significant impact on p53 expression in lymphocytes 
collected from both healthy individuals and TB patients. The data displayed non-
significant up-regulation of p53 in lymphocytes collected from TB patients (P ≤ 0.05). 
In a combination of the quercetin with irradiation to treat the ovarian cancer cells, the 
results showed that upregulation of Bax level and downregulation of Bcl-2 level in 
OV2008 and SKOV3 cell lines compared with that in the cells exposed to quercetin 
or X-rays alone. Furthermore, knocking down of p53 by particular siRNA 
considerably reduced on increase of DSBs (Gong et al., 2017). Maurya and Vinayak, 
(2015) concluded that quercetin produced anticarcinogenic action by upregulation of 
p53 and BAX in HepG2 cells through downregulation of PKC, ROS, COX-2, and 
PI3K. 
Our data also demonstrated that the quercetin nano form was more effective in down 
regulation of COX1 expression; moreover, the quercetin bulk form had no significant 
effect on Bcl-2 expression in lymphocytes collected from healthy individuals and TB 
patients, while the nano form of quercetin showed significance in lymphocytes from 
both healthy individuals and TB patients. Subsequently, we found that quercetin had 
a statistically significant effect on the change in Bcl-2 expression in lymphocytes 
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from healthy and lymphocytes from patient with TB where the p value ranged from *p 
≤ 0.00401 to **p ≤ 0.0060 respectively. The significant result as the down regulation 
of Bcl-2 could adversely affect the survival of the Mycobacterium as over expression 
of Bcl-2 mRNA is a mechanism that leads to anti-apoptotic activity in macrophage 
cell lines ensuring the survival of the mycobacteria within these cells (Zhang et al., 
2008). This suggests a possible role for quercetin, especially the nano form, in 

























































7 Chapter (7) Investigation of catalase proteins in lymphocytes 
collected from healthy individuals and Patients with TB treated 





























7.1 Investigation of effect of quercetin both forms on catalase protein 
production in lymphocytes from healthy individuals and patients 




Flavonoids have long been linked with a wide range of health promoting effects due 
to their anti-oxidative, anti-inflammatory, anti-mutagenic, anti-carcinogenic and 
enzyme modulating properties. Regular intake of flavonoids can have a protective 
effect against a number of diseases, including lung cancer (Serafini et al. 2010). 
Quercetin can activate catalase which is a common enzyme found in nearly all living 
organisms and very important in protecting the cells from oxidative damage caused 
by ROS. It also catalyses the breakdown of hydrogen peroxide to water and oxygen, 
where one molecule of this enzyme can transform millions of hydrogen peroxide 
molecules to water and oxygen in less than one minute (Dieterich et al., 2000). 
Habas et al., (2018) stated that the effect of the IQ food mutagen on the catalase as 
an endogenous antioxidant enzyme was studied using lymphocytes collected from 
COPD patients, the hypothesis included DNA damage due to the production of 
oxidative stress caused by ROS. The data shows that catalase mRNA expression 
levels are significantly increased, and catalase action may play an important role in 
reducing DNA damage in the lymphocytes of COPD patients. However, the cell 
signalling molecules regulate catalase production to reduce DNA damage through 
PKA and PKCζ activators of forskolin and okadaic acid increased catalase activity 
(Yano and Yano, 2018). Moreover, catalase expression has been linked with 
numerous diseases. For instance, certain polymorphisms in the catalase gene have 
been detected in Alzheimer disease, hypertension, and diabetes. Reduced catalase 
activity has been described as acatalasemia (Glorieux et al., 2015). Nishikawa et al, 
(2009) pointed out that the CAT gene expression can control the levels of catalase; 
135 
 
the gene expression is detected at the transcription, post-transcription and post-
translation levels (Nishikawa et al., 2009). It has been shown that the CAT gene 
expression can be affected by the peroxisome proliferator activated receptor γ 
(PPARγ). PPARγ is a ligand-activated transcription factor that might control the 
expression of the CAT gene by binding to a distal PPARγ response element (PPRE) 
in its promoter region (Kodydkov á J et al., 2014). Gargouri et al, (2011) studied the 
protective influence of quercetin versus oxidative stress produced by dimethoate in 
human lymphocytes using a spectrophotometer to measure the enzyme levels; they 
reported that the breakdown of H2O2 to nontoxic compounds is the major function of 
catalase and the enzyme activities such as, CAT and SOD were significantly 
increased and linked with antioxidant defence mechanisms.  Studies on lymphocytes 
from colorectal cancer patients and healthy donors using the Comet assay showed 
that the DNA damage induced by PhIP in lymphocytes was effectively decreased by 
supplementation with the quercetin as an ant-oxidant (Najafzadeh et al., 2009).  
 
In the present study, we investigated the expression of mRNA of catalase protein in 
lymphocytes collected from healthy individuals and patients with TB. PhIP (140µM) 
was used as a DNA damage inducer; the cells were treated with both forms (bulk 
and nano) of quercetin individually.  
 
The Western blot method was used in this project, to study the effect of two 
quercetin forms on the expression of mRNA catalase protein as it a commonly used 
research tool to detect and evaluate proteins. In this technique, different types of 
proteins are isolated on the basis of their molecular weight, through gel 
electrophoresis. The segregated proteins are then transferred on to a special 
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membrane called PVDF/nitrocellulose and incubated with specific primary and 
secondary antibodies (Mahmood and Yang, 2012). However, the specific antibodies 
are attached with target proteins forming protein bands on the membrane, the bands 
can be easily imaged using (ECL) mixture and an imaging box. The size of the 
bands reflects the amount of proteins; consequently, a standard can be used to 
detect the amount of protein found at a certain level expressed in Kilo Daltons (kDa) 
(Mahmood and Yang, 2012).  
 
7.3  Material and methods 
All the material and method used in the Western blot technique were mentioned and 
displayed in chapter 2 section (2.14, 2.14.1, 2.14.2, 2.14.3, 2.14.4, 2.14.5, 2.14.6 





























7.4.1  Catalase expression in lymphocytes from healthy individuals treated 
with bulk and nano forms of quercetin in the presence of PhIP (140µM). 
  
 Figure 77 shows the catalase protein expression using isolated lymphocytes 
collected from healthy individuals. 140µM of PhIP induced optimal DNA damage in 
lymphocyte as shown in figures 59 and 60. Lymphocytes were treated with 140µM of 
PhIP and corresponding lymphocytes were measured in the presence of either 100 
µM bulk or nano forms of quercetin. PhIP (140µM) does not modulate the expression 
of catalase in lymphocytes. Two hours incubation time was used for all treatments. 
Untreated cells were used as a control to detect the level of catalase expression for 
comparison at 60 KDa.  Incubation with PhIP alone or in the presence of bulk or 









































































Figure 77:  The effect of quercetin both forms on catalase protein expression in lymphocytes 
collected from three different healthy individuals incubated for 2 hours and (A, B) developed 
bands of catalase, and GAPDH by immunoblotting at 60 kDa. GAPDH was used as a 
control, ±SEM, One-Way AVOVA test and significance compared to untreated cells, 140µM 






















7.4.2       Catalase expression in lymphocytes from patient with TB treated 
with bulk and nano forms of quercetin in the presence of PhIP (140µM).       
 
The figure 78 illustrates the effect of quercetin on catalase protein expression in 
isolated lymphocytes from TB patients where DNA damage was induced by PhIP. 
140µM of PhIP induced optimal DNA damage in lymphocyte as shown in figures 59 
and 60. Lymphocytes were treated with 140µM of PhIP for two hours and 
corresponding lymphocytes were assessed for changes in the expression of catalase 
in the presence of either 100 µM bulk or nano forms of quercetin. Untreated cells 
were considered as a control to detect the quantity of catalase expression for 
comparison. A significant up-regulation for catalase protein was observed in 
lymphocytes from patients with TB treated with nano form of quercetin *p ≤ 0.0236, 
the up-regulation of catalase can be noticed at 60 KDa (Figure 78). On the other 
hand, up-regulation of the catalase in lymphocytes from TB patients was non-
significant, using the bulk form of quercetin. Both forms of quercetin, untreated cells 



















































































Figure 78: The effect of quercetin both forms on catalase protein expression in lymphocytes 
from three different patients with TB incubated for 2 hours and (A, B) developed bands of 
catalase, and GAPDH by immunoblotting at 60 KDa. GAPDH was used as a control. ±SEM, 









7.4.3 Comparison of Catalase protein expression in PhIP induced DNA 
damaged lymphocytes from healthy individuals and patients with 
TB, treated with bulk and nano forms of quercetin.  
 
The comparative effects of quercetin bulk and nano forms on catalase protein 
expression using lymphocyte from healthy individuals and TB patients are 
shown in the bar chart 79, the expression of catalase protein displayed a non-
significant (ns) change when treated by the bulk form of quercetin, using 
lymphocytes from healthy individuals and TB patients. The effect of quercetin 
nano was non-significant p ≥ 0.05 in protein expression in lymphocyte from 
healthy individuals. By contrast, the quercetin nano was the only treatment 
which showed significant up-regulation in lymphocytes from patients with TB *p 
≤ 0.0236 and represented the only significant upregulations. The GPPDH was 
used as a control demonstrating relative expression of catalase after treatment 
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Figure 79: A comparison of the effect of quercetin in both nano and bulk forms on 
catalase protein expression in lymphocytes from three different healthy individuals and 
three different TB patients incubated for 2 hours and GAPDH by immunoblotting at 60 
kDa. GAPDH was used as a control. ±SE, Two-Way ANOVA test and significance 









7.5  Discussion 
The DNA comes in contact with different damaging compounds daily. In normal 
cells the repair mechanism can protect from DNA damage; if the repair 
mechanism is dysfunctional it could lead to DNA disorder which could 
accumulate and lead to mutations.  Some of these mutations could lead to 
development of cancer (Chakarov et al., 2013). The food mutagen, PhIP and 
IQ, are heterocyclic amines (HCA), produced while heating proteinaceous food, 
and could be a reason for oxidative stress that finally causes DNA damage 
(Kurzawa-Zegota et al., 2012). Investigations on the protective effect of 
quercetin against oxidative stress induced by IQ and PhIP in vitro using 
lymphocytes from healthy individuals and colon cancer patients showed that the 
DNA damage caused by a high dose of IQ and PhIP was significantly ***p≤ 
0.001 reduced when treated by quercetin (Kurzawa-Zegota et al., 2011). The 
current study uses the Western blotting technique to examine the potential 
genoprotective effect of nano- and bulk- forms of quercetin 100 µM; the effect 
was examined through enzyme modulating properties of the catalase as an anti-
oxidant.  
For catalase protein expression, lymphocyte from healthy individuals treated 
with the anti-oxidant, incubated for two hours after treatment had a non-
significant increase in its expression for both quercetin bulk and nano P≤ 0.05. 
However, for both treatments (nano and bulk) there was a change in catalase 
protein expression compared to the untreated cells. Habas et al, (2018) studied 
that the detection of catalase high-expression by ROS was changeable. Cells 
were treated with the food mutagen IQ 140µM and the levels of catalase mRNA 
was detected in lymphocytes from COPD patients. The results illustrated that IQ 
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significantly increased mRNA expression of catalase compared with untreated 
cells. They concluded that the anti-oxidant compound such as quercetin has the 
ability to reduce oxidative stress and stimulated protective enzyme systems, in 
lymphocytes from healthy individuals and COPD patients. Therefore, quercetin 
could be very beneficial in decreasing oxidative DNA damage in lymphocytes 
from COPD patients and consequently decrease the risk of possible cancer and 
other respiratory disease (Habas et al., 2018). In the current study lymphocytes 
collected from TB patients, the catalase protein expression was more 
productive with the quercetin nano form and was statistically significant *P ≤ 
0.0236 compared to the untreated cells. There is non-significant catalase 
protein production with quercetin bulk form, because this expression was rated 
at p ≤ 0.05 using lymphocytes from TB patients. This is in line with many studies 
that report an important role for endogenous catalase, and catalase mRNA in 
stressful conditions. For instance, catalase is upregulated in the human heart 
after concern of a stress suffering. Dieterich et al, (2000) pointed out that 
amplified oxidative stress in transmural tissue samples collected from the left 
ventricle after human heart failure leads to upregulation of catalase gene 
expression as a compensatory mechanism, whereas glutathione peroxidase 
(GPX) and superoxide dismutase (SOD) gene expression were normal. 
Similarly, the oxidative stress and apoptotic factories relationship have been 
investigated in lymphocytes from diabetic patients using the Western blot 
technique, and it has been found that catalase activity is decreased in both 
groups healthy and patients compared to untreated cells. This decrease in CAT 
activity could result from inactivation by glycosylation of the enzyme, or by the 
accumulation of superoxide radicals and hydrogen peroxides (Arya et al., 
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2011). Results from Western blot technique indicate that the nano form of 
quercetin was more effective than the bulk form, in the lymphocytes from TB 
patients, with an upregulation of the catalase protein *p ≤ 0.0236 and had a 
higher genoprotective effect suggesting a possible role for quercetin, especially 
the nano form, in genoprotection through its enzyme modulating effect among 











































































8.1  General Discussion 
 
Genotoxicity can be defined as any alteration or damage by a toxicant in the 
genome, which under some conditions correlates to mutagenicity. Hence, 
genotoxicity can be divided into different gene alterations (insertion, deletion 
and point mutation), clastogenic impacts (breakage in DNA strands leading to 
alterations in chromosomes structures), and aneugenic defects (numeral 
chromosomal aberrations leading to the development of aneuploidy or 
polyploidy) (Eastmond et al., 2009). Genetic mutation and DNA damage can be 
introduced by different factors having genotoxic potential such as chemical 
substances and physical agents (UV and X radiation). This genetic alteration 
could be detrimental where it increases the chance of cancer, congenital 
defects, and inflammation. Consequently, genotoxicology research becomes an 
essential part of biomedical science that enable scientists to study and discover 
the impact of other chemicals, and physical agents. Lymphocytes can be 
suitable reflect cells for cancer and other diseases to determine DNA damage 
caused by a chemical or physical substance that contains exogenous or 
endogenous genotoxins (Najafzadeh et al., 2012). Hence, lymphocytes have 
been selected for this study to examine DNA damage.  
Tuberculosis is a disease caused by Mycobacterium tuberculosis which affects 
around 10 million people worldwide. Though the incidence of TB in England has 
shown a decline in the past 5 years, the globalisation and the fast and easy 
travel opportunities has created a situation where TB can be swiftly exported 
anywhere in the world (Global tuberculosis report (2017) (Glorieuxet al.,2018). 
Moreover, the TB mortality is higher in urban areas particularly London and the 
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emergence of multidrug resistant TB has made the control of TB more 
complicated. Hence it is important to identify compounds that supplement the 
current TB treatment options.   
Several studies have suggested that the regular intake of flavonoids, such as 
quercetin, lead to a wide range of positive health effects due to their anti-
oxidative, anti-inflammatory, anti-mutagenic, anti-carcinogenic, and enzyme 
modulating properties; furthermore, the regular intake of flavonoids has also 
been shown to have a protective effect against a number of diseases, including 
lung cancer (Johnson and Loo, 2000; Nijveldt et al., 2001). The protective effect 
of quercetin is thought to be mediated by the regulation of different pathways, 
including the inhibition of COX1 and COX2, and the up-regulation of certain 
tumour suppressor genes, such as p53 and Bax and Bak. This can lead to the 
down-regulation of Bcl-2 and Bcl-xL, which help guide cells into apoptosis 
(Gibellini et al., 2010). A survey of literature has identified a gap in 
investigations on the beneficial effect of different (bulk and nano) forms of 
quercetin among TB patients. Consequently, in this study, quercetin 
nanoparticles and bulk forms were examined for their impact on DNA damage 
using lymphocytes from both healthy individuals and patients with TB. 
Nanotechnology refers to the application of materials at a scale of one-billionth 
of a meter. Once the materials are reduced to this nano form, they display 
newly improved properties, including physicochemical and biological 
characteristics, compared to those of bulk materials. Moreover, they can 
penetrate cell membranes in several ways, particularly in mitosis division 
wherein the nanoparticles (NPs) become enclosed in the nucleus membrane, 
148 
 
allowing for direct contact with the DNA due to the disintegration of the nucleuar 
membrane (Ochekpe et al., 2009, Singh et al., 2009). 
This study began with the collection of 20 blood samples and 20 sperm 
samples from different healthy individuals. The control samples were examined 
with different concentrations of hydrogen peroxide to detect which concentration 
causes the highest DNA damage (Figures 14 and 15). The concentration 60µM 
of hydrogen peroxide was chosen as a positive control for the lymphocytes. 
Additionally, the blood was treated with bleomycin in the micronucleus assay to 
detect the maximum DNA damage (Figure 44 and table 9). The concentration of 
0.75µg/ml was identified as causing the highest levels of damage in the 
micronucleus assay. 50µl of MITC (0.4µM) was used as a positive control in the 
micronucleus assay, acting as a system control, whereas the negative control 
was medium and original excipient. 
Moreover, the concentrations 160µM of IQ and 140µM of PhIP food mutagen 
were selected as the genotoxic doses causing the highest DNA damage without 
toxicity in lymphocytes from healthy individuals, these doses were used as a 
DNA damage inducer (Henderson et al., 2000) (Figures 49, 50, 59, and 60). A 
concentration of 50µM hydrogen peroxide was used as a positive control for the 
sperm experiment (Figures 16 and 17), and a concentration of 100µM and 120 
µM of food mutagens IQ and PhIP were identified as that can cause the highest 
DNA damage in sperm from healthy individuals (Figures 55-56, 65-66). 
The project results were evaluated when quercetin was combined with 
hydrogen peroxide in the Comet assay, with bleomycin in the micronucleus 
assay, and with PhIP in qPCR and Western blot techniques. The differences 
149 
 
between the bulk and nano forms of quercetin in each assay are shown in 
(Figures 38, 39 and 46). The effect of quercetin on both cells’ types, haploid 
(germ cells) and diploid (lymphocytes) are illustrated in (Figures 30, 31, 32, and 
33). 
8.2  The Effect of the Bulk and Nano Forms of Quercetin on DNA 
Damage via the Comet Assay 
The comet assay can be defined as a micro-electrophoretic assay that allows 
for the direct measurement and imaging of DNA damage (Ostling & Johanson, 
1984). This test has become the globally preferred assay due to its simplicity: 
small amount of blood samples is needed, making it inexpensive compared to 
other techniques (Anderson et al., 1991). In 2000, Tice et al. reported that the 
percentage of head and tail DNA damage could be efficiently investigated by 
the Comet assay wherever the head displays undamaged DNA, whereas the 
tail can identify damage (Tice et al., 2000). In this study both forms of quercetin 
(bulk and nano) were separately incubated in vitro at 37°C for 30 min. 
Subsequently, the lymphocytes were electrophoresed in alkaline conditions PH 
≥13, which was followed by staining and scoring. Three different concentrations, 
10µM, 25µM, and 100µM, of quercetin, bulk and nano, were used. Using 
Statistical Package for the Social Sciences (SPSS) and graph pad prism 6, a 
One-Way ANOVA test showed a non-significant effect of the lymphocytes 
collected from healthy individuals treated with the bulk form; these results were 
compared to the positive control of 60 µM of hydrogen peroxide and exhibited a 
P value P ≥ 0.05 (Figures 18 and 19). The same concentrations were used to 
treat the lymphocytes collected from the TB patients; however, in this case, the 
nano form was observed to be significant at 25 µM with *P ≤ 0.0283 and 100 
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µM *** P ≤ 0.001. The bulk form was non-significant in treating the same cells 
(Figures 24 and 25), and this may refer to cellular metabolism process in 
lymphocytes collected from healthy individuals can stop chemically-induced 
DNA damage by either DNA repair or apoptosis where the machinery repair not 
working efficiently in inflammatory or cancer cells (brendler et al.,2005) 
The DNA damage levels in spermatozoa collected from healthy individuals were 
higher than that in the lymphocytes of the healthy individuals (Figures 30 and 
31).  Previous researchers have pointed out that spermatogenic cells exhibit a 
higher mutation frequency than somatic cells (Hess 2005, Walter et al. 1998; 
Winn et al. 2000). These results confirmed that sperm are more sensitive for 
DNA damage than lymphocytes, since sperm consists of haploid cells, while 
lymphocytes consist of diploid cells. Moreover, there was a substantial 
reduction in DNA damage when the spermatozoa were treated with 25 µM and 
100 µM of quercetin nano form. Statistically, the One-Way ANOVA test 
presented *P≤0.0283 with 25µM and ***P≤0.001 with 100 µM (Figures 32 and 
33). In regard to the bulk form that treated spermatozoa in the presence of 50 
µM of H2O2, the reduction was not observed to be significant, with the value P 
≥0.05 (Figure 30 and 31). These results were in accordance with the fact that 
reducing the size to the nano form can increase the surface area, solubility, 
immunogenicity, and drug delivery. Furthermore, NPs have a greater ability to 
penetrate the nuclear membrane than the bulk size (Zhang et al., 2008, Singh 




8.3 The Effect of the Bulk and Nano Forms of Quercetin on MNi 
Lymphocytes via the Micronucleus Assay 
A micronucleus is a smaller, isolated, extra fragment produced when a 
chromosome fails to combine with the spindle fibres during the mitosis stage. 
Additionally, centric components or a full chromosome can form the MNi. This 
abnormal structure reflects cytogenetics damage. This assay was selected for 
this study to examine cell abnormalities, chromosome rearrangement, buds, 
nuclear bridges, MNi, necrosis, apoptosis, and chromosome loss (Fenech, 
2006, 2007). Bleomycin was used as a DNA damage inducer in the 
micronucleus assay, and a mean of values from three healthy individuals 
treated with different concentrations of bleomycin showed that 0.75µg/ml 
caused the highest MNi frequency. The experiments in this assay were 
repeated from three different individuals healthy or patients, the results 
exhibited a normal nuclear division index (NDI), rated between 1.3 to 1.5 
(Tables 10-11) with a normal value of (NDI) between one and two (Fenech, 
2007). The percentage of bi-nucleated cells was estimated upon the 
examination of 1000 cells each concentration. The decline of multi-nucleated 
cells showed that the activity of Cytochalasin B was efficient and blocked cell 
division following the first division (Fenech, 2007). The effect of quercetin bulk 
and nano in the lymphocytes with DNA damage collected from healthy 
individuals was not significant with 10µM of the bulk form, whereas with the 
other concentrations it was significant with a value of P ≤ 0.001 (Figure 45, 
Table 10). A comparison between the bulk and nano forms of quercetin treated 
lymphocytes from patients with TB (figure 46), showed significant DNA damage 
reduction with values *P ≤ 0.0281 to**P ≤ 0.027 and ***P≤ 0.001 with 10µM, 
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25µM, and 100µM, with the nano form being more efficient than the bulk form in 
reducing the occurrence of micronuclei. (Figures 46). The concentration of 
100µM of the nano form of quercetin displayed a greater reduction in MNi 
development compared to the other concentrations (Figure 48), the reason for 
that quercetin can control oxidative stress resulting from phagocytosis process 
which resistance Mycobacteria tuberculosis. Furthermore, H2O2 is continuously 
produced by the macrophages that resulting high free radical loaded in 
pulmonary cells which may lead to cancer, quercetin has ability to scavenging 
free radicals that casing DNA damage, therefore small dose of quercetin nano 
could help to improve TB patient’s immunity (Adebimpeet al., 2016).    
8.4  Comparison between Results Obtained from the Comet and 
Micronucleus Assays 
Overall, the quercetin-treated lymphocytes collected from the healthy individuals 
or the lymphocytes collected from the patients with TB both efficiently reduced 
DNA damage; however, they displayed different grades of this reduction, which 
depended on the quercetin form. The Comet assay results from experiments on 
lymphocytes showed that the nano form of quercetin reduced DNA damage 
more than the bulk form; however, the effect of the nano form of quercetin was 
observed to be significant (Figures 24 and 25) at any concentration P ≥ 0.05. 
On the other hand, there was significant reduction in DNA damage in sperm 
collected from healthy individuals that were treated with the nano form of 
quercetin with maximum reduction observed at 100µM *P≤ 0.001 both for % 
Tail in DNA and Olive tail moment. This could indicate that the sperm is more 
sensitive in DNA damage than lymphocytes (Figures 32 and 33). In the 
micronucleus assay, both the nano and bulk forms of quercetin reduced the 
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number of MNi resulting from the bleomycin treatment in lymphocytes from 
healthy individuals. This reduction was more effective *** P ≤ 0.001 at two 
concentrations (100 µM and 25 µM); and insignificant at 10 µM concentration 
for the bulk form (Figure 45). The possible reason for this could be the longer 
incubation time for the micronucleus assay compared to the Comet assay. This 
longer incubation time possibly allows the NPs to repair DNA damage via the 
penetration of the nuclear membrane. Moreover, the NPs have the ability to 
protect DNA because they can easily contact the nuclear components (Rasaie 
et al., 2014). A bulk form of quercetin can reduce genotoxicity at a certain level 
only due to its size. Specifically, the results from this study showed that bulk 
size can reduce DNA damage partially caused by H2O2 or bleomycin (Figure 
45,46 and tables 10 and 11). In 2004, Oliveira et al. identified a weak interaction 
between quercetin and DNA in a bulk solution and these results are compatible 
with the perspective reported by Razavi (Prasain et al., 2016, Razavi et al., 
2009). 
Oxidative stress plays a major part in in the development of many chronic and 
degenerative illnesses (Reuter et al., 2010). Hydrogen peroxide is responsible 
for oxidative stress in TB patients due to phagocytosis and immune response. 
Several studies have examined how quercetin acts as a protective compound 
against Tuberculosis. The mechanisms of quercetin can inhibit DNA damage in 
TB patients by restricting the production of free radicals at high levels that 
induce DNA damage in a pro-oxidative state by causing chromosomal instability 
(Gibellini et al., 2010).  
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The mechanism of oxidative stress that causes genomic instability, gene 
expression dysfunction, and a rise in abnormal cell proliferation that can lead to 
cancer was described by Hanahan and Weinberg in 2011. Furthermore, DNA 
damage occur in cellular macromolecules including the lipid structures, due to 
increased oxidative stresses (Nordberg & Arner, 2001; Valko et al., 2007).  
Reactive oxygen species (ROS) can produce double-single DNA strand breaks 
and change the chemical structure of DNA by replacing purine and pyrimidine 
bases with 2′-deoxyribose (Hazra et al., 2007). It has been shown that DNA 
damage caused by oxidative stress could be a crucial cause of cancer and 
linked with the normal process of ageing (Bjelland & Seeberg, 2003). 
Furthermore, in order to determine quercetin genotoxicity, the effect of 
quercetin-induced lung cancer was investigated by the cell line NCL-H209 using 
flow cytometry and Western blot analysis to examine pro- and anti-apoptotic 
proteins, caspase -3 activities, and gene expression. The results showed that 
the proliferation of lung cancer was decreased in cells through G2/M, the 
capture of the cell cycle, and the encouraged apoptosis via a pathway called 
caspase-3 (Yang et al., 2005). Though, bleomycin can be used as an anti-
cancer treatment it also increases the levels of oxidative stress that cause DNA 
damage (Dedon and Goldberg, 1992). The side effects of bleomycin could 
cause other complications, such as the recurrence of cancer, as a result of 
increased DNA damage (Cho et al., 2016). Therefore, it is important to control 
the oxidative stress when the cancer is being treated with bleomycin. As the 
natural compound quercetin has the ability to reduce oxidative stress, 
bleomycin can be used in combination with quercetin nano, which would be 
overall help reduce drug toxicity (El-Denshary et al., 2015). 
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8.5 The Effect of the Bulk and Nano Forms of Quercetin on 
Lymphocytes and Sperm-induced DNA damage by 
Heterocyclic Amines PhIP and IQ 
The two food mutagens PhIP and IQ are heterocyclic amines created via the 
heating of proteinaceous food, and both compounds have been classified as 
genotoxic and carcinogenic (Durling and Abramsson-Zetterberg., 2005). In this 
section, the damaging DNA effects of various dietary and environmental 
compounds were studied by treating in vitro lymphocytes in TB patients in 
addition to sperm and lymphocytes in healthy donors. IQ and PhIP were used 
as DNA damage inducers in the lymphocytes collected from TB patients, and 
then the corresponding results were compared with the lymphocytes and sperm 
from healthy donors. Different concentrations of quercetin were mixed together 
with IQ or PhIP, and the DNA damage and protective potential of the flavonoid’s 
quercetin were evaluated using the Comet assay. The results showed that 
160µM of IQ and 140µM of PhIP were considered genotoxic doses (Figures 49, 
50, 59 and 60) in the above of toxicity (Henderson et al., 2000). In the 
lymphocytes from the healthy individuals, the DNA damage resulting from the 
food mutagen effect treated with quercetin was significantly reduced to **p ≤ 
0.0043 and ***P≤0.001 when compared to the IQ- or PhIP-induced lymphocytes 
without quercetin treatment (Figures 51, 52, 61 and 62). The lymphocytes from 
the TB patients displayed greater DNA damage than those from the healthy 
individuals, and these higher levels of damage were also observed in the 
untreated cells from the in vitro treatment. Furthermore, it has been shown that 
quercetin has the potential to reduce DNA damage caused by the food 
mutagens IQ and PhIP. This reduction was observed to be significant in both 
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the Comet assay parameters of the % Tail DNA damage and Olive tail moment. 
The significance level ranged between *p ≤ 0.0405 and ***P ≤ 0.001 based on 
the One-Way ANOVA test (Figures53, 54, 63 and 64). Kurzawa-Zegota et al, 
(2012) highlighted the fact that quercetin decreases oxidative stress in vitro 
caused by IQ and PhIP using lymphocytes from colon cancer patients and 
comparing the results with those of healthy individuals. The protective effect of 
quercetin on PhIP- and IQ- induced DNA damage in the spermatozoa of healthy 
individuals, were evaluated using Comet assay showed significant DNA 
protection. The DNA damage was reduced when 10 µM, 25µM, and 100µM of 
quercetin (in both forms) was introduced; furthermore, the significance value 
was between * P ≤ 0.00405, **p ≤ 0.0031, and ***P ≤ 0.001, respectively. 
Anderson et al. (1998) noted that the flavonoids were examined in combination 
with IQ via the Comet assay for lymphocytes and sperm in healthy individuals. 
These results suggested that the flavonoid compounds produced antigenotoxic 
effects, since DNA damage was reduced in both the sperm and lymphocytes. 
Since, dietary supplements containing flavonoids from fruits and vegetables 
could help in protecting DNA against oxidative stress, it is simple to implement 
anti-mutagens into the daily diet in order to decrease the progression of cancer, 
stimulate cells into apoptosis, and remove mutant cells (Ferguson et al., 2004). 
Spermatozoa exhibited greater baseline DNA damage than the lymphocytes 
from healthy individuals. In addition, the DNA damage and abnormal 
chromosomal structure were much greater in the haploid cells than in the diploid 
cells (Genesc et al., 1990). In conclusion, quercetin was shown to decrease 
oxidative stress resulting from IQ and PhIP in vitro treatment. The data 
indicated that 25 µM or 100µM of quercetin nano could be a useful protective 
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compound to decrease DNA damage resulting from oxidative stress in patients 
with TB. 
8.6 The Effect of Both Quercetin Forms on COX1, COX2, P53, and 
Bcl-2 Gene Expression in Lymphocytes from Healthy 
Individuals and TB Patients Using Real Time PCR 
COX1 and COX2 are enzymes that play an important role in the production of 
prostaglandin-endoperoxide. The prostanoids are vital biological mediators that 
assist in different biological processes. The main role of COX1 and COX2 
enzymes is to transform arachidonic acid into prostaglandin H2, a process that 
ends with synthesising the biological form of prostaglandin, which has a 
function in cell division and apoptosis (Ulrich et al., 2006). Marakalala et al. 
(2016) analysed the proteomes of granulomas in TB patients using laser-
capture microdissection, mass spectrometry, and confocal microscopy and then 
created detailed molecular maps of human granulomas. In cavity and caseous 
granulomas, the COX1 and COX2 were diffusely expressed in the cellular 
layers, although they were primarily absent in the caseous granulomas; 
however, COX1 and COX2 expression was detected in fibroblasts and 
macrophages (Marakalala et al., 2016). In this section, this study examined the 
influence of quercetin nano and bulk forms on the expression of COX1 and 
COX2 in lymphocytes of TB patients and compared the results with those of 
healthy individuals. The data exhibited a non-significant change in the 
expression of COX2 genes in the lymphocytes from both healthy and TB-
affected individuals following two hours of treatment with the bulk and nano 
forms of quercetin. (Figures 71-72). Ramyaa et al. (2014) studied the protective 
effect of quercetin by examining HepG2 cells induced oxidative stress, the 
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results of which illustrated the down-regulation of NF-κB and COX-2 and the up-
regulation of Nrf2 expression. However, COX1 gene expression was down-
regulated by both forms of quercetin (Figures 69-70). In the lymphocytes from 
healthy individuals, the bulk form of quercetin downregulated the COX1, which 
was not significant compared to the untreated cells. On the other hand, the 
lymphocytes from the TB patients showed significant down-regulation of COX1 
with both the bulk and nano forms of quercetin with significance values between 
*p ≤ 0.045 and **p ≤ 0.0074, respectively. When the results of nano form was 
compared to the untreated cells and 140µM concentration of PhIP, the 
significant down-regulation of COX1 was observed in the lymphocytes from 
healthy individuals and patients with TB. This perspective reflects the idea that 
the large surface area of the nano form could explain the difference in DNA 
repair between the two quercetin forms, expanding upon the notion that 
perhaps the nano size allows for the more rapid penetration of the nucleus 
compared to the bulk size (Huang et al., 2012).   
 Regarding the p53 gene expression, there was no significant up-regulation of 
gene expression via the quercetin treatment of bulk and nano forms with 
lymphocytes from patients with TB and healthy individuals. Because quercetin 
activated p21 which supports cell cycle arrest. Tanigawa et al. (2008) illustrated 
that the stabilization of p53 is involved in the quercetin-induced cell cycle arrest 
and apoptosis using the Hep G2 cell line (i.e., hepatocyte carcinoma). They 
attempted to reactivate p53 in HepG2 cell line via the implementation of 
quercetin. The data demonstrated that quercetin prevents the proliferation of 
HepG2 cells through the incitement of cell cycle arrest and programmed cell 
death. Additionally, they found that at the molecular level, the quercetin 
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encouraged p53 phosphorylation and total p53 protein; however, it did not up-
regulate p53 mRNA at the transcription level. Subsequently, quercetin up-
regulated the p21 gene expression and blocked the cyclin D1 expression in 
support of cell cycle arrest (Tanigawa et al., 2008). By comparing the estimation 
of dose-dependent differences, the effects of quercetin and curcumin were 
investigated in relation to treating double-strand break DNA damage from two 
natural polyphenols: quercetin (QUE) and curcumin (CUR), 3 μM curcumin, and 
8 μM quercetin, which showed a statistically significant increase in p53 
activation that was similar in magnitude to both chemicals at lower doses. 
However, at the highest dosage, more than10 μM curcumin and 30 μM 
quercetin, the cells were directed to apoptosis (Sun et al., 2013). 
The BCL-2 gene is in the B cell lymphoma family and plays an essential role in 
regulating apoptosis by controlling intracellular mechanisms such as pro-
apoptotic and anti-apoptotic signals. In cancer, apoptosis avoidance caused by 
the malfunctioning of the Bcl-2 gene is a recurring phenomenon, and, as a 
result, a decrease in specific anti-apoptotic Bcl-2 protein could indicate an 
essential treatment opportunity (Ashkenazi et al., 2017). In this respect, this 
study examined the effect of quercetin bulk and nano forms on Bcl-2 gene 
expression. This effect was investigated during a two-hour incubation period 
using 140 PhIP as a DNA damage inducement in the lymphocytes of both 
healthy individuals and patients with TB. The results showed that significant 
down-regulation of Bcl-2 gene expression was evident in the nano form of 
quercetin, with a P value of *p ≤ 0.0401 in the lymphocytes from healthy 
individuals and **p ≤ 0.0060 in the lymphocytes from patients with TB, whereas 
the bulk form displayed a non-significant effect. These findings were compatible 
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with a study on HepG2 cell line in hepatocellular carcinoma patients and treated 
with quercetin that investigated the influence of quercetin on the activation of 
the apoptotic pathway in the HepG2 cell line. The cells were treated for 18 
hours, and the vast majority of these cells were dead in a dose-dependent 
manner. At the time of incubation, the quercetin-induced apoptosis occurred via 
the activation of caspase -3 and -9. Furthermore, the quercetin reduced the Bcl-
xL and Bcl-xs ratio and amplified the translocation of Bax to the mitochondrial 
membrane (Granado-Serrano et al., 2006). Gibellini et al. (2010) highlighted 
that quercetin activates programmed cell death through the mitochondria 
pathway, beginning with the loss of the mitochondria membrane and the 
release of the cytochrome c from the mitochondria to the cytosol and ending 
with the stimulation of the caspase-3 and caspase-7. Moreover, the quercetin 
encouraged the up-regulation of Bax and Bak that cause the downregulation of 
Bcl-2 and Bcl-x (Gibellini et al., 2010). The results of this project were in 
accordance with the perspective that quercetin plays a promising role in 
reducing oxidative stress which causing cancer. Moreover, as the survival of 
virulent mycobacterium tuberculosis depends on prevention of apoptosis of 
pulmonary cells through upregulation of Bcl-2, quercetin with its ability to down 
regulate Bcl-2 can play an important role in slowing the progression of TB 
(Zhang et al., 2013).    
8.7 Investigation of the Catalase Protein in Lymphocytes from 
Healthy Individuals and TB Patients Treated with Both Forms 
of Quercetin Using Western Blot Analysis 
Catalase is a common enzyme able to breakdown hydrogen peroxide (H2O2) 
into water and oxygen. This antioxidant enzyme is produced in all main body 
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organs, particularly in blood cells, the liver, and the kidney. In these organs, 
catalase plays a crucial role in cell defence against oxidative stress (Glorieux et 
al., 2018). This study examined the effect of the two forms of quercetin on the 
expression of catalase protein in lymphocytes from both healthy individuals and 
TB patients using the Western blot method. Two-hour incubation times were 
selected for each treatment. In regard to the catalase protein expression in the 
lymphocytes of healthy individuals the 140µM of PhIP was used as a DNA 
damage inducer (Figures 59 and 60), the results illustrated that both forms of 
quercetin when compared to the untreated cells and140µM of PhIP was not 
significant in regard to the lymphocytes collected from the healthy individuals 
(Figure 77). Conversely, the nano form of quercetin displayed a significant 
change in catalase protein expression during the same period of incubation *p ≤ 
0.0236. Furthermore, the increase in the protein expression following quercetin 
treatment using lymphocytes from healthy individuals could explain the minor 
increase in DNA damage that was observed by the Comet assay in chapter 3 
(Figures 24 and 25). In the lymphocytes from patients with TB, the catalase 
protein expression was not found to be significant for the bulk form of quercetin, 
whereas significant protein expression was observed in the nano form of 
quercetin. These results were in accordance with the study published by Singh 
(2009), highlighting that NPs possess stable and recognized chemical and 
physical properties in their normal size. However, it should be noted that the 
smaller size of NPs permits them to penetrate the cell membrane in several 
ways and helps them diffuse through the nuclear membrane. During the mitosis 
stage, NPs can become enclosed by the nucleus, since the nuclear membrane 
disintegrates during this stage. This, in turn, can lead to a direct reaction 
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occurring between the NPs and chromosomes that can then promote contact 
with DNA (Singh et al., 2009). Furthermore, this knowledge may explain the 
DNA damage reduction that was detected by the Comet assay experiments in 
chapter 3 (Figures 36 and 37), also demonstrated the reduction of DNA 
damage resulting from oxidative stress during phagocytosis against 
Mycobacterium tuberculosis and support the role of quercetin as a nutritional 
supplement in TB patients. 
8.8  Conclusion 
Data from the Comet assay indicated that the nano form of quercetin produced 
a significant reduction in DNA damage resulting from oxidative stress that 
caused by H2O2 in the lymphocytes of patients with TB and sperm from healthy 
individuals. However, this significant reduction in DNA damage was showed 
with the nano form compared to the positive control. Moreover, the 
micronucleus assay results displayed a larger decrease in MNi frequency and 
DNA damage compared to those of the Comet assay. This is probably due to 
increased incubation times, since the micronucleus assay tracked a comparable 
pattern to that of the Comet assay data. In both techniques, the nano form of 
quercetin was more effective than the bulk form in reducing DNA damage and 
MNi frequency. In regard to the examination of gene expression, both types of 
quercetin were observed significant down-regulate to the expression of COX1. 
The Bcl-2 gene was significantly down-regulated with the nano form. This could 
be the possible role of quercetin to guide the lymphocytes to apoptosis. 
Western blot analysis also found that the catalase protein expression was 
significantly up-regulated by the nano form of quercetin in the lymphocytes of 
patients with TB, whereas the up-regulation was not significant with the bulk 
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form. The data from this study as compatible with the perspective that 
flavonoids such as quercetin can be linked to having health-promoting effects 
due to their anti-oxidative, anti-inflammatory, anti-mutagenic, anti-carcinogenic, 
and enzyme modulating properties. 
In conclusion, quercetin is responsible for the downregulation of the Bcl-2 
expression that could adversely affect the survival of the mycobacterium and it 
simultaneously upregulates the catalase protein to reduce the oxidative stress 
which is prevalent during chronic illnesses. This combined with the 
genoprotective effect seen in the Comet assay and micronucleus assay 
suggests a possible role for quercetin, especially the nano form, in 
genoprotection in lymphocytes from patient with TB through its enzyme 
modulating properties and genoprotective effects.  
 
8.9  Future Work 
Based on this discussion and the above-mentioned findings, it would be 
valuable that examining the effect of quercetin studied extensively and using 
further methods to confirm these data. Micronucleus FISH (Fluorescence in situ 
hybridisation) is one of these methods which permit the assessment of the 
nature of chromosome damage lesions. It would be interesting if this work could 
be repeated with lymphocytes from different types of respiratory disease to 
determine whether the results will be similar or different compared to patient 
with TB. Other cancer types, such as Leukaemia, and breast cancer, are 
suggested to establish whether similar responses could be obtained. Similar or 
differing genetic end-points using qPCR could be investigated, including Bcl-xl, 
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BAX, BAK, P21, and P38. The gene expression and DNA repair studies are 
known to be associated with oxidative stress and cell cycle arrest. Caspase-3 
and caspase-7 can be linked to the cytochrome c level to investigate apoptosis 
through the mitochondria pathway. Superoxide dismutase enzymes SOD1 and 
SOD2, which are responsible for destroying free superoxide radicals in the 


















































Abbotts, R., Thompson, N ., and Madhusudan, S. (2014). DNA repair in cancer: 
emerging targets for personalized therapy. Breast Cancer: Targets and Therapy 
2014, 77-92 
Aboyade-Cole, A., Darling-Reed, S., Oriaku, E., McCaskill, M., and Thomas, R. 
(2008). Diallyl sulfide inhibits PhIP-induced cell death via the inhibition of DNA 
strand breaks in normal human breast epithelial cells. Oncol Rep 20, 319-323. 
Adebimpe, W., Faremi, A. and Nassar, S. (2016). Effects of treatment on free 
radicals in patients with pulmonary tuberculosis in South Western Nigeria. 
African Health Sciences, 15(4), p.1256. 
Ahmad, J., Ahamed, M., Akhtar, M. J., Alrokayan, S. A., Siddiqui, M. A., 
Musarrat, J. & AL-khedhairy, A. A. 2012. Apoptosis induction by silica 
nanoparticles mediated through reactive oxygen species in human liver cell line 
HepG2. Toxicology and Applied Pharmacology, 259, 160-168. 
Albertini, R.J., Anderson, D., Douglas, G.R., Hagmar, L., Hemminki, K., Merlo, 
F., Natarajan, A., Norppa, H., Shuker, D.E., and Tice, R. (2000). IPCS 
guidelines for the monitoring of genotoxic effects of carcinogens in humans. 
Mutation Research/Reviews in Mutation Research 463, 111-172. 
Akhtar, M. J., Ahamed, M., Kumar, S., Khan, M. A. M., Ahmad, J. & Alrokayan, 
S. A. 2012. Zinc oxide nanoparticles selectively induce apoptosis in human 
cancer cells through reactive oxygen species. International Journal of 
Nanomedicine, 7, 845-857. 
Anderson D, Schmid TE, Baumgartner A, Cemeli-carratala E, Brinkworth mh, 
Wood jm. 2003. Oestrogenic compounds and oxidative stress (in human sperm 
and lymphocytes in the Comet assay). mutation research/reviews in mutation 
research 544(2):173-178. 
Anderson, D., Dhawan, A. & Laubenthal, J. 2013. The Comet assay in human 
biomonitoring. Genotoxicity Assessment: Methods and Protocols, 347-362. 
 
Anderson, D., Dobryńska, M., Başaran, N., Başaran, A. and Yu, T. (1998). 
Flavonoids modulate Comet assay responses to food mutagens in human 
lymphocytes and sperm. Mutation Research/Fundamental and Molecular 
Mechanisms of Mutagenesis, 402(1-2), pp.269-277. 
Anderson, D., Francis, A. J., Godbert, P., Jenkinson, P. & Butterworth, K. 1991. 
Chromosome aberrations (CA), sister-chromatid exchanges (SCE) and 
mitogen-induced blastogenesis in cultured peripheral lymphocytes from 48 
control individuals sampled 8 times over 2 years. Mutation 
Research/Fundamental and Molecular Mechanisms of Mutagenesis, 250, 467-
476. 
 
Anderson, D., Yu, T.-W., and McGregor, D.B. (1998). Comet assay responses 
as indicators of carcinogen exposure. Mutagenesis 13, 539-555. 
166 
 
Anderson, D.,YU, T., PHILLIPS, B. and SCHMEZER, P. (1994). The effect of 
various antioxidants and other modifying agents on oxygen-radical-generated 
DNA damage in human lymphocytes in the COMET assay. Mutation 
Research/Fundamental and Molecular Mechanisms of Mutagenesis, 307(1), 
pp.261-271 
Ansari, M. A., Abdul, H. M., Joshi, G., Opii, W. O. & Butterfield, D. A. 2009. 
Protective effect of quercetin in primary neurons against Aβ (1–42): relevance 
to Alzheimer's disease. The Journal of nutritional biochemistry, 20, 269-275. 
Appasamy, M., Muttukrishna, S., Pizzey, A., Ozturk, O., Groome, N., SerhaL, P. 
& Jauniaux, E. 2007. Relationship between male reproductive hormones, sperm 
DNA damage and markers of oxidative stress in infertility. Reproductive 
biomedicine online, 14, 159-165. 
Ashkenazi, A., Fairbrother, W., Leverson, J. and Souers, A. (2017). From basic 
apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nature 
Reviews Drug Discovery, 16(4), pp.273-284. 
Arya, A., Pokharia, D. and Tripathi, K. (2011). Relationship between oxidative 
stress and apoptotic markers in lymphocytes of diabetic patients with chronic 
non-healing wound. Diabetes Research and Clinical Practice, 94(3), pp.377-
384. 
Balazs, L. & Leon, M. 1994. Evidence of an oxidative challenge in the 
Alzheimer's brain. Neurochemical research, 19, 1131-1137. 
Banerjee, T., Van der Vliet, A. and Ziboh, V. (2002). Downregulation of COX-2 
and iNOS by amentoflavone and quercetin in A549 human lung 
adenocarcinoma cell line. Prostaglandins, Leukotrienes and Essential Fatty 
Acids, 66(5-6), pp.485-492. 
Bartlett, J. M. S.; Stirling, D. (2003). "A Short History of the Polymerase Chain 
Reaction". PCR Protocols. Methods in Molecular Biology 226 (2nd ed.). pp. 3–6   
Bartosz, G. (2006). Use of spectroscopic probes for detection of reactive 
oxygen species. Clinica Chimica Acta 368, 53-76. 
Begum, A. N. & Terao, J. 2002. Protective effect of quercetin against cigarette 
tar extract-induced impairment of erythrocyte deformability. The Journal of 
nutritional biochemistry, 13, 265-272. 
Ben-Shaul, V., Lomnitski, L., Nyska, A., Zurovsky, Y., Bergman, M., and 
Grossman, S. (2001). The effect of natural antioxidants, NAO and apocynin, on 
oxidative stress in the rat heart following LPS challenge. Toxicology letters 123, 
1-10. 
Bentz, A. B. 2009. A review of quercetin: Chemistry, antioxidant properties, and 
bioavailability. Journal of young investigators, 19. Biomed Life Sci 802, 19-26 
 
Bieging, K.T., Mello, S.S., and Attardi, L.D. (2014). Unravelling mechanisms of 
p53mediated tumour suppression. Nat Rev Cancer 14. 
167 
 
Bischoff, S. C. 2008. Quercetin: potentials in the prevention and therapy of 
disease. Current Opinion in Clinical Nutrition & Metabolic Care, 11, 733-740. 
Bjelland, I., Ueland, P.M., and Vollset, S.E. (2003). Folate and depression. 
Psychotherapy and psychosomatics 72, 59-60. 
Bolton, J. L. 2002. Quinoids, quinoid radicals, and phenoxyl radicals formed 
from estrogens and antiestrogens. Toxicology, 177, 55-65. Cell transformation. 
Carcinogenesis 20, 545-551. 
Boots, A. W., Wilms, L. C., Swennen, E. L., Kleinjans, J. C., Bast, A. & Haenen, 
G. R. 2008. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy 
volunteers. Nutrition, 24, 703-710. 
Brendler-Schwaab, S., Hartmann, A., Pfuhler, S. & Speit, G. 2005. The in vivo 
comet assay: use and status in genotoxicity testing. Mutagenesis, 20, 245-254. 
Bromberg, J. (2000). Signal transducers and activators of transcription as 
regulators of growth, apoptosis and breast development. Breast Cancer Res 2, 
86-90. 
Burns, J.M., Cooper, W.J., Ferry, J.L., King, D.W., DiMento, B.P., McNeill, K., 
Miller, C.J., Miller, W.L., Peake, B.M., and Rusak, S.A. (2012). Methods for 
reactive oxygen species (ROS) detection in aqueous environments. Aquatic 
Sciences 74, 683-734. 
Canonica, S., Kohn, T., Mac, M., Real, F.J., Wirz, J., and von Gunten, U. 
(2005). Photosensitizer method to determine rate constants for the reaction of 
carbonate radical with organic compounds. Environmental science & 
technology 39, 9182-9188. 
Caylà, J. A. & Orcau, A. 2011. Control of tuberculosis in large cities in 
developed countries: an organizational problem. BMC medicine, 9, 127. 
Cemeli, E., Schmid, T. and Anderson, D. (2004). Modulation by flavonoids of 
DNA damage induced by estrogen-like compounds. Environmental and 
Molecular Mutagenesis, 44(5), pp.420-426. 
Chakarov, S., Petkova, R., and Russev, G.C. (2013). Individual capacity for 
detoxification of genotoxic compounds and repair of DNA damage. Commonly 
used methods for assessment of capacity for DNA repair. Biodiscovery 11. 
Chan, V.S. (2006). Nanomedicine: an unresolved regulatory issue. Regulatory 
Toxicology and Pharmacology 46, 218-224. 
Chapurkin, V. (2016) Particularity primary peroxide derivative synthesis from 
reaction fluorinated carbonyl compounds with hydrogen peroxide. Fluorine 
notes, 5(108) 
Chen, Y.-S., Hung, Y.-C., Liau, I. & Huang, G. S. 2009. Assessment of the In 
Vivo Toxicity of Gold    Nanoparticles. Nanoscale Research Letters, 4, 858-864. 
Chen, Y.-S., Hung, Y.-C., Liau, I. & Huang, G. S. 2009. Assessment of the In 
Vivo Toxicity of Gold Nanoparticles. Nanoscale Research Letters, 4, 858-864. 
168 
 
Cho yh, Lee JW, Woo HD, Lee S, Kim YJ, Lee Y, Shin S, Joung H, Chung HW. 
2016. Protective Effect of Onion Extract on Bleomycin-Induced Cytotoxicity and 
Genotoxicity in Human Lymphocytes. International journal of environmental 
research and public health 13(2):227. 
 
Clancy, S. (2008). DNA Damage & Repair: Mechanisms for Maintaining DNA 
Integrity. Nature Education 1, 103 
Cleaver, J.E., Lam, E.T., and Revet, I. (2009). Disorders of nucleotide excision 
repair: the genetic and molecular basis of heterogeneity. Nature Reviews 
Genetics 10, 756-768. 
Collins, A. R. 2004. The Comet assay for DNA damage and repair. Molecular 
biotechnology, 26, 249-261.  
Collins, A., Dušinská, M., Franklin, M., Somorovská, M., Petrovská, H., Duthie, 
S., Fillion, L., Panayiotidis, M., Rašlová, K. & Vaughan, N. 1997a. Comet assay 
in human biomonitoring studies: Reliability, validation, and applications. 
Environmental and Molecular Mutagenesis, 30, 139-146. 
Collins, K., Jacks, T. & Pavletich, N. P. 1997b. The cell cycle and cancer. 
Proceedings of the National Academy of Sciences, 94, 2776-2778. 
Collins, K., Jacks, T. & Pavletich, N. P. 1997b. The cell cycle and cancer. 
Proceedings of the National Academy of Sciences, 94, 2776-2778. 
Da Silva, Andréa Lúcia Gonçalves et al. "DNA Damage And Cellular 
Abnormalities In Tuberculosis, Lung Cancer And Chronic Obstructive 
Pulmonary Disease". Multidisciplinary Respiratory Medicine 10.1 (2015): n. pag. 
Web. 
Damm, C., Münstedt, H. & Rösch, A. 2008. The antimicrobial efficacy of 
polyamide 6/silver-nano-and microcomposites. Materials Chemistry and 
Physics, 108, 61-66. 
Davis, E. O., Springer, B., Gopaul, K. K., Papavinasasundaram, K., Sander, P. 
& Böttger, E. C. 2002. DNA damage induction of recA in Mycobacterium 
tuberculosis independently of RecA and LexA. Molecular microbiology, 46, 791-
800. 
Davis, L. (2012). Basic methods in molecular biology (Elsevier). 
Dechend, R., V. Homuth, G. Wallukat, D. N. Müller, M. Krause, J. 
Dudenhausen, H. Haller and F. C. Luft (2006). "Agonistic antibodies directed at 
the angiotensin II, AT1 receptor in preeclampsia." Journal of the Society for 
Gynecologic Investigation 13(2): 79-86. 
Dexheimer, T.S. (2013). DNA repair pathways and mechanisms. In DNA repair 
of cancer stem cells (Springer), pp. 19-32. 
Dedon PC, Goldberg IH. 1992. Free-radical mechanisms involved in the 
formation of sequence-dependent bistranded DNA lesions by the antitumor 
169 
 
antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chemical research 
in toxicology 5(3):311-332 
Doane, T. L. & Burda, C. 2012. The unique role of nanoparticles in 
nanomedicine: imaging, drug delivery and therapy. Chemical Society Reviews, 
41, 2885-2911. 
Dohi, K., Ohtaki, H., Nakamachi, T., Yofu, S., Satoh, K., Miyamoto, K., Song, 
D., Tsunawaki, S., Shioda, S., and Aruga, T. (2010). Gp91 phox (NOX2) in 
classically activated microglia exacerbates traumatic brain injury. Journal of 
neuroinflammation 7, 41. 
Doll, R., and Peto, R. (1981). The causes of cancer: quantitative estimates of 
avoidable risks of cancer in the United States today. J Natl Cancer Inst 66, 
1191-1308. 
Donaldson, K., Poland, C., Donaldson, K. & Poland, C. 2012. Inhaled 
nanoparticles and lung cancer - what we can learn from conventional particle 
toxicology. Swiss medical weekly, 142, 0. 
Durling, L, and Abramsson-Zetterberg, L. (2005) A comparison of genotoxicity 
between three common heterocyclic amines and acrylamide Mutation 
Research/Genetic Toxicology and Environmental Mutagenesis, 580(1-2), 
pp.103-110. 
 
Dušinská, M., Džupinková, Z., Wsólová, L., Harrington, V., and Collins, A.R. 
(2006). Possible involvement of XPA in repair of oxidative DNA damage 
deduced from analysis of damage, repair and genotype in a human population 
study. Mutagenesis 21, 205-211. 
Eastmond, D.A., Hartwig, A., Anderson, D., Anwar, W.A., Cimino, M.C., Dobrev, 
I., Douglas, G.R., Nohmi, T., Phillips, D.H., and Vickers, C. (2009). Mutagenicity 
testing for chemical risk assessment: update of the WHO/IPCS Harmonized 
Scheme. Mutagenesis 24, 341-349. 
El-Denshary, E. S., Aljawish, A., El-Nekeety, A. A., Hassan, N. S., Saleh, R. H., 
Rihn, B. H. and Abdel-Wahhab, M. A. (2015) Possible Synergistic Effect and 
Antioxidant Properties of Chitosan Nanoparticles and Quercetin against Carbon 
Tetrachloride-Induce Hepatotoxicity in Rats. Soft Nanoscience Letters, 5(02), 
pp. 36. 
Emmons, K.M., McBride, C.M., Puleo, E., Pollak, K.I., Marcus, B.H., Napolitano, 
M., Clipp, E., Onken, J., Farraye, F.A., and Fletcher, R. (2005). Prevalence and 
predictors of multiple behavioral risk factors for colon cancer. Prev Med 40, 527. 
 
Endo, H., Schut, H.a., and Snyderwine , E.G.(1994). Mutagenic specificity of 2-
amino-3-methylimidazo[4,5f] quinoline and 2-amino-1methyl-6-




Felton, J., Knize, M., Bennett, L., Malfatti, M., Colvin, M., and Kulp, K. (2004) 
Impact of environmental exposures on the mutagenicity/carcinogenicity of 
heterocyclic amines. Toxicology, 198(1-3), pp.135-145. 
Felton, J.S., and Knize, M.G. (1991). Occurrence, identification, and bacterial 
mutagenicity of heterocyclic amines in cooked food. Mutat Res 259, 205-217. 
 
Felton, J.S., Knize,M.G.,Wu,R.W., Colvin, M.E.,Hatch, F.t., and Malfatti, M.A. 
(2007). Mutagenic potency of food-derived heterocyclic amines. Mutat Res 616, 
90-94. 
Fenech, M. (1997). The advantages and disadvantages of the cytokinesis-block 
micronucleus method. Mutation Research/Genetic Toxicology and 
Environmental Mutagenesis 392, 11-18. 
Fenech, M. (2002). Biomarkers of genetic damage for cancer epidemiology. 
Toxicology 181-182, 411-416. 
Fenech, M. (2006). Cytokinesis-block micronucleus assay evolves into a 
“cytome” assay of chromosomal instability, mitotic dysfunction and cell death. 
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 
600, 58-66. 
Fenech, M. (2007). Cytokinesis-block micronucleus cytome assay. Nature 
protocols 2, 1084-1104. 
Fenech, M., Kirsch-Volders, M., Natarajan, A.T., Surralles, J., Crott, J.W., Parry, 
J., Norppa, H., Eastmond, D.A., Tucker, J.D., and Thomas, P. (2011). Molecular 
mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation 
in mammalian and human cells. Mutagenesis 26, 125-132. 
Fenech, Michael. 'The In Vitro Micronucleus Technique'. Mutation 
Research/Fundamental and Molecular Mechanisms of Mutagenesis 455.1-2 
(2000): 81-95. Web. 
Feng, Z., Hu, W., Teresky, A.K., Hernando, E., Cordon-Cardo, C., and Levine, 
A.J. (2007). Declining p53 function in the aging process: a possible mechanism 
for the increased tumor incidence in older populations. Proc Natl Acad Sci U S 
A 104, 16633-16638. 
Ferguson, L.R., Philpott, M., and Karunasinghe, N. (2004). Dietary cancer and 
Frampton, M. W., UTELL, M. J., ZAREBA, W., OBERDÖRSTER, G., COX, C., 
HUANG, L.-S., MORROW, P. E., LEE, F., CHALUPA, D. & FRASIER, L. M. 
2004. Effects of exposure to ultrafine carbon particles in healthy subjects and 
subjects with asthma. Research Report (Health Effects Institute), 1-47; 
discussion 49-63. 
 
Fukui, K. (2010). DNA mismatch repair in eukaryotes and bacteria. Journal of 
nucleic acids, 260512. 
Gao, J., Kang, H.-F., Ma, X.-B., Tang, W., Liu, D., Zhao, Y., Zhang, S.-Q., 
Guan, H.-T., Lin, S., and Ren, H.-T. (2014). Functional promoter-765 G> C 
171 
 
variant in COX-2 gene is associated with the susceptibility of breast cancer in 
Chinese Han women. Cancer cell international 14, 1. 
Genesc, A., Barrios, L., Mir, R., Caballn, M., Benet, J., Fuster, C., Bonfill, X. and 
Egozcue, J. (1990). Lymphocyte and sperm chromosome studies in cancer-
treated men. Human Genetics, 84(4). 
Gibellini, L., Pinti, M., Nasi, M., De Biasi, S., Roat, E., Bertoncelli, L. and 
Cossarizza, A. (2010). Interfering with ROS Metabolism in Cancer Cells: The 
Potential Role of Quercetin. Cancers, 2(2), pp.1288-1311. 
Glorieux, C., Sandoval, J., Dejeans, N., Nonckreman, S., Bahloula, K., Poirel, 
H. and Calderon, P. (2018). Evaluation of Potential Mechanisms Controlling the 
Catalase Expression in Breast Cancer Cells. Oxidative Medicine and Cellular 
Longevity, 2018, pp.1-10 
Glorieux, C., Zamocky, M., Sandoval, J., Verrax, J. and Calderon, P. (2015). 
Regulation of catalase expression in healthy an d cancerous cells. Free Radical 
Biology and Medicine, 87, pp.84-97. 
Global tuberculosis report 2017. (2017). Geneva: World Health Organization. 
Goldman, R., and Shields, P.G. (2003). Food mutagens. J Nutr 133 Suppl 3, 
965S-973S. 
 
Gong, C., Yang, Z., Zhang, L., Wang, Y., Gong, W. and Liu, Y. (2017). 
Quercetin suppresses DNA double-strand break repair and enhances the 
radiosensitivity of human ovarian cancer cells via p53-dependent endoplasmic 
reticulum stress pathway. OncoTargets and Therapy, Volume 11, pp.17-27. 
Górniak, I., Bartoszewski, R. and Króliczewski, J. (2018). Comprehensive 
review of antimicrobial activities of plant flavonoids. Phytochemistry Reviews, 
18(1), pp.241-272. 
Glorieux, C., Sandoval, J., Dejeans, N., Nonckreman, S., Bahloula, K., Poirel, 
H. and Calderon, P. (2018). Evaluation of Potential Mechanisms Controlling the 
Catalase Expression in Breast Cancer Cells. Oxidative Medicine and Cellular 
Longevity, 2018, pp.1-10 
Granado-Serrano, A., Martín, M., Bravo, L., Goya, L. and Ramos, S. (2006). 
Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and 
Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell 
Line (HepG2). The Journal of Nutrition, 136(11), pp.2715-2721 
Groner, B., and Gouilleux, F. (1995). Prolactin-mediated gene activation in 
mammary epithelial cells. Curr Opin Genet Dev 5, 587-594. 
GschwendT, M., Horn, F., Kittstein, W., and Marks, F. (1983). Inhibition of the 
calcium-and phospholipid-dependent protein kinase activity from mouse brain 




Gutteridge, J.M. (1994). Antioxidants, nutritional supplements and life-
threatening diseases. British journal of biomedical science 51, 288-295. 
Habas, K., Abdulmwli, M., Demir, E., Jacob, B., Najafzadeh, M. and Anderson, 
D. (2018). DNA damage protection by bulk and nano forms of quercetin in 
lymphocytes of patients with chronic obstructive pulmonary disease exposed to 
the food mutagen 2-amino-3-methylimidazo [4,5-f]quinolone (IQ). Environmental 
Research, 166, pp.10 
Haliwell, B. 1994. Free radicals antioxidants and human disease: curiosity, 
cause or consequence. Lancet, 344, 21-724. 
 
Han, J.F., He, X.Y., Herrington, J.S., White, L.A., Zhang, J.F., and Hong, J.Y. 
(2008). Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) 
by human CYP1B1 genetic variants. Drug Metab Dispos 36, 745-752. 
Hard, G., Seely, J., Betz, L. and Hayashi, S. (2007). Re-evaluation of the kidney 
tumors and renal histopathology occurring in a 2-year rat carcinogenicity 
bioassay of quercetin. Food and Chemical Toxicology, 45(4), pp.600-608. 
Hartmann, A., Plappert, U., Raddata, K., Grünert-Fuchs, M., and Speit, G. 
(1994). Does physical activity induce DNA damage? Mutagenesis 9, 269-272. 
Harwood, M., Danielewska-Nikiel, B., Borzelleca, J., Flamm, G., Williams, G. 
and Lines, T. (2007). A critical review of the data related to the safety of 
quercetin and lack of evidence of in vivo toxicity, including lack of 
genotoxic/carcinogenic properties. Food and Chemical Toxicology, 45(11), 
pp.2179-2205. 
 
Hazra, T.K., Das, A., Das, S., Choudhury, S., Kow, Y.W., and Roy, R. (2007). 
Oxidative DNA damage repair in mammalian cells: a new perspective. DNA 
repair 6, 470-480. 
Henderson, L., Albertini, S. and Aardema, M. (2000). Thresholds in genotoxicity 
responses, Mutation Research/Genetic Toxicology and Environmental 
Mutagenesis, 464(1), pp.123-128. 
 
Henderson, L., Wolfreys ,A.,Fedyk, J., Bourner, C., and Windebank, S.(1998). 
The ability of the Comet assay to discriminate between genotoxins and 
cytotoxins. Mutagenesis 13,89-94. 
Hess, R. & Franca, L. 2005. History of the sertoli cell discovery. Sertoli cell 
biology, 10. 
Hollman, P. C. H. & Katan, M. 1999. Dietary flavonoids: intake, health effects 
and bioavailability. Food and Chemical Toxicology, 37, 937-942. 
Hollman, P. C. H. & Katan, M. 1999. Dietary flavonoids: intake, health effects 
and bioavailability. Food and Chemical Toxicology, 37, 937-942. 
173 
 
Houtgraaf, J.H., Versmissen, J., and van der Giessen, W.J. (2006). A concise 
review of DNA damage checkpoints and repair in mammalian cells. 
Cardiovascular Revascularization Medicine 7, 165-172. 
Huang, C.-C., Aronstam, R. S., Chen, D.-R. & Huang, Y.-W. 2010. Oxidative 
stress, calcium homeostasis, and altered gene expression in human lung 
epithelial cells exposed to ZnO nanoparticles. Toxicology in Vitro, 24, 45-55. 
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, 
Y., and Wang, P.C. (2012). Size-dependent localization and penetration of 
ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors 
in vivo. ACS nano 6, 4483-4493. 
Huang, J., Papadopoulos, N., McKinley, A.J., Farrington, S.M., Curtis, L.J., 
Wyllie, A.H., Zheng,S., Willson, J.k., Markowitz, S.D., Morin, P., et al .(1996). 
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl 
Acad Sci USA 93, 9049-9054. 
In Silico Methods Applied in Food Chemistry: A Short Review with Bitter and 
Mutagenic Compounds - Scientific Figure on ResearchGate. Available from: 
https://www.researchgate.net/figure/Fig-4-Structures-of-PhIP-and-3-Me-
PhIP_fig2_271198523 [accessed 8 Oct, 2019] 
Image.slidesharecdn.com. (2019). [online] Available at: 
http://image.slidesharecdn.com/passmore-20-20session-20wed-201-
131120054623-phpapp02/95/animaltohuman-transmission-of-mycobacterium-
tuberculosis-3-638.jpg?cb=1384926467 date 17.07.2016 [Accessed 24 Jan. 
2019]. 
Johnson, M. K. and Loo, G. (2000) Effects of epigallocatechin gallate and 
quercetin on oxidative damage to cellular DNA. Mutation Research/DNA Repair, 
459(3), pp. 211-218. 
 
Joshi, Mohini, and J. D. Deshpande. 'POLYMERASE CHAIN REACTION: 
METHODS, PRINCIPLES AND APPLICATION'. International Journal of 
Biomedical Research 2.1 (2011): n. pag. Web. 
Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J.h., 
Sugimura, T., and Nagao, M.(1995). Specific 5-GGGA-3’—5’-GG-3’ mutation  of 
the Apc gene in  rat colon tumors induced by 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 92, 910-914. 
Kandaswami, C. & Middleton jr, E. 1994. Free radical scavenging and 
antioxidant activity of plant flavonoids. Free radicals in diagnostic medicine. 
Springe. 
 
Kapka-Skrzypczak, L., Cyranka, M., Skrzypczak, M., and Kruszewski, M. (2011) 
Biomonitoring and biomarkers of organophosphate pesticides exposure-state of 




Khanna, K.K., and Jackson, S.P. (2001). DNA double-strand breaks: signaling, 
repair and the cancer connection. Nature genetics 27, 247-254 
Khoo, N., White, C., Pozzo-Miller, L., Zhou, F., Constance, C., Inoue, T., Patel, 
R. and Parks, D. (2010). Dietary flavonoid quercetin stimulates vasorelaxation 
in aortic vessels. Free Radical Biology and Medicine, 49(3), pp.339-347 
Kim, R.H., Kang, M.K., Kim, T., Yang, P., Bae, S., Williams, D.W., Phung, S., 
Shin, K.H., Hong, C., and Park, N.H. (2015). Regulation of p53 during 
senescence in normal human keratinocytes. Aging Cell 14, 838-846. 
Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Eastmond, D., 
Fenech, M., Ishidate, M., Kirchner, S., Lorge, E., Morita, T., Norppa, H., 
Surrallés, J., Vanhauwaert, A. and Wakata, A. (2003). Report from the in vitro 
micronucleus assay working group. Mutation Research/Genetic Toxicology and 
Environmental Mutagenesis, 540(2), pp.153-163. 
Klapacz, J., Pottenger, L.H., Engelward, B.P., Heinen, C.D., Johnson, G.E., 
Clewell, R.A., Carmichael, P.L., Adeleye, Y., and Andersen, M.E. (2015). 
Contributions of DNA repair and damage response pathways to the non-linear 
genotoxic responses of alkylating agents. Mutation Research/Reviews in 
Mutation Research 767, 77-91. 
Klein, D. (2002). Quantification using real-time PCR technology: applications 
and limitations. Trends Mol Med 8, 257-260. 
Knize, M.g., Dolbeare, F.A., Cunningham, P.L., and felton, J.S (1995). 
Mutagenic activity and hetrocyclic amine content of human diet. Princess 
Takamatsu Symp 23, 30-38. 
Kodydkov á J, Vávrov á, K., L, Koc ík V. Žák and M, K. (2014). Human 
Catalase, Its PolymorphismsRegulation and Changes of Its Activity in Different 
Diseases. Folia Biologica (Praha), 60(64165/2012), pp.153-167 
Krul, C., Luiten-Schuite, A., Baandagger, R., Verhagen, H., Mohn, G., Feron, V., 
and Havenaar, R. (2000). Application of a dynamic in vitro gastrointestinal tract 
model to study the availability of food mutagens , using using heterocyclic 
aromatic amines as model compounds food chem Toxicol 38, 783-792. 
Kryston, T.B., Georgiev, A.B., Pissis, P., and Georgakilas, A.G. (2011). Role of 
oxidative stress and DNA damage in human carcinogenesis. Mutation 
Research/Fundamental and Molecular Mechanisms of Mutagenesis 711, 193-
201 
Kühna. The flavonoids. A class of semi-essential food components: their role in 
human nutrition World Review of Nutrition and Dietetics, 24 (1976), pp. 117–
191 
Kumar, A., Najafzadeh, M., Jacob, B.K., Dhawan, A., and Anderson, D. (2014). 
Zinc oxide nanoparticles affect the expression of p53, Ras p21 and JNKs: an ex 
vivo/in vitro exposure study in respiratory disease patients. Mutagenesis 30, 
237-245. 
Kurien, B.T., and Scofield, R.H. (2006). Western blotting. Methods 38, 283-293. 
175 
 
 Kuroda, E., and Yamashita, U. (2002). Regulation of immune response by 
prostaglandin. Journal of UOEH 24, 289-299. 
Kurthkoti, Krishna and Umesh Varshney. "Distinct Mechanisms Of DNA Repair 
In Mycobacteria And Their Implications In Attenuation Of The Pathogen 
Growth". Mechanisms of Ageing and Development 133.4 (2012): 138-146. 
Web. 
Kurzawa-Zegota, M., Najafzadeh, M., Baumgartner, A. and Anderson, D. 
(2012). The protective effect of the flavonoids on food-mutagen-induced DNA 
damage in peripheral blood lymphocytes from colon cancer patients. Food and 
Chemical Toxicology, 50(2), pp.124-129. 
Kurzawa-Zegota, M., Sharma, V., Najafzadeh, M., Reynolds, P., Davies, J., 
Shukla, R., Dhawan, A. and Anderson, D. (2017). Titanium Dioxide 
Nanoparticles Induce DNA Damage in Peripheral Blood Lymphocytes from 
Polyposis coli, Colon Cancer Patients and Healthy Individuals: An Ex Vivo/In 
Vitro Study. Journal of Nanoscience and Nanotechnology, 17(12), pp.9274-
9285. 
Lam, C.-W., James, J.T., McCluskey, R., and Hunter, R.L. (2004). Pulmonary 
toxicity of single-wall carbon nanotubes in mice 7 and 90 days after 
intratracheal instillation. Toxicological sciences 77, 126-134. 
Larrea, A.A., Lujan, S.A., and Kunkel, T.A. (2010). SnapShot: DNA mismatch 
repair. Cell 141, 730-730. e731. 
Lee, Y., Park, S., Kim, Y., Lee, W. and Park, O. (2009). AMP 
kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of 
cancer cells treated with quercetin. Experimental and Molecular Medicine, 
41(3), p.201.  
Lee, Y.J., Ruby, D.S., Peters, D.W., McKenzie, B.B., and Hsu, J.W. (2008). 
ZnO nanostructures as efficient antireflection layers in solar cells. Nano Lett 8, 
1501-1505. 
Li, K., Zhao, X., K. Hammer, B., DU, S. & Chen, Y. 2013. Nanoparticles Inhibit 
DNA Replication by Binding to DNA: Modeling and Experimental Validation. 
ACS Nano, 7, 9664-9674. 
Li, L., Weinberg, C. R., Darden, T. A. & Pedersen, L. G. 2001. Gene selection 
for sample classification based on gene expression data: study of sensitivity to 
choice of parameters of the GA/KNN method. Bioinformatics, 17, 1131-1142. 
Li, N., Xia, T., and Nel, A.E. (2008). The role of oxidative stress in ambient 
particulate matter-induced lung diseases and its implications in the toxicity of 
engineered nanoparticles. Free Radic Biol Med 44, 1689-1699. 
Lieber, M.R. (2010). The mechanism of double-strand DNA break repair by the 




Lindahl, Tomas. 'Recovery Of Antediluvian DNA'. Nature 365.6448 (1993): 700-
700. Web. 
Liu, Z.-Q., Mahmood, T., and Yang, P.-C. (2014). Western blot: Technique, 
theory and trouble shooting. North American journal of medical sciences 6, 160 
Lodish, H., Berk, A., Zipursky, L., Matsudaira, P., Baltimore, D., and Darnell, J. 
(2000). Molecular Cell Biology 4th edn (New York: WH Freeman). 
Lord, C.J., and Ashworth, A. (2012). The DNA damage response and cancer 
therapy. Nature 481, 287-294 
Lushchak, V. (2015). Free radicals, reactive oxygen species, oxidative stresses 
and their classifications. The Ukrainian Biochemical Journal, 87(6), pp.11-18 
Luzhna, L., Kathiria, P. & Kovalchuk, O. 2013. Micronuclei in genotoxicity 
assessment: from genetics to epigenetics and beyond. Frontiers in genetics, 4, 
131. 
Maeda, H., Sawa, T., Yubisui, T. and Akaike, T (1999) Free radical generation 
from heterocyclic amines by cytochrome b5 reductase in the presence of 
NADH Cancer Letters, 143(2), pp.117-121. 
Magdolenova, Z., Collins, A., Kumar, A., Dhawan, A., Stone, V., and Dusinska, 
M. (2013). Mechanisms of genotoxicity. A review of in vitro and in vivo studies 
with engineered nanoparticles. Nanotoxicology 8, 233-278. 
Mahmood, T., and Yang, P.-C. (2012). Western blot: technique, theory, and 
trouble shooting. North American journal of medical sciences 4, 429. 
Manke, A., Wang, L. & Rojanasakul, Y. 2013. Mechanisms of Nanoparticle-
Induced Oxidative Stress and Toxicity. BioMed Research International, 2013, 
15. 
Manke, A., Wang, L. & Rojanasakul, Y. 2013. Mechanisms of Nanoparticle-
Induced Oxidative Stress and Toxicity. BioMed Research International, 2013, 
15. 
Merk, O., and Speit, G. (1999). Detection of crosslinks with the comet assay in 
relationship to genotoxicity and cytotoxicity. Environmental and Molecular 
Mutagenesis 33, 167-172. 
Marakalala, M., Raju, R., Sharma, K., Zhang, Y., Eugenin, E., Prideaux, B., 
Daudelin, I., Chen, P., Booty, M., Kim, J., Eum, S., Via, L., Behar, S., Barry, C., 
Mann, M., Dartois, V. and Rubin, E. (2016). Inflammatory signaling in human 
tuberculosis granulomas is spatially organized. Nature Medicine, 22(5), pp.531-
538. 
Marchetti, F. & WYROBEK, A. J. 2005. Mechanisms and consequences of 
paternally‐transmitted chromosomal abnormalities. Birth Defects Research Part 
C: Embryo Today: Reviews, 75, 112-129. 




Maurya, A. and Vinayak, M. (2015). Anticarcinogenic action of quercetin by 
downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C 
(PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. 
Molecular Biology Reports, 42(9), pp.1419-1429. 
Mckay1, T. B., , D. L., , A. S.-N., , S. P., , J. M. A . D. K., 2Agarwal, Ashok & 
Said, T. M. 2015. Quercetin Attenuates Lactate Production 
 
McKelvey-Martin, V.J., Melia, N., Walsh, I.K., Johnston, S.R., Hughes, C.M., 
Lewis, S.E., and Thompson, W. (1997). Two potential clinical applications of the 
alkaline single-cell gel electrophoresis assay: (1). Human bladder washings and 
transitional cell carcinoma of the bladder; and (2). Human sperm and male 
infertility. 
Mutat Res 375, 93-104 
Messner, C., and Murkovic, M. (2004). Evaluation of a new model system for 
studying the formation of heterocyclic amines. J Chromatogr B Analyt Technol  
 
Moon, S., Cho, G., Jung, S., Gal, S., Kwon, T., Lee, Y., Madamanchi, N. and 
Kim, C. (2003). Quercetin exerts multiple inhibitory effects on vascular smooth 
muscle cells: role of ERK1/2, cell-cycle regulation, and matrix 
metalloproteinase-9. Biochemical and Biophysical Research Communications, 
301(4), pp.1069-1078. 
Mouat, M. F., Kolli, K., Orlando, R., Hargrove, J. L. & Grider, A. 2005. The 
effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. 
Nutrition journal, 4, 1. 
Morita, R., Nakane, S., Shimada, A., Inoue, M., Iino, H., Wakamatsu, T., Fukui, 
K., Nakagawa, N., Masui, R., and Kuramitsu, S. (2010). Molecular mechanisms 
of the whole DNA repair system: a comparison of bacterial and eukaryotic 
systems. Journal of nucleic acids, 179594. 
Mudalir, A. 25/12/2018. Process of spermatogenesis [Online]. Available: 
http://www.buzzle.com/articles/the-process-of-spermatogenesis-explained.html 
[Accessed]. 
Muriel, L.,Segrelles, E.,Goyanes, V.,Gosalvez, J., and Fernandez, J.L.(2004) 
Structure of human sperm DNA and background damage, analysed by in situ 
enzymatic treatment and digital image analysis. Mol Hum Repord 10,203-209. 
Murray, V., Chen, J. and Chung, L. (2018). The Interaction of the Metallo-
Glycopeptide Anti-Tumour Drug Bleomycin with DNA. International Journal of 
Molecular Sciences, 19(5), p.1372. 
 Nagao, M., Sato, Y., and Yamauchi, A. (2013). A meta-analysis of PTGS1 and 
PTGS2 polymorphisms and NSAID intake on the risk of developing cancer. 
PloS one 8, e71126. 
Nagao, M., Ushijima, T., Toyota, M., Inoue, R., and Sugimura, T. (1997). 




Nagarathna, P., Wesley, M., and Reddy, P. (2013). Reena. K. Review on 
Genotoxicity, its Molecular Mechanisms and Prevention. Int J Pharm Sci Rev 
Res 22, 236-243.  
Najafzadeh, M., BAUMGARTNER, A., GOPALAN, R., DAVIES, J. B., WRIGHT, 
A., REYNOLDS, P. D. & Anderson, D. 2012.In vitro sensitivities to UVA of 
lymphocytes from patients with colon and melanoma cancers and precancerous 
states in the micronucleus and the Comet assays. Mutagenesis, 27, 351-357. 
Najafzadeh, M., Reynolds, P., Baumgartner, A. and Anderson, D. (2009). 
Flavonoids inhibit the genotoxicity of hydrogen peroxide (H2O2) and of the food 
mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from 
patients with inflammatory bowel disease (IBD). Mutagenesis, 24(5), pp.405-
411. 
Naveenkumar, C., Raghunandhakumar, S., Asokkumar, S., and Devaki, T. 
(2013). Baicalein Abrogates Reactive Oxygen Species (ROS)‐mediated 
Mitochondrial Dysfunction during Experimental Pulmonary Carcinogenesis In 
Vivo. Basic & clinical pharmacology & toxicology 112, 270-281. 
Neto, F. T. L., Bach, P. V., Najari, B. B., LI, P. S. & Goldstein, M. 
Spermatogenesis in humans and its affecting factors.  Seminars in cell & 
developmental biology, 2016. Elsevier. 
Ng, Vincent H. et al. "Role Of Katg Catalase-Peroxidase In Mycobacterial 
Pathogenesis: Countering The Phagocyte Oxidative Burst". Molecular 
Microbiology 52.5 (2004): 1291-1302. Web. 
Nguyen, T., Tran, E., Nguyen, T., DO, P., Huynh, T. & Huynh, H. 2004. The role 
of activated MEK-ERK pathway in quercetin-induced growth inhibition and 
apoptosis in A549 lung cancer cells. Carcinogenesis, 25, 647-659. 
 
Nijveldt, R. J., Van Nood, E., Van Hoorn, D. E., Boelens, P. G., Van Norren, K. 
and Van Leeuwen, P. A. (2001) Flavonoids: a review of probable mechanisms 
of action and potential applications. The American journal of clinical nutrition, 
74(4), pp. 418-425. 
 
Nishikawa, M., Hashida, M. and Takakura, Y. (2009). Catalase delivery for 
inhibiting ROS-mediated tissue injury and tumor metastasis. Advanced Drug 
Delivery Reviews, 61(4), pp.319-326. 
Nordberg, J., and Arner, E.S. (2001). Reactive oxygen species, antioxidants, 
and the mammalian thioredoxin system. Free radical biology and medicine 31, 
1287-1312. 
Norbury, C. & Nurse, P. 1992. Animal cell cycles and their control. Annual 
review of biochemistry, 61, 441-468. 
Oberdörster, G., Oberdörster, E. & Oberdörster, J. 2005. Nanotoxicology: An 
Emerging Discipline Evolving from Studies of Ultrafine Particles. Environmental 
Health Perspectives, 113, 823-839. 
179 
 
Ochekpe, N., Olorunfemi, P. and Ngwuluka, N. (2009). Nanotechnology and 
Drug Delivery Part 1:     Background and Applications. Tropical Journal of 
Pharmaceutical Research, 8(3). 
Organization, W. H. 2013. Tuberculosis. Saudi Medical Journal, 34, 1205-1207. 
Ostling, O. & Johanson, K. 1984. Microelectrophoretic study of radiation-
induced DNA damages in individual mammalian cells. Biochemical and 
biophysical research communications, 123, 291-298. 
Otsuka, C., Miura, K.F., Satoh, T., Hatanaka, M., Wakabayashi, K., and 
Ishidate, M., Jr. (1996). Cytogenetic effects of a food mutagen, 2-amino-1-
methyl-6-phenylimidazo[4,5-beta]pyridine (PhIP), and its metabolite, 2-
hydroxyamino-1-methy-6-phenylimidazo[4,5-beta]pyridine (N-OH-PhIP), on 
human and Chinese hamster cells in vitro. Mutat Res 367, 115-121. 
Overvik, E., and Gustafsson, J.A. (1990). Cooked-food mutagens: current 
knowledge of formation and biological significance. Mutagenesis 5, 437-446. 
Panche AN, Diwan AD, Chandra SR.  Flavonoids: an overview. J Nutr Sci. 2016 
Dec 29; 5:e47. doi: 10.1017/jns.2016.41. eCollection 2016. Review. 
Papadopoulos,K.(2006).Targeting the Bcl-2 Family in Cancer Therapy. 
Seminars in Oncology,33(4), pp.449-456. 
Park, E.-J. & Park, K. 2009. Oxidative stress and pro-inflammatory responses 
induced by silica nanoparticles in vivo and in vitro. Toxicology Letters, 184, 18-
25 
Parveen, S., Misra, R. & Sahoo, S. K. 2012. Nanoparticles: a boon to drug 
delivery, therapeutics, diagnostics and imaging. Nanomedicine: 
Nanotechnology, Biology and Medicine, 8, 147-166. 
Peluso, M., Castegnaro, M., Malaveille, C., Friesen, M., Garren, L., Hautefeuille, 
A., Vineis, P., Kadlubar, F., and Bartsch, H. (1991). 32P Postlabelling analysis 
of urinary mutagens from smokers of black tobacco implicates 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. 
Carcinogenesis 12, 713-717. 
Petti, S. 2016. Tuberculosis: Occupational risk among dental healthcare 
workers and risk for infection among dental patients. A meta-narrative review. 
Journal of dentistry, 49, 1-8. 
Pfau, W., Martin, F.L., Cole, K.J., Venitt, S., Phillips, D.H., Grover, P.L., 1999. 
prevention using antimutagens. Toxicology 198, 147-159. 
 
Pool-Zobel, B., Dornacher, I., Lambertz, R., Knoll, M. and Seitz, H. (2004) 
Genetic damage and repair in human rectal cells for biomonitoring: sex 
differences, effects of alcohol exposure, and susceptibilities in comparison to 
peripheral blood lymphocytes Mutation Research/Fundamental and Molecular 




Ramyaa, P., krishnaswamy, R. and Padma, V. (2014). Quercetin modulates 
OTA-induced oxidative stress and redox signalling in HepG2 cells — up 
regulation of Nrf2 expression and down regulation of NF-κB and COX-2. 
Biochimica et Biophysica Acta (BBA) - General Subjects, 1840(1), pp.681-692. 
Rasaie, S., Ghanbarzadeh, S., Mohammadi, M. and Hamishehkar, H. (2014) 
Nano phytosomes of quercetin: A promising formulation for fortification of food 
products with antioxidants. Pharmaceutical Sciences, 20(3), pp. 96. 
 
Razavi, S. M., Zahri, S., Zarrini, G., Nazemiyeh, H. & Mohammadi, S. 2009. 
Biological activity of quercetin-3-O-glucoside, a known plant flavonoid. Russian 
Journal of Bioorganic Chemistry, 35, 376-378. 
Reuter, S., Gupta, S.C., Chaturvedi, M.M., and Aggarwal, B.B. (2010). 
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic 
Biol Med 49, 1603-1616. 
Ribeiro, D., Freitas, M., Tomé, S., Silva, A., Laufer, S., Lima, J. and Fernandes, 
E. (2014). Flavonoids Inhibit COX-1 and COX-2 Enzymes and 
Cytokine/Chemokine Production in Human Whole Blood. Inflammation, 38(2), 
pp.858-870 
Rossetto, A. L. D. O. F., Melegari, S. P., Ouriques, L. C. & Matias, W. G. 2014. 
Comparative evaluation of acute and chronic toxicities of CuO nanoparticles 
and bulk using Daphnia magna and Vibrio fischeri. Science of The Total 
Environment, 490, 807-814. 
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S. & Russo, G. L. 2012. The 
flavonoid quercetin in disease prevention and therapy: facts and fancies. 
Biochemical pharmacology, 83, 6-15. 
Saiki, R., Gelfand, D., Stoffel, S., Scharf, S., Higuchi, R., Horn, G., Mullis, K. 
and Erlich, H. (1988). Primer-directed enzymatic amplification of DNA with a 
thermostable DNA polymerase. Science, 239(4839), pp.487-491. 
Sandhu, GursimratK. "Tuberculosis: Current Situation, Challenges And 
Overview Of Its Control Programs In India". Journal of Global Infectious 
Diseases 3.2 (2011): 143. Web. 
Schins, R. P. F. 2002. MECHANISMS OF GENOTOXICITY OF PARTICLES 
AND FIBERS. Inhalation Toxicology, 14, 57-78. 
Schmid, W. 1975. The micronucleus test. Mutation Research/Environmental 
Mutagenesis and Related Subjects, 31, 9-15. 
Schroeder, W., Shelton, J. and Shelton, J. (1969). An examination of conditions 
for the cleavage of polypeptide chains with cyanogen bromide: Application to 
catalase. Archives of Biochemistry and Biophysics, 130, pp.551-555. 
Schroeder, W., Shelton, J. and Shelton, J. (1969). An examination of conditions 
for the cleavage of polypeptide chains with cyanogen bromide: Application to 
catalase. Archives of Biochemistry and Biophysics, 130, pp.551-555. 
181 
 
Serafini M, Peluso I, Raguzzini A. 2010. Flavonoids as anti-inflammatory 
agents. Proceedings of the Nutrition Society 69(03):273-278. 
Serrano-Garcia, L., and Montero-Montoya, R. (2001). Micronuclei and 
chromatid buds are the result of related genotoxic events. Environ Mol Mutagen 
38, 38-45. 
Sewerynek, E., Ortiz, G.G., Reiter, R.J., Pablos, M.I., Melchiorri, D., and 
Daniels, W.M. (1996). Lipopolysaccharide-induced DNA damage is greatly 
reduced in rats treated with the pineal hormone melatonin. Molecular and 
cellular endocrinology 117, 183-188. 
Shalini Kapoor Mehta and Sivakumar Joghi Thatha Gowder (November 11th 
2015). Members of Antioxidant Machinery and Their Functions, Basic Principles 
and Clinical Significance of Oxidative Stress, Sivakumar Joghi Thatha Gowder, 
IntechOpen, DOI: 10.5772/61884. Available from: 
https://www.intechopen.com/books/basic-principles-and-clinical-significance-of-
oxidative-stress/members-of-antioxidant-machinery-and-their-functions 
Shuck, S.C., Short, E.A., and Turchi, J.J. (2008). Eukaryotic nucleotide excision 
repair: from understanding mechanisms to influencing biology. Cell research 18, 
64-72. 
Sierens, J., Hartley, J., Campbell, M., Leathem, A. and Woodside, J. (2002). In 
vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA 
damage in sperm. Teratogenesis, Carcinogenesis, and Mutagenesis, 22(3), 
pp.227-234 
Singh, N., Manshian, B., Jenkins, G. J., Griffiths, S. M., Williams, P. M., Maffeis, 
T. G., Wright, C. J. & Doak, S. H. 2009. NanoGenotoxicology: the DNA 
damaging potential of engineered nanomaterials. Biomaterials, 30, 3891-3914. 
 
Singh, N. P., Mccoy, M. T., Tice, R. R. & Schneider, E. L. 1988. A simple 
technique for quantitation of low levels of DNA damage in individual cells. 
Experimental Cell Research, 175, 184-191. 
Singh, N., Manshian, B., Jenkins, G. J., Griffiths, S. M., Williams, P. M., Maffeis, 
T. G., Wright, C. J. & Doak, S. H. 2009. NanoGenotoxicology: the DNA 
damaging potential of engineered nanomaterials. Biomaterials, 30, 3891-3914. 
Sikic, B.I., Rozencweig, M., and Carter, S.K. (1985). Bleomycin chemotherapy 
(Orlando: Academic Press). 
Skog, K. (1993). Cooking procedures and food mutagens: a literature review. 
Food Chem Toxicol 31, 655-675. 
Strimb,  Kyle, and Jorge A Tavel. 'What Are Biomarkers?'. Current Opinion in 
HIV and AIDS 5.6 (2010): 463-466. Web  
Sugasawa, K. (2010). Regulation of damage recognition in mammalian global 
genomic nucleotide excision repair. Mutation Research/Fundamental and 
Molecular Mechanisms of Mutagenesis 685, 29-37. 
182 
 
Sugimura, T. (1997). Overview of carcinogenic heterocyclic amines. Mutat Res 
376, 211-219. 
Sumner, J. and Gralen, N. (1938). THE MOLECULAR WEIGHT OF 
CRYSTALLINE CATALASE. Science, 87(2256), pp.284-284. 
Sun, B., Ross, S., Joseph Trask, O., Carmichael, P., Dent, M., White, A., 
Andersen, M. and Clewell, R. (2013). Assessing dose-dependent differences in 
DNA-damage, p53 response and genotoxicity for quercetin and curcumin. 
Toxicology in Vitro, 27(6), pp.1877-1887. 
Sun, N.-F., LIU, Z.-A., Huang, W.-B., Tian, A.-L. & HU, S.-Y. 2014. The 
research of nanoparticles as gene vector for tumor gene therapy. Critical 
Reviews in Oncology/Hematology, 89, 352-357. 
Surrallés, J., Carbonell, E., Marcos, R., Degrassi, F., Antoccia, A. & Tanzarella, 
C. 1992. A collaborative study on the improvement of the micronucleus test in 
cultured human lymphocytes. Mutagenesis, 7, 407-410. 
Svilar, D., et al. (2011). "Base excision repair and lesion-dependent 
subpathways for repair of oxidative DNA damage." Antioxidants & Redox 
Signaling 14(12): 2491-2507.  
Tanigawa, S., FujiI, M. and Hou, D. (2008). Stabilization of p53 Is Involved in 
Quercetin-Induced Cell Cycle Arrest and Apoptosis in HepG2 Cells. Bioscience, 
Biotechnology, and Biochemistry, 72(3), pp.797-804. 
Thomas, P., Umegaki, K. & Fenech, M. 2003. Nucleoplasmic bridges are a 
sensitive measure of chromosome rearrangement in the cytokinesis-block 
micronucleus assay. Mutagenesis, 18, 187-194. 
Tice, R.R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, 
H., Miyamae, Y., Rojas, E., Ryu, J.C., and Sasaki, Y.F. (2000). Single cell 
gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. 
Environmental and Molecular Mutagenesis 35, 206-221. 
Trouiller, B., Reliene, R., Westbrook, A., Solaimani, P. & Schiestl, R. H. 2009. 
Titanium dioxide nanoparticles induce DNA damage and genetic instability in 
vivo in mice. Cancer research, 69, 10.1158/0008-5472.CAN-09-2496. 
Truglio, J.J., Croteau, D.L., Van Houten, B., and Kisker, C. (2006). Prokaryotic 
nucleotide excision repair: the UvrABC system. Chem Rev 106, 233-252 
Tsujimoto, Y. (1998). Role of Bcl-2 family proteins in apoptosis: apoptosomes or 
mitochondria?. Genes to Cells, 3(11), pp.697-707 
Ulrich, C.M., Bigler, J., and Potter, J.D. (2006). Non-steroidal anti-inflammatory 
drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev 
Cancer 6, 130-140. 
Ushiyama, H., Wakabayashi, K., Hirose, M., Itoh, H., Sugimura, T., and Nagao, 
M. (1991). Presence of carcinogenic heterocyclic amines in urine of healthy 
183 
 
volunteers eating normal diet, but not of inpatients receiving parenteral 
alimentation. Carcinogenesis 12, 1417-1422. 
Valavanidis, Athanasios et al. "Pulmonary Oxidative Stress, Inflammation And 
Cancer: Respirable Particulate Matter, Fibrous Dusts And Ozone As Major 
Causes Of Lung Carcinogenesis Through Reactive Oxygen Species 
Mechanisms". International Journal of Environmental Research and Public 
Health 10.9 (2013): 3886-3907. Web. 
Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., and Telser, J. 
(2007). Free radicals and antioxidants in normal physiological functions and 
human disease. The international journal of biochemistry & cell biology 39, 44-
84. 
Van Duyn , M. and Pivonka , E. (2000). Overview of the Health Benefits of Fruit 
and Vegetable Consumption for the Dietetics Professional. Journal of the 
American Dietetic Association, 100(12), pp.1511-1521.   
Verywell Health. (2018). What Are Lymphocytes?. [online] Available at: 
https://www.verywellhealth.com/what-are-lymphocytes-4140826 [Accessed 19 
Dec. 2018]. 
Vitaglione, P. and Fogliano, V. (2004). Use of antioxidants to minimize the 
human health risk associated with mutagenic/carcinogenic heterocyclic amines 
in food. Journal of Chromatography B, 802(1), pp.189-199. 
Wach, A., Pyrzyńska, K. & Biesaga, M. 2007. Quercetin content in some food 
and herbal samples. Food Chemistry, 100, 699-704. 
Wakabayashi, K., Nagao, M., Esumi, H., and Sugimura, T. (1992). Food-
derivedmutagens and carcinogens. Cancer Res 52, 2092s-2098s. 
 
Walter, C. A., Intano, G. W., Mccarrey, J. R., Mcmahan, C. A. & Walter, R. B. 
1998. Mutation frequency declines during spermatogenesis in young mice but 
increases in old mice. Proceedings of the National Academy of Sciences, 95, 
10015-10019. 
Wasson, G.R., McKelvey-Martin, V.J., and Downes, C.S. (2008). The use of the 
comet assay in the study of human nutrition and cancer. Mutagenesis 23, 153-
162. 
Westermeier, R., and Marouga, R. (2005). Protein detection methods in 
proteomics research. Bioscience reports 25, 19-32 
WHO 2014 global tuberculosis report—further to go. The Lancet Global Health, 
3, e10-e12. 
Wieacker P, e. (2019). Assignment of the gene coding for human catalase to 
the short arm of chromosome11-PubMed-
NCBI.[online]Ncbi.nlm.nih.gov.Available at: 
https://www.ncbi.nlm.nih.gov/pubmed/6967289 [Accessed 10 Jan. 2019]. 
184 
 
Wilson, A., Shehadeh, L.A., Yu, H., and Webster, K.A. (2010). Age-related 
molecular genetic changes of murine bone marrow mesenchymal stem cells. 
BMC Genomics 11, 229. 
Winn, R. N., NORRIS, M. B., BRAYER, K. J., TORRES, C. & MULLER, S. L. 
2000. Detection of mutations in transgenic fish carrying a bacteriophage λcII 
transgene target. Proceedings of the National Academy of Sciences, 97, 12655-
12660. 
Wong, M.L., and Medrano, J.F. (2005). Real-time PCR for mRNA quantitation. 
Biotechniques 39, 75-85. 
World Health Organization (2000) Laboratory Manual for Examination of Human 
Semen and Sperm–Cervical Mucus Interaction. Cambridge University Press, 
Cambridge, UK. World Health Organization (2000) Laboratory Manual for 
Examination of Human Semen and Sperm–Cervical Mucus Interaction. 
Cambridge University Press, Cambridge, UK. 
World Health Organization. (2001). [Laboratory manual of the WHO for the 
examination of human semen and sperm-cervical mucus interaction]. Ann Ist 
Super Sanita 37, I-XII, 1-123. 
Wu, J.H., and Jones, N.J. (2012). Assessment of DNA interstrand crosslinks 
using the modified alkaline comet assay. Genetic Toxicology: Principles and 
Methods, 165-181. 
Wu, R.W., Tucker, J.D., Sorensen, K.J., Thompson, L.H., and Felton, J.S. 
(1997). Differential effect of acetyltransferase expression on the genotoxicity of 
heterocyclic amines in CHO cells. Mutat Res 390, 93-103. 
Xiong, T., Chen, X., Wei, H. and Xiao, H. (2015). Influence of PJ34 on the 
genotoxicity induced by melphalan in human multiple myeloma cells. Archives 
of Medical Science, 2, pp.267-273. 
Yamashita, M., Wakabayashi, K., Nagao, M., Sato, S., Yamaizumi, Z., 
Takahashi, M.,Kinae, N., Tomita, i., and Sugimura, T. (1986). Detection of 2-
amino-3-methylimidazo[4,5f]quinoline in cigarette smok condensate. Jpn J pn J 
Cancer Res 77, 419-422. 
Yang, J. (2005). Inhibition of lung cancer cell growth by quercetin glucuronides 
via g2/m arrest and induction of apoptosis. Drug Metabolism and Disposition, 
34(2), pp.296-304. 
 
Youle, R.and Strasser, A. (2008). The BCL-2 protein family: opposing activities 
that mediate cell death. Nature Reviews Molecular Cell Biology, 9(1), pp.47-59 
Yu, K.-D., Chen, A.-X., Yang, C., Qiu, L.-X., Fan, L., Xu, W.-H., and Shao, Z.-M. 
(2010). Current evidence on the relationship between polymorphisms in the 
COX-2 gene and breast cancer risk: a meta-analysis. Breast cancer research 
and treatment 122, 251-257. 
185 
 
Yu, Y.-H., Liao, C.-C., HSU, W.-H., CHEN, H.-J., LIAO, W.-C., MUO, C.-H., 
SUNG, F.-C. & CHEN, C.-Y. 2011. Increased lung cancer risk among patients 
with pulmonary tuberculosis: a population cohort study. Journal of Thoracic 
Oncology, 6, 32-37. 
Zhang, L., GU, F., Chan, J., Wang, A., Langer, R. & Farokhzad, O. 2008. 
Nanoparticles in medicine: therapeutic applications and developments. Clinical 
pharmacology and therapeutics, 83, 761-769. 
Zhang, L., Gu, F.X., Chan, J.M., Wang, A.Z., Langer, R.S., and Farokhzad, 
O.C. (2007) 
Zhang, Y.-Y., and Gu, K.-S. (2013). DNA repair capacity in peripheral blood 
lymphocytes predicts efficacy of platinum-based chemotherapy in patients with 
gastric cancer. Asian Pacific Journal of Cancer Prevention 14, 5507-5512. 
Zumla, A., George, A., Sharma, V., Herbert, R. H. N., OF Ilton, B. M., Oxley, A. 

















































Appenix I Blood consent form 
 
 
Consent form for patients with TB and healthy individuals 
 
Title of Project: The genotoxic effect in respiratory disease of Tuberculosis (TB) 
patients compared to healthy controls in diploid lymphocyte and haploid sperm cells, 
after treated with heterocyclic amines and quercetin bulk and nano form. 
 
Reviewed by Leeds Central Research Ethics Committee 
(REC) (REC reference number: 12/YH/0464) 
 
1. I confirm that I have read and understand the information 
sheet (version 3, 19- 06-09) for the above study. I have had 
the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, 
without my medical care or legal rights beingaffected. 
 
3. I understand that relevant sections of my medical notes and 
data collected during the study may be looked at by 
individuals from the NHS Trust or the University of 
Bradford, where it is relevant to my taking part in this 
research. I give permission for these individuals to have 
access to my records. 
 
4. I agree that the sample I have given, and the information 
gathered about me can be stored at the University of 
Bradford, as described in the attached information sheet. 
 
5. I agree to take part in the above study. 
 
Name of Patient/donner                         Date                       Signature 
 
 




    Signature 
 





Appendix II Invitation to the research study 
 
 
Participant Information Sheet for patient and healthy volunteer  
Reviewed by Leeds Central Research Ethics Committee (REC)  
(REC reference number: 12/YH/0464) 
 
Invitation to the research study 
 
We would like to invite you to take part in a research study. Before you 
decide you need to understand why the research is being done and what 
it would involve for you. Please take time to read the following 
information carefully. Talk to others about the study if you wish to and 
you will be allowed around 24hours to consider this. 
(Part 1 tells you the purpose of this study and what will happen 
to you if    you take part. 
Part 2 gives you more detailed information about the conduct 
of the study).  
Ask us if there is anything that is not clear or if you would like 





What is the purpose of the study? 
In this study white blood cells will be treated in a test tube with very small 
chemical particles to determine if patients with cancerous and 
inflammatory diseases are more at risk after exposure. A blood sample of 
around 6-8 teaspoons (40 ml) will be taken. Samples will be stored only for 
the duration of the study and used for studies of a similar nature or to 
check original responses. The research is for a PhD programmed 
involving post-doctoral fellows and PhDs. 
 
Why have I been invited? 
You have invited because you have disease states and we should like to 
determine if these small chemical particles could be more harmful to you 
than to people without diseases state than those without such disease. 
Do I have to take part? 
It is up to you to decide. We shall outline the study and go through this 
information sheet, which we shall then give to you. We shall ask you to sign a 
consent form to show you have agreed to take part. You are free to withdraw 
at any time, without giving a reason.  This would not affect the standard of 







What will happen to me if I take part? 
A single blood sample will be taken, and you will not need to attend the Clinic 
again for this research study. A brief questionnaire will need to be completed 
by the researchers. 
 
We shall need to access your notes so that they can be linked in an 
anonymous way to your clinical data which can be tied up with the research 
results. Everyone will be given a coded study number. 
 
The data obtained will only be available to the research team and will not be 
returned to you. Responses will be compared only on group basis i.e. 
collective responses from patients with chest diseases compared to collective 
responses from people without chest diseases. Results could be published in 
the form of scientific papers. The work will benefit the medical and scientific 
community at large but will not be of direct benefit to you as an individual. If, 
however, you would like more information, Dr BK Jacobs will be prepared to 
talk to you individually about study results. 
 
People who cannot take part in the study. 
People who are not well enough to take part will be excluded (e.g. those with 
anaemia) If you have any further questions, you could contact the research 
team:  
Professor Diana Anderson, Established Chair in Biomedical Sciences, BSc MSc 
PhD DipEd FSB, FATS, FRC Path, FIFST, FBTS, FRSM, FHEA, FRSC, 
University of Bradford Richmond Road, Bradford, West Yorkshire BD7 1DP, 
United Kingdom and Honorary Research Consultant to Bradford NHS Trust. 
Email: d.anderson1@bradford.ac.uk. 
 
Dr Mojgan Najafzadeh. Division of Medical Sciences, University of Bradford, 














RECREATIONAL DRUG USE 
 








CANCER   
Inflammation diseases  
Precancerous state  
Other medical conditions please list  
Family history of cancer and inflammatory 
disease 
 
















Appendix IV Table 1 Brief information about the blood samples collected from 
healthy donors. 
 
No Sample code Ag
e 
Ethnicity Gender Smoking history Family 
history 
1 KE27.8.15 47 Asian Male Smoker - 
2 MS 27.8.15 42 Arab Male Smoker - 
3 HS 27.8.15 55 Brattain Male Non-smoker - 
4 MA17.6.2015 45 EU Male Smoker - 
5 DN25.8.15 47 Arab Male Non-smoker - 
6 MS23615 35 Asian Male Non-smoker - 
7 M 23.3.15 56 Arab Male Non-smoker - 
8 A 10.3.15 37 Asian Male Non-smoker - 
9 CK12.5.15 26 Asian Male Non-smoker - 
10 1PA0 27.01.2016 41 Asian Male Non-smoker - 
11 1PA18.3.2016 40 Arab Male Smoker - 
12 1PA2 26.4.2016 34 EU Male Smoker - 
13 1PA3 11.72016 42 Asian Male Smoker - 
14 1PA4 17.8.2016 34 Arab Male Non-smoker - 
15 1PA5 06.9.2016 40 Asian Male Non-smoker - 
16 1PA6 02.9.2016 38 Asian Male Smoker - 
17 1PA7 15.9.2016 32 English Male Smoker - 
18 1PA8 21.9.2016 36 Arab Male Smoker - 
19 1PA9 21.9.2016 33 Arab Male Non-smoker - 
20 1PA10 21.9.2016 48 Arab Male Non-smoker - 
 
Appendix V Table 2 Brief information about the blood samples collected from 
patient with TB used in the Micronucleus assay. 
No Sample 
code 




1 RAE0816990 56 Bratish Male Non-smoker -- 
2 9576 49 Bratish Male Non-smoker -- 










Appendix VI Table 3 Brief information about the blood samples collected from 








1 TB1.27.4.15 55 Asian Male Non-smoking --- 
2 TB2.27.4.15 48 British Male smoking --- 
3 TB 1.6.15 39 Asian Male Non-smoking --- 
4 TB 27.7.15 41 Asian Male Non-smoking --- 
5 TB 3.8.2015 57 Asian Male smoking --- 
6 TB2 27.7.15 58 Arab Male Non-smoking --- 
7 TB2 27.4.15 49 EU Male Non-smoking --- 
8 TB 3.5.15 52 Asian Male Non-smoking --- 
9 TB 6.10.15 55 Asian Male smoking --- 
10 TB1 26.1.15 58 Asian Male Non-smoking --- 
 
Appendix VII Table 4 Brief information about the blood samples collected from 








1 TB2.23.3.15 55 Asian Male Non-smoking --- 
2 TB3.9.3.15 48 British Male Smoking --- 
3 TB1 3.2.15 39 Asian Male Non-smoking --- 
4 TB2 3.02.15 41 Asian Male Non-smoking --- 
5 TB1 3.2.15 57 Asian Male Smoking --- 
6 TB 27.7.15 58 Arab Male Non-smoking --- 
7 TB  27.4.15 49 EU Male Non-smoking --- 
8 TB2 24.1.15  52 Asian Male Non-smoking --- 
9 TB3 6.10.15 55 Asian Male Smoking --- 
10 TB2 26.1.15 58 Asian Male Non-smoking --- 
 
Appendix VIII Table 5 Brief information about the blood samples collected from 
patient with TB used in the QPCR and Western blot. 
 




1 MRN0161282 41 Asian Male Non-smokikg --- 
2 1453780 38 British Female Non-smokikg --- 
3 1385793 28 Asian Female Non-smokikg --- 
4 1242606 36 British Female Non-smokikg --- 





Appendix IX Consent form was used to collect sperm form healthy individuals 
donated sperm samples. 
 
 
Sperm consent form 
University of Bradford 
Department of Biomedical Sciences 
Richmond Road 
Bradford, BD7 IDP 
United Kingdom 
Project Title: The genotoxic effect in respiratory disease of Tuberculosis (TB) 
patients compared to healthy controls in diploid lymphocyte and haploid 







1. I hereby authorise Prof. D. Anderson or her assistants, Dr. A. 
Baumgartner and Dr. E. Cemeli, to receive semen samples 
from me to be utilised for genotoxic in vitro experimental 
purposes (but NOT for in vitro fertilisation-type procedures or 
reproductive cloning). 
2. I understand that the procedure for obtaining samples is 
standard and not harmful. 
3. I understand that there is no obvious risk associated with the 
procedure. 




5. I understand that I will not be affected in any way by my 
decision to participate or not. 
6. I understand that the purpose of performing these procedures 
is to obtain semen for biomedical and biochemical tests 
outside the human body. Specifically, the material will be 
used for the following procedures: 
 to develop various new methods for detecting defective 
sperm,  to evaluate food mutagens and in future other 
chemicals acting 'in vitro' on the sperm DNA/chromatin  to 
become part of an archive of frozen and coded semen 
samples. 
I understand that semen is stored and frozen. However, the 
sperm will never be used for fertilisation or reproductive 
cloning experiments. 
7. I understand that this study will result in no direct benefit to 
me but it may contribute to the understanding of the possible 
effects of various chemicals for producing DNA damage in 
sperm. These findings may therefore be of some benefit to all 
of us and our children in the future. 
8. I understand that Prof. D. Anderson or her assistants will 
encode the sample to protect my identity and will not disclose 
my name to other individuals. I will be assigned a random 
donor code that will be used for all of my samples. Only the 
above person(s) will know that I am a participant in this study 
and what my code is. Personal data will be kept in 
accordance with data protection laws. 
 Informal consent sperm donation.doc 1 1 6/10/2006 
9. I understand that Prof. D. Anderson or her assistants will 
answer any inquiries I may have at any time concerning the 
procedures and/or investigation. Her address and phone 
number are indicated in item 14 below. 
10. I understand that Prof. D. Anderson or her assistants cannot 
disclose any possible findings to me concerning my own 
sample. 
 10. Any publication arising from this study will be made without specific 




1 1. I recognise that my participation in this experiment is entirely 
voluntary and I may refuse to participate or may withdraw at 
any time without jeopardy. Owing to the scientific nature of 
the study, the investigator may at his/her absolute discretion 
terminate the procedures and/or investigations at any time. 
12. I acknowledge that, if I wish, I can keep the copy of the 
consent form, which is provided. 
13. Prof. D. Anderson is responsible for the conduct of the 
research in which I am to participate. This research is 
sponsored by the European Union (NewGeneris contract no. 
016320-2). Laboratory analyses will be done in the University 
of Bradford, Division of Biomedical Sciences, Bradford, UK. 
14. I understand that if I have any complaints or concerns about 
the procedures, I may address them to Prof. D. Anderson or 
her assistant(s), in person, by telephone, or in writing. Prof. 
D. Anderson can be reached by phone at 01274-23-3569, by 
Fax at 01274-30-9742, by email at 
d.andersonl@bradford.ac.uk or by mail at the University of 
Bradford, Devision of Biomedical Sciences, Richmond Road, 
Bradford, BD7 IDP, UK. 




Appendix X Reproductive health questionnaire was used to collect sperm form 
healthy individuals. 
Reproductive Health Questionnaire 
Donor ID 
 
START HERE Tick the boxes ZI of your response or fill in the blank 
 





4. Which of the following best describes your ethnic background? Asian 
 Indian, C] Pakistani, Chinese 
Black 
 Caribbean, Cl African, Afroamerican 
Caucasian 
 West-european, East-european, 
 Mediterranean, Cl American 
O Other or mixed ethnic background 
Please specify: 
 
2. What is your weight? kg / lbs 
3. What is your height? cm / in 









You can provide further 
details about your ethnic 
background if you wish 
 
 
Are they healthy?  Yes 
No 
6. Have you ever had difficulties fathering a 
child?  Yes 
 No 




7. How would you describe your sexual activity in the  more than 5 
times per week last three months?  3-5 times per week 
  1-3 times per week 
 Cl less than once per week 
 
1  
8. What is your current or most recent 
job title? 
9. How long have you been working in 
this job? 
1 0. Do you currently smoke, are you an 
ex-smoker, or have you ever smoked 
cigarettes, cigars or pipes regularly? 
If current smoker: 
How many cigarettes did you smoke? 
How many years have you been 
smoking? 
If ex-smoker: 
When was the last time you 
smoked? 
How many cigarettes did you 
smoke? 
1 1. On average, how many glasses 
of wine, pints of beer or mixed 




drinks with hard alcohol do you drink each 
week? 
12. On average, how many cups of 
caffeinated coffee, tea or beverage do 
you drink each day? 
13. Do you take multivitamins or vitamin 







 Yes, current smoker  No, ex-
smoker 
 No, never smoked 
cigarettes per day (in last 3 
months) years 
 
 months or years ago 
 
cigarettes per day 
 
drinks per week (in last 3 months) 
 
cups (cans, drinks) per day 
(in last 3 months) 
C] Yes 
 No 
Cl Vitamin C 
Cl Vitamin E 




14. During the last year have you had any notable exposure to.  Yes No 
Maybe 





drugs like marijuana, heroin,  






















What medication or treatments did you take for 
the illness (drug + dose)? 
 
 
17. Have you had any fever in the past 3 
months? 
If yes: 





 How high was your temperature? day OC month year 
15. Do you have any chronic health problem(s)? 
If yes: 





16. Have you had any other illness in the past  Yes 
 three months? 
If yes: 






18. Have you ever had any of the following procedures or conditions? Yes No 
a. Vasectomy 
 If yes, when?  
 month year 
b. Undescended testicle If yes, when treated?  
 month year 
c. Varicocele (varicose veins of the scrotum) 
 If yes, when treated?  
 month year 
d. Other urinary or genital conditions Specify: 
 
 When treated?  
 month year 
 e. Cancer 
Specify type of cancer: 
 
Year of diagnosis: 
 
1  
f. Chemotherapy for cancer 
Start of therapy: End of therapy: 
 
g. Radiation therapy for cancer 





End of therapy:  
h. X-ray diagnosis during the last year What part of the body? 
 
How many films were taken? 
 
 When?  
 month year 
 
19. We would like to ask you about your level of stress — at present, how would you 
rate your satisfaction with.  
very unsatisfied <<--OK-->> very satisfied 
 . yourself? 10 20 30 40 50 
 . your family? 10 20 30 40 50 
 . your friends? 10 20 30 40 50 
 . where you live? 10 20 30 40 50 
 . your job? 10 20 30 40 50 
 (other:)  10 20 30 40 50 
20. Regarding your sample, how long was your 
sexual abstinence? days 
i. Date (questionnaire completed) day month year 
 






Appendix XI date sheet analysis was used to investigate sperm form healthy 
individuals. 
 
Semen Analysis Protocol and Data Sheet 
Prerequisites before semen examination 
Collect samples after a minimum of 3 days of sexual abstinence. 
Label the container with date and time of the collection and the anonymous donor code. 
Avoid extreme temperatures (<20, >400 C) during any transport of the semen. 
The donor's questionnaire has to be finished. 
Let the semen liquify for 1 hour at room temperature. Mix the semen thoroughly in the 
container. 
Finish the semen examination within 2 hours after collection.( Please attach anv raw data 
sheets to this form.) 
Donor Code: Date: 
 
Abstinence: days 
Time of Sampling: 
 
Time of Analysis: 
  
Tick the boxes with the answer or fill in the result:  
A) General Impression normal (grey-opalizing, homogeneous) abnormal (brown when red blood cells are present,etc.) 
B) Volume ml 
C) Consistence (viscosity) normal abnormal 
Submerge a glass rod into the semen and pull it slowly out. 
If a thread could be drawn longer than 2 cm then note 
it as abnormal. 
C) pH  
Put a drop of semen onto a pH-paper and wait for 30 
seconds. The normal pH-range should be between 




D) Motility % fast-progressive Number of cells evaluated:  
% slow-progressive 
% non-progressive, but tail movement 
% immobile, no tail movement 
Characterise on 2 different slides 100 sperm cells (slide on 
a 37 o c slide warmer, 10 pl semen covered with a 
22x22 mm cover-slip, let it sit for 1 minute after 
cover-slipping, standardised depth of 20 pm, 
magnification of 200-600x). Calculate the mean. If the 
results differ by more than 10 %, characterise a third 
slide. 
E) Morphology Number of cells evaluated: 
% normal 
% abnormal 
Normal sperm: oval head with a acrosomal region. No head, 
midpiece, or tail defects. 
Cytoplasmic drops smaller than a 1/3 of a normal head. 
Characterise on 2 different slides 100 sperm cells 
each. Calculate the mean. If the results differ by more 
than 10 %, characterize a third slide. 
F) Sperm Concentration  million per ml 
Dilute 50 pi semen (1:20) in 950 pi NaHCOdformalin 
(5g/100ml NaHC03, Iml 35% v/v formalin). Mix well, 
put a drop onto each grid of a cell-counting chamber, 
cover-slip it. Let it sit for 5 min. Use phase-contrast. 
On both grids, count only normal sperm with tails in 
two of the four outer fields (each consisting of 4x4 
squares). Calculate the sperm concentration. 
 Neubauer-lmproved chamber: = n • x DF = n • 
5000mrl • 20 = n • 100,000mrl 
= sperm conc. [106mrl ], n = mean of the two scored grids, x 
= 5000ml-l - extrapolation factor to reach vol. of 1 ml, 
DF = 20 - dilution factor for a 1:20 dilution) 
[an 4x4 outer field has an area of Imm2 with a depth of 





Appendix XII Table Brief information about the sperm samples collected from 
healthy individuals 
No Sample code Age Ethnicity Smoking history Family 
history 
1 AG 03042016 42 Arab Non-smoking No 
2 M210052015 38 Asian Non-smoking No 
3 HITH24102015 41 Arab Non-smoking No 
4 MH217112015 35 Slovakian Non-smoking No 
5 EN30112015 32 Turkish Non-smoking No 
6 M428082015 47 Asian Non-smoking No 
7 GA28112016 48 Polish Non-smoking No 
8 M102212205 43 Arab Non-smoking No 
9 EN30112015 33 Asian Non-smoking No 
10 M325082015 42 Asian Non-smoking No 
11 MM01122015 46 Polish Non-smoking No 
12 AM1512206 28 Spanish Non-smoking No 
13 ME08122015 35 Asian Non-smoking No 
14 M1022122015 42 Arab Non-smoking No 
15 EA16012016 46 Asian Non-smoking No 
16 EABDUL18116 37 Arab Non-smoking No 
17 AG23012016 29 Asian Non-smoking No 
18 FB1222016 36 Asian Non-smoking No 
19 MB1822016 41 British Non-smoking No 
20 AR25012016 27 Polish Non-smoking No 
 
 
 
 
 
